 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0004003	ATP-dependent DNA helicase activity	1	2.705496e-3	1.000000e+0	1.000000e+0	3.696180e+2	2.705496e-3	1	2.705496e-3	1.000000e+0	1	3.765745e-3	1.000000e+0	1.000000e+0	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	NBN
GO Molecular Function	GO:0003678	DNA helicase activity	2	3.301940e-3	1.000000e+0	1.000000e+0	3.028523e+2	3.301940e-3	1	3.301940e-3	1.000000e+0	2	5.093135e-3	1.000000e+0	1.000000e+0	1.960978e+2	5.099496e-3	1	46	5.000000e-1	2.173913e-2	unnamed	NBN
GO Molecular Function	GO:0003684	damaged DNA binding	3	3.594888e-3	1.000000e+0	1.000000e+0	2.781728e+2	3.594888e-3	1	3.594888e-3	1.000000e+0	3	5.535402e-3	1.000000e+0	1.000000e+0	1.804100e+2	5.542930e-3	1	50	5.000000e-1	2.000000e-2	unnamed	NBN
GO Molecular Function	GO:0008094	DNA-dependent ATPase activity	4	6.777082e-3	1.000000e+0	1.000000e+0	1.475561e+2	6.777082e-3	1	6.777082e-3	1.000000e+0	4	7.966112e-3	1.000000e+0	1.000000e+0	1.252847e+2	7.981819e-3	1	72	5.000000e-1	1.388889e-2	unnamed	NBN
GO Molecular Function	GO:0047485	protein N-terminus binding	5	8.519548e-3	1.000000e+0	1.000000e+0	1.173771e+2	8.519548e-3	1	8.519548e-3	1.000000e+0	5	1.006297e-2	1.000000e+0	1.000000e+0	9.912637e+1	1.008813e-2	1	91	5.000000e-1	1.098901e-2	unnamed	NBN
GO Molecular Function	GO:0008026	ATP-dependent helicase activity	6	8.890478e-3	1.000000e+0	1.000000e+0	1.124799e+2	8.890478e-3	1	8.890478e-3	1.000000e+0	6	1.226779e-2	1.000000e+0	1.000000e+0	8.126577e+1	1.230530e-2	1	111	5.000000e-1	9.009009e-3	unnamed	NBN
GO Molecular Function	GO:0004386	helicase activity	7	1.261902e-2	1.000000e+0	1.000000e+0	7.924543e+1	1.261902e-2	1	1.261902e-2	1.000000e+0	7	1.656012e-2	1.000000e+0	1.000000e+0	6.013667e+1	1.662879e-2	1	150	5.000000e-1	6.666667e-3	unnamed	NBN
GO Molecular Function	GO:0042623	ATPase activity, coupled	8	2.500268e-2	1.000000e+0	1.000000e+0	3.999572e+1	2.500268e-2	1	2.500268e-2	1.000000e+0	8	3.145511e-2	1.000000e+0	1.000000e+0	3.154021e+1	3.170556e-2	1	286	5.000000e-1	3.496503e-3	unnamed	NBN
GO Molecular Function	GO:0016887	ATPase activity	9	3.096702e-2	1.000000e+0	1.000000e+0	3.229242e+1	3.096702e-2	1	3.096702e-2	1.000000e+0	9	3.918602e-2	1.000000e+0	1.000000e+0	2.526751e+1	3.957652e-2	1	357	5.000000e-1	2.801120e-3	unnamed	NBN
GO Molecular Function	GO:0008134	transcription factor binding	10	5.376409e-2	1.000000e+0	1.000000e+0	1.859977e+1	5.376409e-2	1	5.376409e-2	1.000000e+0	10	5.023817e-2	1.000000e+0	1.000000e+0	1.965251e+1	5.088410e-2	1	459	5.000000e-1	2.178649e-3	unnamed	NBN
GO Molecular Function	GO:0017111	nucleoside-triphosphatase activity	11	6.384690e-2	1.000000e+0	1.000000e+0	1.566247e+1	6.384690e-2	1	6.384690e-2	1.000000e+0	11	8.258634e-2	1.000000e+0	1.000000e+0	1.185348e+1	8.436339e-2	1	761	5.000000e-1	1.314060e-3	unnamed	NBN
GO Molecular Function	GO:0016462	pyrophosphatase activity	12	6.707668e-2	1.000000e+0	1.000000e+0	1.490831e+1	6.707668e-2	1	6.707668e-2	1.000000e+0	12	8.661694e-2	1.000000e+0	1.000000e+0	1.128974e+1	8.857602e-2	1	799	5.000000e-1	1.251564e-3	unnamed	NBN
GO Molecular Function	GO:0016818	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	13	6.729645e-2	1.000000e+0	1.000000e+0	1.485962e+1	6.729645e-2	1	6.729645e-2	1.000000e+0	13	8.693477e-2	1.000000e+0	1.000000e+0	1.124751e+1	8.890860e-2	1	802	5.000000e-1	1.246883e-3	unnamed	NBN
GO Molecular Function	GO:0016817	hydrolase activity, acting on acid anhydrides	14	6.743909e-2	1.000000e+0	1.000000e+0	1.482820e+1	6.743909e-2	1	6.743909e-2	1.000000e+0	14	8.746436e-2	1.000000e+0	1.000000e+0	1.117782e+1	8.946289e-2	1	807	5.000000e-1	1.239157e-3	unnamed	NBN
GO Molecular Function	GO:0016787	hydrolase activity	15	1.965374e-1	1.000000e+0	1.000000e+0	5.088091e+0	1.965374e-1	1	1.965374e-1	1.000000e+0	16	2.486583e-1	1.000000e+0	1.000000e+0	3.753849e+0	2.663932e-1	1	2403	5.000000e-1	4.161465e-4	unnamed	NBN
GO Molecular Function	GO:0003677	DNA binding	16	2.170876e-1	1.000000e+0	1.000000e+0	4.606435e+0	2.170876e-1	1	2.170876e-1	1.000000e+0	15	2.465427e-1	1.000000e+0	1.000000e+0	3.788534e+0	2.639543e-1	1	2381	5.000000e-1	4.199916e-4	unnamed	NBN
GO Molecular Function	GO:0003676	nucleic acid binding	17	2.841930e-1	1.000000e+0	1.000000e+0	3.518736e+0	2.841930e-1	1	2.841930e-1	1.000000e+0	17	3.411408e-1	1.000000e+0	1.000000e+0	2.655431e+0	3.765867e-1	1	3397	5.000000e-1	2.943774e-4	unnamed	NBN
GO Molecular Function	GO:1901363	heterocyclic compound binding	18	4.273925e-1	1.000000e+0	1.000000e+0	2.339769e+0	4.273925e-1	1	4.273925e-1	1.000000e+0	18	5.012582e-1	1.000000e+0	1.000000e+0	1.701981e+0	5.875506e-1	1	5300	5.000000e-1	1.886792e-4	unnamed	NBN
GO Molecular Function	GO:0097159	organic cyclic compound binding	19	4.323803e-1	1.000000e+0	1.000000e+0	2.312779e+0	4.323803e-1	1	4.323803e-1	1.000000e+0	19	5.069571e-1	1.000000e+0	1.000000e+0	1.678857e+0	5.956433e-1	1	5373	5.000000e-1	1.861158e-4	unnamed	NBN
GO Molecular Function	GO:0003824	catalytic activity	20	4.361959e-1	1.000000e+0	1.000000e+0	2.292548e+0	4.361959e-1	1	4.361959e-1	1.000000e+0	20	5.163312e-1	1.000000e+0	1.000000e+0	1.641882e+0	6.090571e-1	1	5494	5.000000e-1	1.820167e-4	unnamed	NBN
GO Molecular Function	GO:0005515	protein binding	21	6.181781e-1	1.000000e+0	1.000000e+0	1.617657e+0	6.181781e-1	1	6.181781e-1	1.000000e+0	21	6.900633e-1	1.000000e+0	1.000000e+0	1.127985e+0	8.865362e-1	1	7997	5.000000e-1	1.250469e-4	unnamed	NBN
GO Molecular Function	GO:0005488	binding	22	8.171102e-1	1.000000e+0	1.000000e+0	1.223825e+0	8.171102e-1	1	8.171102e-1	1.000000e+0	22	8.942547e-1	1.000000e+0	1.000000e+0	7.409644e-1	1.349593e+0	1	12174	5.000000e-1	8.214227e-5	unnamed	NBN
GO Biological Process	GO:0030174	regulation of DNA-dependent DNA replication initiation	1	1.490507e-4	1.000000e+0	1.000000e+0	6.709128e+3	1.490507e-4	1	1.490507e-4	1.000000e+0	4	6.650594e-4	1.000000e+0	1.000000e+0	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	NBN
GO Biological Process	GO:0007095	mitotic G2 DNA damage checkpoint	2	1.202104e-3	1.000000e+0	1.000000e+0	8.318746e+2	1.202104e-3	1	1.202104e-3	1.000000e+0	5	8.866967e-4	1.000000e+0	1.000000e+0	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	NBN
GO Biological Process	GO:0001832	blastocyst growth	3	1.243187e-3	1.000000e+0	1.000000e+0	8.043845e+2	1.243187e-3	1	1.243187e-3	1.000000e+0	7	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	NBN
GO Biological Process	GO:0045190	isotype switching	4	1.396641e-3	1.000000e+0	1.000000e+0	7.160035e+2	1.396641e-3	1	1.396641e-3	1.000000e+0	7	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	NBN
GO Biological Process	GO:0002381	immunoglobulin production involved in immunoglobulin mediated immune response	5	1.596204e-3	1.000000e+0	1.000000e+0	6.264863e+2	1.596204e-3	1	1.596204e-3	1.000000e+0	9	2.437470e-3	1.000000e+0	1.000000e+0	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	NBN
GO Biological Process	GO:0016447	somatic recombination of immunoglobulin gene segments	6	2.138386e-3	1.000000e+0	1.000000e+0	4.676423e+2	2.138386e-3	1	2.138386e-3	1.000000e+0	10	2.769621e-3	1.000000e+0	1.000000e+0	3.608200e+2	2.771465e-3	1	25	5.000000e-1	4.000000e-2	unnamed	NBN
GO Biological Process	GO:0031954	positive regulation of protein autophosphorylation	7	2.336806e-3	1.000000e+0	1.000000e+0	4.279345e+2	2.336806e-3	1	2.336806e-3	1.000000e+0	6	1.551461e-3	1.000000e+0	1.000000e+0	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	NBN
GO Biological Process	GO:0032508	DNA duplex unwinding	8	2.401524e-3	1.000000e+0	1.000000e+0	4.164023e+2	2.401524e-3	1	2.401524e-3	1.000000e+0	17	3.655089e-3	1.000000e+0	1.000000e+0	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	NBN
GO Biological Process	GO:0031572	G2 DNA damage checkpoint	9	2.652383e-3	1.000000e+0	1.000000e+0	3.770195e+2	2.652383e-3	1	2.652383e-3	1.000000e+0	16	3.544427e-3	1.000000e+0	1.000000e+0	2.818906e+2	3.547475e-3	1	32	5.000000e-1	3.125000e-2	unnamed	NBN
GO Biological Process	GO:0016445	somatic diversification of immunoglobulins	10	2.719009e-3	1.000000e+0	1.000000e+0	3.677810e+2	2.719009e-3	1	2.719009e-3	1.000000e+0	15	3.212404e-3	1.000000e+0	1.000000e+0	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	NBN
GO Biological Process	GO:0032392	DNA geometric change	11	2.804598e-3	1.000000e+0	1.000000e+0	3.565573e+2	2.804598e-3	1	2.804598e-3	1.000000e+0	20	3.876395e-3	1.000000e+0	1.000000e+0	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	NBN
GO Biological Process	GO:0002312	B cell activation involved in immune response	12	2.973792e-3	1.000000e+0	1.000000e+0	3.362710e+2	2.973792e-3	1	2.973792e-3	1.000000e+0	14	3.101718e-3	1.000000e+0	1.000000e+0	3.221607e+2	3.104041e-3	1	28	5.000000e-1	3.571429e-2	unnamed	NBN
GO Biological Process	GO:0090329	regulation of DNA-dependent DNA replication	13	3.341270e-3	1.000000e+0	1.000000e+0	2.992874e+2	3.341270e-3	1	3.341270e-3	1.000000e+0	12	2.991025e-3	1.000000e+0	1.000000e+0	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	NBN
GO Biological Process	GO:0002562	somatic diversification of immune receptors via germline recombination within a single locus	14	3.415576e-3	1.000000e+0	1.000000e+0	2.927763e+2	3.415576e-3	1	3.415576e-3	1.000000e+0	17	3.655089e-3	1.000000e+0	1.000000e+0	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	NBN
GO Biological Process	GO:0002200	somatic diversification of immune receptors	15	3.636505e-3	1.000000e+0	1.000000e+0	2.749893e+2	3.636505e-3	1	3.636505e-3	1.000000e+0	21	3.987038e-3	1.000000e+0	1.000000e+0	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	NBN
GO Biological Process	GO:0016064	immunoglobulin mediated immune response	16	3.909104e-3	1.000000e+0	1.000000e+0	2.558131e+2	3.909104e-3	1	3.909104e-3	1.000000e+0	29	7.303486e-3	1.000000e+0	1.000000e+0	1.366742e+2	7.316668e-3	1	66	5.000000e-1	1.515152e-2	unnamed	NBN
GO Biological Process	GO:0002377	immunoglobulin production	17	4.032525e-3	1.000000e+0	1.000000e+0	2.479836e+2	4.032525e-3	1	4.032525e-3	1.000000e+0	22	4.429551e-3	1.000000e+0	1.000000e+0	2.255125e+2	4.434344e-3	1	40	5.000000e-1	2.500000e-2	unnamed	NBN
GO Biological Process	GO:0019724	B cell mediated immunity	18	4.060937e-3	1.000000e+0	1.000000e+0	2.462486e+2	4.060937e-3	1	4.060937e-3	1.000000e+0	31	7.634827e-3	1.000000e+0	1.000000e+0	1.307319e+2	7.649243e-3	1	69	5.000000e-1	1.449275e-2	unnamed	NBN
GO Biological Process	GO:0031952	regulation of protein autophosphorylation	19	4.133384e-3	1.000000e+0	1.000000e+0	2.419325e+2	4.133384e-3	1	4.133384e-3	1.000000e+0	11	2.880326e-3	1.000000e+0	1.000000e+0	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	NBN
GO Biological Process	GO:0000724	double-strand break repair via homologous recombination	20	4.523581e-3	1.000000e+0	1.000000e+0	2.210638e+2	4.523581e-3	1	4.523581e-3	1.000000e+0	25	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	NBN
GO Biological Process	GO:0000725	recombinational repair	21	4.528366e-3	1.000000e+0	1.000000e+0	2.208302e+2	4.528366e-3	1	4.528366e-3	1.000000e+0	26	5.756499e-3	1.000000e+0	1.000000e+0	1.734712e+2	5.764647e-3	1	52	5.000000e-1	1.923077e-2	unnamed	NBN
GO Biological Process	GO:0002440	production of molecular mediator of immune response	22	4.922324e-3	1.000000e+0	1.000000e+0	2.031561e+2	4.922324e-3	1	4.922324e-3	1.000000e+0	24	5.203711e-3	1.000000e+0	1.000000e+0	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	NBN
GO Biological Process	GO:0000723	telomere maintenance	23	5.004352e-3	1.000000e+0	1.000000e+0	1.998261e+2	5.004352e-3	1	5.004352e-3	1.000000e+0	32	8.186938e-3	1.000000e+0	1.000000e+0	1.218986e+2	8.203536e-3	1	74	5.000000e-1	1.351351e-2	unnamed	NBN
GO Biological Process	GO:0032200	telomere organization	24	5.016650e-3	1.000000e+0	1.000000e+0	1.993362e+2	5.016650e-3	1	5.016650e-3	1.000000e+0	33	8.297342e-3	1.000000e+0	1.000000e+0	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	NBN
GO Biological Process	GO:0044773	mitotic DNA damage checkpoint	25	5.695026e-3	1.000000e+0	1.000000e+0	1.755918e+2	5.695026e-3	1	5.695026e-3	1.000000e+0	34	9.069997e-3	1.000000e+0	1.000000e+0	1.100061e+2	9.090405e-3	1	82	5.000000e-1	1.219512e-2	unnamed	NBN
GO Biological Process	GO:0002449	lymphocyte mediated immunity	26	5.745465e-3	1.000000e+0	1.000000e+0	1.740503e+2	5.745465e-3	1	5.745465e-3	1.000000e+0	39	1.105544e-2	1.000000e+0	1.000000e+0	9.020500e+1	1.108586e-2	1	100	5.000000e-1	1.000000e-2	unnamed	NBN
GO Biological Process	GO:0044774	mitotic DNA integrity checkpoint	27	5.771856e-3	1.000000e+0	1.000000e+0	1.732545e+2	5.771856e-3	1	5.771856e-3	1.000000e+0	35	9.401043e-3	1.000000e+0	1.000000e+0	1.061235e+2	9.422981e-3	1	85	5.000000e-1	1.176471e-2	unnamed	NBN
GO Biological Process	GO:0002285	lymphocyte activation involved in immune response	28	5.796329e-3	1.000000e+0	1.000000e+0	1.725230e+2	5.796329e-3	1	5.796329e-3	1.000000e+0	28	6.309133e-3	1.000000e+0	1.000000e+0	1.582544e+2	6.318940e-3	1	57	5.000000e-1	1.754386e-2	unnamed	NBN
GO Biological Process	GO:0001824	blastocyst development	29	5.945812e-3	1.000000e+0	1.000000e+0	1.681856e+2	5.945812e-3	1	5.945812e-3	1.000000e+0	30	7.524386e-3	1.000000e+0	1.000000e+0	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	NBN
GO Biological Process	GO:0030330	DNA damage response, signal transduction by p53 class mediator	30	6.186295e-3	1.000000e+0	1.000000e+0	1.616476e+2	6.186295e-3	1	6.186295e-3	1.000000e+0	37	9.842351e-3	1.000000e+0	1.000000e+0	1.013539e+2	9.866415e-3	1	89	5.000000e-1	1.123596e-2	unnamed	NBN
GO Biological Process	GO:0042770	signal transduction in response to DNA damage	31	6.653888e-3	1.000000e+0	1.000000e+0	1.502881e+2	6.653888e-3	1	6.653888e-3	1.000000e+0	39	1.105544e-2	1.000000e+0	1.000000e+0	9.020500e+1	1.108586e-2	1	100	5.000000e-1	1.000000e-2	unnamed	NBN
GO Biological Process	GO:0050885	neuromuscular process controlling balance	32	7.712881e-3	1.000000e+0	1.000000e+0	1.296532e+2	7.712881e-3	1	7.712881e-3	1.000000e+0	27	5.867038e-3	1.000000e+0	1.000000e+0	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	NBN
GO Biological Process	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	33	8.424293e-3	1.000000e+0	1.000000e+0	1.187043e+2	8.424293e-3	1	8.424293e-3	1.000000e+0	42	1.226779e-2	1.000000e+0	1.000000e+0	8.126577e+1	1.230530e-2	1	111	5.000000e-1	9.009009e-3	unnamed	NBN
GO Biological Process	GO:0002443	leukocyte mediated immunity	34	8.643079e-3	1.000000e+0	1.000000e+0	1.156995e+2	8.643079e-3	1	8.643079e-3	1.000000e+0	46	1.402987e-2	1.000000e+0	1.000000e+0	7.102756e+1	1.407904e-2	1	127	5.000000e-1	7.874016e-3	unnamed	NBN
GO Biological Process	GO:0072331	signal transduction by p53 class mediator	35	8.850259e-3	1.000000e+0	1.000000e+0	1.129910e+2	8.850259e-3	1	8.850259e-3	1.000000e+0	45	1.325916e-2	1.000000e+0	1.000000e+0	7.517083e+1	1.330303e-2	1	120	5.000000e-1	8.333333e-3	unnamed	NBN
GO Biological Process	GO:0006302	double-strand break repair	36	8.931580e-3	1.000000e+0	1.000000e+0	1.119623e+2	8.931580e-3	1	8.931580e-3	1.000000e+0	41	1.160660e-2	1.000000e+0	1.000000e+0	8.590952e+1	1.164015e-2	1	105	5.000000e-1	9.523810e-3	unnamed	NBN
GO Biological Process	GO:0002366	leukocyte activation involved in immune response	37	8.959278e-3	1.000000e+0	1.000000e+0	1.116161e+2	8.959278e-3	1	8.959278e-3	1.000000e+0	36	9.732033e-3	1.000000e+0	1.000000e+0	1.025057e+2	9.755557e-3	1	88	5.000000e-1	1.136364e-2	unnamed	NBN
GO Biological Process	GO:0000077	DNA damage checkpoint	38	9.331232e-3	1.000000e+0	1.000000e+0	1.071670e+2	9.331232e-3	1	9.331232e-3	1.000000e+0	49	1.513038e-2	1.000000e+0	1.000000e+0	6.584307e+1	1.518763e-2	1	137	5.000000e-1	7.299270e-3	unnamed	NBN
GO Biological Process	GO:0031570	DNA integrity checkpoint	39	9.607175e-3	1.000000e+0	1.000000e+0	1.040889e+2	9.607175e-3	1	9.607175e-3	1.000000e+0	51	1.590037e-2	1.000000e+0	1.000000e+0	6.264236e+1	1.596364e-2	1	144	5.000000e-1	6.944444e-3	unnamed	NBN
GO Biological Process	GO:0002250	adaptive immune response	40	1.044836e-2	1.000000e+0	1.000000e+0	9.570883e+1	1.044836e-2	1	1.044836e-2	1.000000e+0	46	1.402987e-2	1.000000e+0	1.000000e+0	7.102756e+1	1.407904e-2	1	127	5.000000e-1	7.874016e-3	unnamed	NBN
GO Biological Process	GO:0006275	regulation of DNA replication	41	1.083893e-2	1.000000e+0	1.000000e+0	9.225999e+1	1.083893e-2	1	1.083893e-2	1.000000e+0	42	1.226779e-2	1.000000e+0	1.000000e+0	8.126577e+1	1.230530e-2	1	111	5.000000e-1	9.009009e-3	unnamed	NBN
GO Biological Process	GO:0007093	mitotic cell cycle checkpoint	42	1.093625e-2	1.000000e+0	1.000000e+0	9.143898e+1	1.093625e-2	1	1.093625e-2	1.000000e+0	51	1.590037e-2	1.000000e+0	1.000000e+0	6.264236e+1	1.596364e-2	1	144	5.000000e-1	6.944444e-3	unnamed	NBN
GO Biological Process	GO:0007126	meiosis	43	1.161777e-2	1.000000e+0	1.000000e+0	8.607507e+1	1.161777e-2	1	1.161777e-2	1.000000e+0	1	6.594366e-5	6.884518e-1	6.884518e-1	1.227279e+2	1.629621e-2	2	147	1.000000e+0	1.360544e-2	unnamed	NBN,OSGIN2
GO Biological Process	GO:0051321	meiotic cell cycle	44	1.229757e-2	1.000000e+0	1.000000e+0	8.131686e+1	1.229757e-2	1	1.229757e-2	1.000000e+0	2	7.052180e-5	7.362476e-1	3.681238e-1	1.186908e+2	1.685051e-2	2	152	1.000000e+0	1.315789e-2	unnamed	NBN,OSGIN2
GO Biological Process	GO:1901991	negative regulation of mitotic cell cycle phase transition	45	1.328035e-2	1.000000e+0	1.000000e+0	7.529923e+1	1.328035e-2	1	1.328035e-2	1.000000e+0	53	1.809867e-2	1.000000e+0	1.000000e+0	5.500305e+1	1.818081e-2	1	164	5.000000e-1	6.097561e-3	unnamed	NBN
GO Biological Process	GO:0042113	B cell activation	46	1.396950e-2	1.000000e+0	1.000000e+0	7.158450e+1	1.396950e-2	1	1.396950e-2	1.000000e+0	44	1.270846e-2	1.000000e+0	1.000000e+0	7.843913e+1	1.274874e-2	1	115	5.000000e-1	8.695652e-3	unnamed	NBN
GO Biological Process	GO:0050905	neuromuscular process	47	1.399656e-2	1.000000e+0	1.000000e+0	7.144615e+1	1.399656e-2	1	1.399656e-2	1.000000e+0	38	1.028356e-2	1.000000e+0	1.000000e+0	9.699462e+1	1.030985e-2	1	93	5.000000e-1	1.075269e-2	unnamed	NBN
GO Biological Process	GO:1901988	negative regulation of cell cycle phase transition	48	1.409885e-2	1.000000e+0	1.000000e+0	7.092777e+1	1.409885e-2	1	1.409885e-2	1.000000e+0	54	1.853804e-2	1.000000e+0	1.000000e+0	5.369345e+1	1.862424e-2	1	168	5.000000e-1	5.952381e-3	unnamed	NBN
GO Biological Process	GO:0071103	DNA conformation change	49	1.489538e-2	1.000000e+0	1.000000e+0	6.713492e+1	1.489538e-2	1	1.489538e-2	1.000000e+0	64	2.555453e-2	1.000000e+0	1.000000e+0	3.888147e+1	2.571920e-2	1	232	5.000000e-1	4.310345e-3	unnamed	NBN
GO Biological Process	GO:0007281	germ cell development	50	1.493390e-2	1.000000e+0	1.000000e+0	6.696173e+1	1.493390e-2	1	1.493390e-2	1.000000e+0	50	1.568040e-2	1.000000e+0	1.000000e+0	6.352465e+1	1.574192e-2	1	142	5.000000e-1	7.042254e-3	unnamed	OSGIN2
GO Biological Process	GO:0007050	cell cycle arrest	51	1.528140e-2	1.000000e+0	1.000000e+0	6.543905e+1	1.528140e-2	1	1.528140e-2	1.000000e+0	48	1.491033e-2	1.000000e+0	1.000000e+0	6.681852e+1	1.496591e-2	1	135	5.000000e-1	7.407407e-3	unnamed	NBN
GO Biological Process	GO:0000075	cell cycle checkpoint	52	1.587902e-2	1.000000e+0	1.000000e+0	6.297617e+1	1.587902e-2	1	1.587902e-2	1.000000e+0	60	2.336458e-2	1.000000e+0	1.000000e+0	4.254953e+1	2.350202e-2	1	212	5.000000e-1	4.716981e-3	unnamed	NBN
GO Biological Process	GO:0006310	DNA recombination	53	1.603875e-2	1.000000e+0	1.000000e+0	6.234901e+1	1.603875e-2	1	1.603875e-2	1.000000e+0	56	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	NBN
GO Biological Process	GO:1901990	regulation of mitotic cell cycle phase transition	54	1.910917e-2	1.000000e+0	1.000000e+0	5.233089e+1	1.910917e-2	1	1.910917e-2	1.000000e+0	58	2.292630e-2	1.000000e+0	1.000000e+0	4.336779e+1	2.305859e-2	1	208	5.000000e-1	4.807692e-3	unnamed	NBN
GO Biological Process	GO:0010948	negative regulation of cell cycle process	55	1.920177e-2	1.000000e+0	1.000000e+0	5.207854e+1	1.920177e-2	1	1.920177e-2	1.000000e+0	62	2.380277e-2	1.000000e+0	1.000000e+0	4.176157e+1	2.394546e-2	1	216	5.000000e-1	4.629630e-3	unnamed	NBN
GO Biological Process	GO:1901987	regulation of cell cycle phase transition	56	1.998785e-2	1.000000e+0	1.000000e+0	5.003040e+1	1.998785e-2	1	1.998785e-2	1.000000e+0	61	2.347414e-2	1.000000e+0	1.000000e+0	4.234977e+1	2.361288e-2	1	213	5.000000e-1	4.694836e-3	unnamed	NBN
GO Biological Process	GO:0060249	anatomical structure homeostasis	57	2.096319e-2	1.000000e+0	1.000000e+0	4.770266e+1	2.096319e-2	1	2.096319e-2	1.000000e+0	59	2.303588e-2	1.000000e+0	1.000000e+0	4.316029e+1	2.316945e-2	1	209	5.000000e-1	4.784689e-3	unnamed	NBN
GO Biological Process	GO:0022412	cellular process involved in reproduction in multicellular organism	58	2.143467e-2	1.000000e+0	1.000000e+0	4.665338e+1	2.143467e-2	1	2.143467e-2	1.000000e+0	55	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	OSGIN2
GO Biological Process	GO:0051052	regulation of DNA metabolic process	59	2.344366e-2	1.000000e+0	1.000000e+0	4.265546e+1	2.344366e-2	1	2.344366e-2	1.000000e+0	63	2.533565e-2	1.000000e+0	1.000000e+0	3.921957e+1	2.549748e-2	1	230	5.000000e-1	4.347826e-3	unnamed	NBN
GO Biological Process	GO:0002252	immune effector process	60	2.795289e-2	1.000000e+0	1.000000e+0	3.577448e+1	2.795289e-2	1	2.795289e-2	1.000000e+0	72	4.255177e-2	1.000000e+0	1.000000e+0	2.324871e+1	4.301314e-2	1	388	5.000000e-1	2.577320e-3	unnamed	NBN
GO Biological Process	GO:0045786	negative regulation of cell cycle	61	2.832384e-2	1.000000e+0	1.000000e+0	3.530595e+1	2.832384e-2	1	2.832384e-2	1.000000e+0	65	2.730472e-2	1.000000e+0	1.000000e+0	3.637298e+1	2.749293e-2	1	248	5.000000e-1	4.032258e-3	unnamed	NBN
GO Biological Process	GO:0006281	DNA repair	62	3.018395e-2	1.000000e+0	1.000000e+0	3.313019e+1	3.018395e-2	1	3.018395e-2	1.000000e+0	73	4.363624e-2	1.000000e+0	1.000000e+0	2.266457e+1	4.412172e-2	1	398	5.000000e-1	2.512563e-3	unnamed	NBN
GO Biological Process	GO:0007346	regulation of mitotic cell cycle	63	3.175872e-2	1.000000e+0	1.000000e+0	3.148741e+1	3.175872e-2	1	3.175872e-2	1.000000e+0	68	3.581436e-2	1.000000e+0	1.000000e+0	2.767025e+1	3.613990e-2	1	326	5.000000e-1	3.067485e-3	unnamed	NBN
GO Biological Process	GO:0048589	developmental growth	64	3.197468e-2	1.000000e+0	1.000000e+0	3.127475e+1	3.197468e-2	1	3.197468e-2	1.000000e+0	57	2.204943e-2	1.000000e+0	1.000000e+0	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	NBN
GO Biological Process	GO:0046649	lymphocyte activation	65	3.238380e-2	1.000000e+0	1.000000e+0	3.087964e+1	3.238380e-2	1	3.238380e-2	1.000000e+0	66	3.167331e-2	1.000000e+0	1.000000e+0	3.132118e+1	3.192728e-2	1	288	5.000000e-1	3.472222e-3	unnamed	NBN
GO Biological Process	GO:0045321	leukocyte activation	66	3.863898e-2	1.000000e+0	1.000000e+0	2.588060e+1	3.863898e-2	1	3.863898e-2	1.000000e+0	69	3.864260e-2	1.000000e+0	1.000000e+0	2.562642e+1	3.902223e-2	1	352	5.000000e-1	2.840909e-3	unnamed	NBN
GO Biological Process	GO:0010564	regulation of cell cycle process	67	3.998440e-2	1.000000e+0	1.000000e+0	2.500975e+1	3.998440e-2	1	3.998440e-2	1.000000e+0	73	4.363624e-2	1.000000e+0	1.000000e+0	2.266457e+1	4.412172e-2	1	398	5.000000e-1	2.512563e-3	unnamed	NBN
GO Biological Process	GO:0048610	cellular process involved in reproduction	68	4.383088e-2	1.000000e+0	1.000000e+0	2.281497e+1	4.383088e-2	1	4.383088e-2	1.000000e+0	3	5.484735e-4	1.000000e+0	1.000000e+0	4.265012e+1	4.689319e-2	2	423	1.000000e+0	4.728132e-3	unnamed	NBN,OSGIN2
GO Biological Process	GO:0001701	in utero embryonic development	69	4.511140e-2	1.000000e+0	1.000000e+0	2.216735e+1	4.511140e-2	1	4.511140e-2	1.000000e+0	69	3.864260e-2	1.000000e+0	1.000000e+0	2.562642e+1	3.902223e-2	1	352	5.000000e-1	2.840909e-3	unnamed	NBN
GO Biological Process	GO:0006974	cellular response to DNA damage stimulus	70	4.790195e-2	1.000000e+0	1.000000e+0	2.087598e+1	4.790195e-2	1	4.790195e-2	1.000000e+0	87	6.669653e-2	1.000000e+0	1.000000e+0	1.473938e+1	6.784546e-2	1	612	5.000000e-1	1.633987e-3	unnamed	NBN
GO Biological Process	GO:0033674	positive regulation of kinase activity	71	5.121151e-2	1.000000e+0	1.000000e+0	1.952686e+1	5.121151e-2	1	5.121151e-2	1.000000e+0	77	5.002208e-2	1.000000e+0	1.000000e+0	1.973851e+1	5.066238e-2	1	457	5.000000e-1	2.188184e-3	unnamed	NBN
GO Biological Process	GO:0040007	growth	72	5.170662e-2	1.000000e+0	1.000000e+0	1.933988e+1	5.170662e-2	1	5.170662e-2	1.000000e+0	71	3.962064e-2	1.000000e+0	1.000000e+0	2.498753e+1	4.001995e-2	1	361	5.000000e-1	2.770083e-3	unnamed	NBN
GO Biological Process	GO:0051347	positive regulation of transferase activity	73	5.276106e-2	1.000000e+0	1.000000e+0	1.895337e+1	5.276106e-2	1	5.276106e-2	1.000000e+0	78	5.131828e-2	1.000000e+0	1.000000e+0	1.923348e+1	5.199268e-2	1	469	5.000000e-1	2.132196e-3	unnamed	NBN
GO Biological Process	GO:0007276	gamete generation	74	5.686474e-2	1.000000e+0	1.000000e+0	1.758559e+1	5.686474e-2	1	5.686474e-2	1.000000e+0	80	5.735550e-2	1.000000e+0	1.000000e+0	1.718190e+1	5.820076e-2	1	525	5.000000e-1	1.904762e-3	unnamed	OSGIN2
GO Biological Process	GO:0003006	developmental process involved in reproduction	75	5.715290e-2	1.000000e+0	1.000000e+0	1.749692e+1	5.715290e-2	1	5.715290e-2	1.000000e+0	76	4.721062e-2	1.000000e+0	1.000000e+0	2.092923e+1	4.778006e-2	1	431	5.000000e-1	2.320186e-3	unnamed	OSGIN2
GO Biological Process	GO:0002520	immune system development	76	5.732186e-2	1.000000e+0	1.000000e+0	1.744535e+1	5.732186e-2	1	5.732186e-2	1.000000e+0	79	5.175015e-2	1.000000e+0	1.000000e+0	1.907082e+1	5.243612e-2	1	473	5.000000e-1	2.114165e-3	unnamed	NBN
GO Biological Process	GO:0001775	cell activation	77	5.914753e-2	1.000000e+0	1.000000e+0	1.690688e+1	5.914753e-2	1	5.914753e-2	1.000000e+0	82	6.176339e-2	1.000000e+0	1.000000e+0	1.593728e+1	6.274597e-2	1	566	5.000000e-1	1.766784e-3	unnamed	NBN
GO Biological Process	GO:0006259	DNA metabolic process	78	6.242337e-2	1.000000e+0	1.000000e+0	1.601964e+1	6.242337e-2	1	6.242337e-2	1.000000e+0	99	9.011000e-2	1.000000e+0	1.000000e+0	1.084195e+1	9.223436e-2	1	832	5.000000e-1	1.201923e-3	unnamed	NBN
GO Biological Process	GO:0019953	sexual reproduction	79	6.533147e-2	1.000000e+0	1.000000e+0	1.530656e+1	6.533147e-2	1	6.533147e-2	1.000000e+0	88	6.691072e-2	1.000000e+0	1.000000e+0	1.469137e+1	6.806718e-2	1	614	5.000000e-1	1.628664e-3	unnamed	OSGIN2
GO Biological Process	GO:0001934	positive regulation of protein phosphorylation	80	6.805954e-2	1.000000e+0	1.000000e+0	1.469302e+1	6.805954e-2	1	6.805954e-2	1.000000e+0	85	6.562521e-2	1.000000e+0	1.000000e+0	1.498422e+1	6.673688e-2	1	602	5.000000e-1	1.661130e-3	unnamed	NBN
GO Biological Process	GO:0051276	chromosome organization	81	6.817619e-2	1.000000e+0	1.000000e+0	1.466788e+1	6.817619e-2	1	6.817619e-2	1.000000e+0	97	8.194912e-2	1.000000e+0	1.000000e+0	1.194768e+1	8.369824e-2	1	755	5.000000e-1	1.324503e-3	unnamed	NBN
GO Biological Process	GO:0042327	positive regulation of phosphorylation	82	7.047180e-2	1.000000e+0	1.000000e+0	1.419007e+1	7.047180e-2	1	7.047180e-2	1.000000e+0	89	6.723196e-2	1.000000e+0	1.000000e+0	1.461994e+1	6.839976e-2	1	617	5.000000e-1	1.620746e-3	unnamed	NBN
GO Biological Process	GO:0043549	regulation of kinase activity	83	7.376474e-2	1.000000e+0	1.000000e+0	1.355661e+1	7.376474e-2	1	7.376474e-2	1.000000e+0	91	7.481844e-2	1.000000e+0	1.000000e+0	1.311119e+1	7.627072e-2	1	688	5.000000e-1	1.453488e-3	unnamed	NBN
GO Biological Process	GO:0051726	regulation of cell cycle	84	7.419191e-2	1.000000e+0	1.000000e+0	1.347856e+1	7.419191e-2	1	7.419191e-2	1.000000e+0	94	7.705640e-2	1.000000e+0	1.000000e+0	1.272285e+1	7.859875e-2	1	709	5.000000e-1	1.410437e-3	unnamed	NBN
GO Biological Process	GO:0048609	multicellular organismal reproductive process	85	7.483828e-2	1.000000e+0	1.000000e+0	1.336215e+1	7.483828e-2	1	7.483828e-2	1.000000e+0	90	7.289804e-2	1.000000e+0	1.000000e+0	1.346343e+1	7.427526e-2	1	670	5.000000e-1	1.492537e-3	unnamed	OSGIN2
GO Biological Process	GO:0008283	cell proliferation	86	7.535461e-2	1.000000e+0	1.000000e+0	1.327059e+1	7.535461e-2	1	7.535461e-2	1.000000e+0	86	6.573237e-2	1.000000e+0	1.000000e+0	1.495937e+1	6.684774e-2	1	603	5.000000e-1	1.658375e-3	unnamed	NBN
GO Biological Process	GO:0051338	regulation of transferase activity	87	7.596729e-2	1.000000e+0	1.000000e+0	1.316356e+1	7.596729e-2	1	7.596729e-2	1.000000e+0	95	7.716290e-2	1.000000e+0	1.000000e+0	1.270493e+1	7.870961e-2	1	710	5.000000e-1	1.408451e-3	unnamed	NBN
GO Biological Process	GO:0043009	chordate embryonic development	88	7.717062e-2	1.000000e+0	1.000000e+0	1.295830e+1	7.717062e-2	1	7.717062e-2	1.000000e+0	83	6.230023e-2	1.000000e+0	1.000000e+0	1.579772e+1	6.330026e-2	1	571	5.000000e-1	1.751313e-3	unnamed	NBN
GO Biological Process	GO:0032504	multicellular organism reproduction	89	7.740256e-2	1.000000e+0	1.000000e+0	1.291947e+1	7.740256e-2	1	7.740256e-2	1.000000e+0	92	7.503170e-2	1.000000e+0	1.000000e+0	1.307319e+1	7.649243e-2	1	690	5.000000e-1	1.449275e-3	unnamed	OSGIN2
GO Biological Process	GO:0009792	embryo development ending in birth or egg hatching	90	7.766421e-2	1.000000e+0	1.000000e+0	1.287594e+1	7.766421e-2	1	7.766421e-2	1.000000e+0	84	6.305155e-2	1.000000e+0	1.000000e+0	1.560640e+1	6.407627e-2	1	578	5.000000e-1	1.730104e-3	unnamed	NBN
GO Biological Process	GO:0044702	single organism reproductive process	91	7.805445e-2	1.000000e+0	1.000000e+0	1.281157e+1	7.805445e-2	1	7.805445e-2	1.000000e+0	96	7.812114e-2	1.000000e+0	1.000000e+0	1.254590e+1	7.970733e-2	1	719	5.000000e-1	1.390821e-3	unnamed	OSGIN2
GO Biological Process	GO:0045937	positive regulation of phosphate metabolic process	92	8.017370e-2	1.000000e+0	1.000000e+0	1.247292e+1	8.017370e-2	1	8.017370e-2	1.000000e+0	93	7.577790e-2	1.000000e+0	1.000000e+0	1.294189e+1	7.726844e-2	1	697	5.000000e-1	1.434720e-3	unnamed	NBN
GO Biological Process	GO:0031401	positive regulation of protein modification process	93	8.358603e-2	1.000000e+0	1.000000e+0	1.196372e+1	8.358603e-2	1	8.358603e-2	1.000000e+0	98	8.439060e-2	1.000000e+0	1.000000e+0	1.159447e+1	8.624799e-2	1	778	5.000000e-1	1.285347e-3	unnamed	NBN
GO Biological Process	GO:0006955	immune response	94	8.762627e-2	1.000000e+0	1.000000e+0	1.141210e+1	8.762627e-2	1	8.762627e-2	1.000000e+0	110	1.192707e-1	1.000000e+0	1.000000e+0	8.126577e+0	1.230530e-1	1	1110	5.000000e-1	9.009009e-4	unnamed	NBN
GO Biological Process	GO:0022402	cell cycle process	95	8.847677e-2	1.000000e+0	1.000000e+0	1.130240e+1	8.847677e-2	1	8.847677e-2	1.000000e+0	13	3.069505e-3	1.000000e+0	1.000000e+0	1.804100e+1	1.108586e-1	2	1000	1.000000e+0	2.000000e-3	unnamed	NBN,OSGIN2
GO Biological Process	GO:0032270	positive regulation of cellular protein metabolic process	96	9.043716e-2	1.000000e+0	1.000000e+0	1.105740e+1	9.043716e-2	1	9.043716e-2	1.000000e+0	101	9.433504e-2	1.000000e+0	1.000000e+0	1.034461e+1	9.666870e-2	1	872	5.000000e-1	1.146789e-3	unnamed	NBN
GO Biological Process	GO:0001932	regulation of protein phosphorylation	97	9.602533e-2	1.000000e+0	1.000000e+0	1.041392e+1	9.602533e-2	1	9.602533e-2	1.000000e+0	100	9.401850e-2	1.000000e+0	1.000000e+0	1.038032e+1	9.633612e-2	1	869	5.000000e-1	1.150748e-3	unnamed	NBN
GO Biological Process	GO:0006915	apoptotic process	98	9.852721e-2	1.000000e+0	1.000000e+0	1.014948e+1	9.852721e-2	1	9.852721e-2	1.000000e+0	107	1.119728e-1	1.000000e+0	1.000000e+0	8.673558e+0	1.152929e-1	1	1040	5.000000e-1	9.615385e-4	unnamed	NBN
GO Biological Process	GO:0012501	programmed cell death	99	1.001273e-1	1.000000e+0	1.000000e+0	9.987290e+0	1.001273e-1	1	1.001273e-1	1.000000e+0	109	1.134348e-1	1.000000e+0	1.000000e+0	8.558349e+0	1.168450e-1	1	1054	5.000000e-1	9.487666e-4	unnamed	NBN
GO Biological Process	GO:0051247	positive regulation of protein metabolic process	100	1.002750e-1	1.000000e+0	1.000000e+0	9.972575e+0	1.002750e-1	1	1.002750e-1	1.000000e+0	104	1.030706e-1	1.000000e+0	1.000000e+0	9.445550e+0	1.058700e-1	1	955	5.000000e-1	1.047120e-3	unnamed	NBN
GO Biological Process	GO:0033554	cellular response to stress	101	1.003642e-1	1.000000e+0	1.000000e+0	9.963713e+0	1.003642e-1	1	1.003642e-1	1.000000e+0	113	1.229084e-1	1.000000e+0	1.000000e+0	7.878166e+0	1.269331e-1	1	1145	5.000000e-1	8.733624e-4	unnamed	NBN
GO Biological Process	GO:0042325	regulation of phosphorylation	102	1.041865e-1	1.000000e+0	1.000000e+0	9.598174e+0	1.041865e-1	1	1.041865e-1	1.000000e+0	102	1.010747e-1	1.000000e+0	1.000000e+0	9.637286e+0	1.037636e-1	1	936	5.000000e-1	1.068376e-3	unnamed	NBN
GO Biological Process	GO:0042592	homeostatic process	103	1.047074e-1	1.000000e+0	1.000000e+0	9.550420e+0	1.047074e-1	1	1.047074e-1	1.000000e+0	108	1.125996e-1	1.000000e+0	1.000000e+0	8.623805e+0	1.159581e-1	1	1046	5.000000e-1	9.560229e-4	unnamed	NBN
GO Biological Process	GO:0007049	cell cycle	104	1.078728e-1	1.000000e+0	1.000000e+0	9.270177e+0	1.078728e-1	1	1.078728e-1	1.000000e+0	23	4.682578e-3	1.000000e+0	1.000000e+0	1.460810e+1	1.369104e-1	2	1235	1.000000e+0	1.619433e-3	unnamed	NBN,OSGIN2
GO Biological Process	GO:0022414	reproductive process	105	1.132946e-1	1.000000e+0	1.000000e+0	8.826548e+0	1.132946e-1	1	1.132946e-1	1.000000e+0	106	1.070559e-1	1.000000e+0	1.000000e+0	9.084089e+0	1.100826e-1	1	993	5.000000e-1	1.007049e-3	unnamed	OSGIN2
GO Biological Process	GO:0008219	cell death	106	1.161348e-1	1.000000e+0	1.000000e+0	8.610686e+0	1.161348e-1	1	1.161348e-1	1.000000e+0	114	1.323311e-1	1.000000e+0	1.000000e+0	7.298139e+0	1.370212e-1	1	1236	5.000000e-1	8.090615e-4	unnamed	NBN
GO Biological Process	GO:0016265	death	107	1.165949e-1	1.000000e+0	1.000000e+0	8.576703e+0	1.165949e-1	1	1.165949e-1	1.000000e+0	115	1.326408e-1	1.000000e+0	1.000000e+0	7.280468e+0	1.373538e-1	1	1239	5.000000e-1	8.071025e-4	unnamed	NBN
GO Biological Process	GO:0031399	regulation of protein modification process	108	1.170270e-1	1.000000e+0	1.000000e+0	8.545037e+0	1.170270e-1	1	1.170270e-1	1.000000e+0	111	1.196868e-1	1.000000e+0	1.000000e+0	8.097397e+0	1.234965e-1	1	1114	5.000000e-1	8.976661e-4	unnamed	NBN
GO Biological Process	GO:0043085	positive regulation of catalytic activity	109	1.192177e-1	1.000000e+0	1.000000e+0	8.388019e+0	1.192177e-1	1	1.192177e-1	1.000000e+0	112	1.198949e-1	1.000000e+0	1.000000e+0	8.082885e+0	1.237182e-1	1	1116	5.000000e-1	8.960573e-4	unnamed	NBN
GO Biological Process	GO:0000003	reproduction	110	1.207341e-1	1.000000e+0	1.000000e+0	8.282661e+0	1.207341e-1	1	1.207341e-1	1.000000e+0	19	3.667293e-3	1.000000e+0	1.000000e+0	1.650595e+1	1.211684e-1	2	1093	1.000000e+0	1.829826e-3	unnamed	NBN,OSGIN2
GO Biological Process	GO:0009790	embryo development	111	1.260409e-1	1.000000e+0	1.000000e+0	7.933935e+0	1.260409e-1	1	1.260409e-1	1.000000e+0	103	1.021254e-1	1.000000e+0	1.000000e+0	9.535412e+0	1.048722e-1	1	946	5.000000e-1	1.057082e-3	unnamed	NBN
GO Biological Process	GO:0032268	regulation of cellular protein metabolic process	112	1.389785e-1	1.000000e+0	1.000000e+0	7.195356e+0	1.389785e-1	1	1.389785e-1	1.000000e+0	118	1.498997e-1	1.000000e+0	1.000000e+0	6.411158e+0	1.559780e-1	1	1407	5.000000e-1	7.107321e-4	unnamed	NBN
GO Biological Process	GO:0044093	positive regulation of molecular function	113	1.422599e-1	1.000000e+0	1.000000e+0	7.029386e+0	1.422599e-1	1	1.422599e-1	1.000000e+0	116	1.401616e-1	1.000000e+0	1.000000e+0	6.875381e+0	1.454465e-1	1	1312	5.000000e-1	7.621951e-4	unnamed	NBN
GO Biological Process	GO:0035556	intracellular signal transduction	114	1.533855e-1	1.000000e+0	1.000000e+0	6.519521e+0	1.533855e-1	1	1.533855e-1	1.000000e+0	119	1.538815e-1	1.000000e+0	1.000000e+0	6.238243e+0	1.603015e-1	1	1446	5.000000e-1	6.915629e-4	unnamed	NBN
GO Biological Process	GO:0002376	immune system process	115	1.536349e-1	1.000000e+0	1.000000e+0	6.508938e+0	1.536349e-1	1	1.536349e-1	1.000000e+0	125	1.884977e-1	1.000000e+0	1.000000e+0	5.042202e+0	1.983260e-1	1	1789	5.000000e-1	5.589715e-4	unnamed	NBN
GO Biological Process	GO:0051246	regulation of protein metabolic process	116	1.559232e-1	1.000000e+0	1.000000e+0	6.413414e+0	1.559232e-1	1	1.559232e-1	1.000000e+0	123	1.698159e-1	1.000000e+0	1.000000e+0	5.627261e+0	1.777063e-1	1	1603	5.000000e-1	6.238303e-4	unnamed	NBN
GO Biological Process	GO:0050877	neurological system process	117	1.566250e-1	1.000000e+0	1.000000e+0	6.384679e+0	1.566250e-1	1	1.566250e-1	1.000000e+0	122	1.641497e-1	1.000000e+0	1.000000e+0	5.830963e+0	1.714983e-1	1	1547	5.000000e-1	6.464124e-4	unnamed	NBN
GO Biological Process	GO:0019220	regulation of phosphate metabolic process	118	1.631781e-1	1.000000e+0	1.000000e+0	6.128273e+0	1.631781e-1	1	1.631781e-1	1.000000e+0	119	1.538815e-1	1.000000e+0	1.000000e+0	6.238243e+0	1.603015e-1	1	1446	5.000000e-1	6.915629e-4	unnamed	NBN
GO Biological Process	GO:0051174	regulation of phosphorus metabolic process	119	1.640067e-1	1.000000e+0	1.000000e+0	6.097311e+0	1.640067e-1	1	1.640067e-1	1.000000e+0	121	1.552066e-1	1.000000e+0	1.000000e+0	6.182659e+0	1.617427e-1	1	1459	5.000000e-1	6.854010e-4	unnamed	NBN
GO Biological Process	GO:0050790	regulation of catalytic activity	120	1.756788e-1	1.000000e+0	1.000000e+0	5.692208e+0	1.756788e-1	1	1.756788e-1	1.000000e+0	124	1.830959e-1	1.000000e+0	1.000000e+0	5.199135e+0	1.923397e-1	1	1735	5.000000e-1	5.763689e-4	unnamed	NBN
GO Biological Process	GO:0048468	cell development	121	1.837839e-1	1.000000e+0	1.000000e+0	5.441172e+0	1.837839e-1	1	1.837839e-1	1.000000e+0	117	1.403671e-1	1.000000e+0	1.000000e+0	6.864916e+0	1.456682e-1	1	1314	5.000000e-1	7.610350e-4	unnamed	OSGIN2
GO Biological Process	GO:0003008	system process	122	1.967197e-1	1.000000e+0	1.000000e+0	5.083376e+0	1.967197e-1	1	1.967197e-1	1.000000e+0	126	2.046945e-1	1.000000e+0	1.000000e+0	4.621158e+0	2.163960e-1	1	1952	5.000000e-1	5.122951e-4	unnamed	NBN
GO Biological Process	GO:0006996	organelle organization	123	1.979117e-1	1.000000e+0	1.000000e+0	5.052758e+0	1.979117e-1	1	1.979117e-1	1.000000e+0	131	2.321362e-1	1.000000e+0	1.000000e+0	4.041443e+0	2.474364e-1	1	2232	5.000000e-1	4.480287e-4	unnamed	NBN
GO Biological Process	GO:0065009	regulation of molecular function	124	2.156945e-1	1.000000e+0	1.000000e+0	4.636187e+0	2.156945e-1	1	2.156945e-1	1.000000e+0	129	2.197492e-1	1.000000e+0	1.000000e+0	4.285273e+0	2.333574e-1	1	2105	5.000000e-1	4.750594e-4	unnamed	NBN
GO Biological Process	GO:0010604	positive regulation of macromolecule metabolic process	125	2.215598e-1	1.000000e+0	1.000000e+0	4.513455e+0	2.215598e-1	1	2.215598e-1	1.000000e+0	127	2.091373e-1	1.000000e+0	1.000000e+0	4.517026e+0	2.213846e-1	1	1997	5.000000e-1	5.007511e-4	unnamed	NBN
GO Biological Process	GO:0031325	positive regulation of cellular metabolic process	126	2.230682e-1	1.000000e+0	1.000000e+0	4.482934e+0	2.230682e-1	1	2.230682e-1	1.000000e+0	128	2.132726e-1	1.000000e+0	1.000000e+0	4.423982e+0	2.260407e-1	1	2039	5.000000e-1	4.904365e-4	unnamed	NBN
GO Biological Process	GO:0009893	positive regulation of metabolic process	127	2.357828e-1	1.000000e+0	1.000000e+0	4.241191e+0	2.357828e-1	1	2.357828e-1	1.000000e+0	130	2.244425e-1	1.000000e+0	1.000000e+0	4.189735e+0	2.386786e-1	1	2153	5.000000e-1	4.644682e-4	unnamed	NBN
GO Biological Process	GO:0006950	response to stress	128	2.428193e-1	1.000000e+0	1.000000e+0	4.118289e+0	2.428193e-1	1	2.428193e-1	1.000000e+0	135	3.014152e-1	1.000000e+0	1.000000e+0	3.045409e+0	3.283632e-1	1	2962	5.000000e-1	3.376097e-4	unnamed	NBN
GO Biological Process	GO:0065008	regulation of biological quality	129	2.713082e-1	1.000000e+0	1.000000e+0	3.685845e+0	2.713082e-1	1	2.713082e-1	1.000000e+0	134	2.887566e-1	1.000000e+0	1.000000e+0	3.191967e+0	3.132864e-1	1	2826	5.000000e-1	3.538570e-4	unnamed	NBN
GO Biological Process	GO:0090304	nucleic acid metabolic process	130	3.065231e-1	1.000000e+0	1.000000e+0	3.262397e+0	3.065231e-1	1	3.065231e-1	1.000000e+0	146	3.768188e-1	1.000000e+0	1.000000e+0	2.374441e+0	4.211518e-1	1	3799	5.000000e-1	2.632272e-4	unnamed	NBN
GO Biological Process	GO:0048523	negative regulation of cellular process	131	3.146568e-1	1.000000e+0	1.000000e+0	3.178065e+0	3.146568e-1	1	3.146568e-1	1.000000e+0	136	3.089005e-1	1.000000e+0	1.000000e+0	2.964344e+0	3.373427e-1	1	3043	5.000000e-1	3.286231e-4	unnamed	NBN
GO Biological Process	GO:0030154	cell differentiation	132	3.160741e-1	1.000000e+0	1.000000e+0	3.163815e+0	3.160741e-1	1	3.160741e-1	1.000000e+0	132	2.690819e-1	1.000000e+0	1.000000e+0	3.446886e+0	2.901170e-1	1	2617	5.000000e-1	3.821169e-4	unnamed	OSGIN2
GO Biological Process	GO:0048869	cellular developmental process	133	3.225257e-1	1.000000e+0	1.000000e+0	3.100528e+0	3.225257e-1	1	3.225257e-1	1.000000e+0	133	2.802231e-1	1.000000e+0	1.000000e+0	3.298172e+0	3.031983e-1	1	2735	5.000000e-1	3.656307e-4	unnamed	OSGIN2
GO Biological Process	GO:2000112	regulation of cellular macromolecule biosynthetic process	134	3.236874e-1	1.000000e+0	1.000000e+0	3.089400e+0	3.236874e-1	1	3.236874e-1	1.000000e+0	141	3.508235e-1	1.000000e+0	1.000000e+0	2.573609e+0	3.885594e-1	1	3505	5.000000e-1	2.853067e-4	unnamed	NBN
GO Biological Process	GO:0010556	regulation of macromolecule biosynthetic process	135	3.285042e-1	1.000000e+0	1.000000e+0	3.044101e+0	3.285042e-1	1	3.285042e-1	1.000000e+0	142	3.578608e-1	1.000000e+0	1.000000e+0	2.516881e+0	3.973172e-1	1	3584	5.000000e-1	2.790179e-4	unnamed	NBN
GO Biological Process	GO:0048519	negative regulation of biological process	136	3.368683e-1	1.000000e+0	1.000000e+0	2.968519e+0	3.368683e-1	1	3.368683e-1	1.000000e+0	139	3.341936e-1	1.000000e+0	1.000000e+0	2.717018e+0	3.680506e-1	1	3320	5.000000e-1	3.012048e-4	unnamed	NBN
GO Biological Process	GO:0048522	positive regulation of cellular process	137	3.411192e-1	1.000000e+0	1.000000e+0	2.931526e+0	3.411192e-1	1	3.411192e-1	1.000000e+0	138	3.331076e-1	1.000000e+0	1.000000e+0	2.726874e+0	3.667202e-1	1	3308	5.000000e-1	3.022975e-4	unnamed	NBN
GO Biological Process	GO:0031326	regulation of cellular biosynthetic process	138	3.434354e-1	1.000000e+0	1.000000e+0	2.911756e+0	3.434354e-1	1	3.434354e-1	1.000000e+0	144	3.710294e-1	1.000000e+0	1.000000e+0	2.416421e+0	4.138352e-1	1	3733	5.000000e-1	2.678811e-4	unnamed	NBN
GO Biological Process	GO:0009889	regulation of biosynthetic process	139	3.455319e-1	1.000000e+0	1.000000e+0	2.894089e+0	3.455319e-1	1	3.455319e-1	1.000000e+0	145	3.736643e-1	1.000000e+0	1.000000e+0	2.397157e+0	4.171609e-1	1	3763	5.000000e-1	2.657454e-4	unnamed	NBN
GO Biological Process	GO:0006139	nucleobase-containing compound metabolic process	140	3.530780e-1	1.000000e+0	1.000000e+0	2.832235e+0	3.530780e-1	1	3.530780e-1	1.000000e+0	154	4.351591e-1	1.000000e+0	1.000000e+0	2.012606e+0	4.968682e-1	1	4482	5.000000e-1	2.231147e-4	unnamed	NBN
GO Biological Process	GO:0019219	regulation of nucleobase-containing compound metabolic process	141	3.657269e-1	1.000000e+0	1.000000e+0	2.734281e+0	3.657269e-1	1	3.657269e-1	1.000000e+0	148	3.879706e-1	1.000000e+0	1.000000e+0	2.297046e+0	4.353417e-1	1	3927	5.000000e-1	2.546473e-4	unnamed	NBN
GO Biological Process	GO:0046483	heterocycle metabolic process	142	3.657512e-1	1.000000e+0	1.000000e+0	2.734099e+0	3.657512e-1	1	3.657512e-1	1.000000e+0	156	4.495636e-1	1.000000e+0	1.000000e+0	1.937393e+0	5.161576e-1	1	4656	5.000000e-1	2.147766e-4	unnamed	NBN
GO Biological Process	GO:0006725	cellular aromatic compound metabolic process	143	3.683046e-1	1.000000e+0	1.000000e+0	2.715144e+0	3.683046e-1	1	3.683046e-1	1.000000e+0	157	4.506323e-1	1.000000e+0	1.000000e+0	1.931998e+0	5.175988e-1	1	4669	5.000000e-1	2.141786e-4	unnamed	NBN
GO Biological Process	GO:0051171	regulation of nitrogen compound metabolic process	144	3.708892e-1	1.000000e+0	1.000000e+0	2.696223e+0	3.708892e-1	1	3.708892e-1	1.000000e+0	150	3.955790e-1	1.000000e+0	1.000000e+0	2.246700e+0	4.450973e-1	1	4015	5.000000e-1	2.490660e-4	unnamed	NBN
GO Biological Process	GO:0048518	positive regulation of biological process	145	3.729968e-1	1.000000e+0	1.000000e+0	2.680988e+0	3.729968e-1	1	3.729968e-1	1.000000e+0	143	3.689175e-1	1.000000e+0	1.000000e+0	2.432057e+0	4.111745e-1	1	3709	5.000000e-1	2.696145e-4	unnamed	NBN
GO Biological Process	GO:0044767	single-organism developmental process	146	3.730678e-1	1.000000e+0	1.000000e+0	2.680478e+0	3.730678e-1	1	3.730678e-1	1.000000e+0	67	3.361263e-2	1.000000e+0	1.000000e+0	5.453748e+0	3.667202e-1	2	3308	1.000000e+0	6.045949e-4	unnamed	NBN,OSGIN2
GO Biological Process	GO:0034641	cellular nitrogen compound metabolic process	147	3.768107e-1	1.000000e+0	1.000000e+0	2.653853e+0	3.768107e-1	1	3.768107e-1	1.000000e+0	159	4.663767e-1	1.000000e+0	1.000000e+0	1.855306e+0	5.389945e-1	1	4862	5.000000e-1	2.056767e-4	unnamed	NBN
GO Biological Process	GO:1901360	organic cyclic compound metabolic process	148	3.827617e-1	1.000000e+0	1.000000e+0	2.612592e+0	3.827617e-1	1	3.827617e-1	1.000000e+0	161	4.683993e-1	1.000000e+0	1.000000e+0	1.845815e+0	5.417660e-1	1	4887	5.000000e-1	2.046245e-4	unnamed	NBN
GO Biological Process	GO:0016043	cellular component organization	149	3.831577e-1	1.000000e+0	1.000000e+0	2.609891e+0	3.831577e-1	1	3.831577e-1	1.000000e+0	151	3.965267e-1	1.000000e+0	1.000000e+0	2.240561e+0	4.463167e-1	1	4026	5.000000e-1	2.483855e-4	unnamed	NBN
GO Biological Process	GO:0071840	cellular component organization or biogenesis	150	3.897194e-1	1.000000e+0	1.000000e+0	2.565949e+0	3.897194e-1	1	3.897194e-1	1.000000e+0	152	4.070731e-1	1.000000e+0	1.000000e+0	2.174138e+0	4.599523e-1	1	4149	5.000000e-1	2.410219e-4	unnamed	NBN
GO Biological Process	GO:0048731	system development	151	3.900631e-1	1.000000e+0	1.000000e+0	2.563688e+0	3.900631e-1	1	3.900631e-1	1.000000e+0	140	3.405107e-1	1.000000e+0	1.000000e+0	2.660914e+0	3.758107e-1	1	3390	5.000000e-1	2.949853e-4	unnamed	NBN
GO Biological Process	GO:0007165	signal transduction	152	3.912589e-1	1.000000e+0	1.000000e+0	2.555852e+0	3.912589e-1	1	3.912589e-1	1.000000e+0	153	4.201465e-1	1.000000e+0	1.000000e+0	2.096328e+0	4.770246e-1	1	4303	5.000000e-1	2.323960e-4	unnamed	NBN
GO Biological Process	GO:0060255	regulation of macromolecule metabolic process	153	4.100897e-1	1.000000e+0	1.000000e+0	2.438491e+0	4.100897e-1	1	4.100897e-1	1.000000e+0	155	4.477526e-1	1.000000e+0	1.000000e+0	1.946590e+0	5.137188e-1	1	4634	5.000000e-1	2.157963e-4	unnamed	NBN
GO Biological Process	GO:0006807	nitrogen compound metabolic process	154	4.138051e-1	1.000000e+0	1.000000e+0	2.416597e+0	4.138051e-1	1	4.138051e-1	1.000000e+0	164	4.994558e-1	1.000000e+0	1.000000e+0	1.709399e+0	5.850008e-1	1	5277	5.000000e-1	1.895016e-4	unnamed	NBN
GO Biological Process	GO:0048856	anatomical structure development	155	4.234725e-1	1.000000e+0	1.000000e+0	2.361429e+0	4.234725e-1	1	4.234725e-1	1.000000e+0	75	4.643481e-2	1.000000e+0	1.000000e+0	4.640175e+0	4.310182e-1	2	3888	1.000000e+0	5.144033e-4	unnamed	NBN,OSGIN2
GO Biological Process	GO:0007275	multicellular organismal development	156	4.357034e-1	1.000000e+0	1.000000e+0	2.295139e+0	4.357034e-1	1	4.357034e-1	1.000000e+0	149	3.919536e-1	1.000000e+0	1.000000e+0	2.270451e+0	4.404412e-1	1	3973	5.000000e-1	2.516990e-4	unnamed	NBN
GO Biological Process	GO:0080090	regulation of primary metabolic process	157	4.363900e-1	1.000000e+0	1.000000e+0	2.291528e+0	4.363900e-1	1	4.363900e-1	1.000000e+0	162	4.714664e-1	1.000000e+0	1.000000e+0	1.831574e+0	5.459786e-1	1	4925	5.000000e-1	2.030457e-4	unnamed	NBN
GO Biological Process	GO:0044700	single organism signaling	158	4.371810e-1	1.000000e+0	1.000000e+0	2.287382e+0	4.371810e-1	1	4.371810e-1	1.000000e+0	158	4.576762e-1	1.000000e+0	1.000000e+0	1.897056e+0	5.271326e-1	1	4755	5.000000e-1	2.103049e-4	unnamed	NBN
GO Biological Process	GO:0031323	regulation of cellular metabolic process	159	4.406599e-1	1.000000e+0	1.000000e+0	2.269324e+0	4.406599e-1	1	4.406599e-1	1.000000e+0	163	4.760505e-1	1.000000e+0	1.000000e+0	1.810618e+0	5.522975e-1	1	4982	5.000000e-1	2.007226e-4	unnamed	NBN
GO Biological Process	GO:0007154	cell communication	160	4.446638e-1	1.000000e+0	1.000000e+0	2.248890e+0	4.446638e-1	1	4.446638e-1	1.000000e+0	160	4.676716e-1	1.000000e+0	1.000000e+0	1.849221e+0	5.407683e-1	1	4878	5.000000e-1	2.050021e-4	unnamed	NBN
GO Biological Process	GO:0051716	cellular response to stimulus	161	4.562761e-1	1.000000e+0	1.000000e+0	2.191655e+0	4.562761e-1	1	4.562761e-1	1.000000e+0	165	5.039946e-1	1.000000e+0	1.000000e+0	1.690815e+0	5.914306e-1	1	5335	5.000000e-1	1.874414e-4	unnamed	NBN
GO Biological Process	GO:0032502	developmental process	162	4.657420e-1	1.000000e+0	1.000000e+0	2.147111e+0	4.657420e-1	1	4.657420e-1	1.000000e+0	81	6.023099e-2	1.000000e+0	1.000000e+0	4.074300e+0	4.908819e-1	2	4428	1.000000e+0	4.516712e-4	unnamed	NBN,OSGIN2
GO Biological Process	GO:0019222	regulation of metabolic process	163	4.728179e-1	1.000000e+0	1.000000e+0	2.114979e+0	4.728179e-1	1	4.728179e-1	1.000000e+0	166	5.177180e-1	1.000000e+0	1.000000e+0	1.636520e+0	6.110526e-1	1	5512	5.000000e-1	1.814224e-4	unnamed	NBN
GO Biological Process	GO:0044260	cellular macromolecule metabolic process	164	4.901841e-1	1.000000e+0	1.000000e+0	2.040050e+0	4.901841e-1	1	4.901841e-1	1.000000e+0	169	5.672657e-1	1.000000e+0	1.000000e+0	1.461283e+0	6.843301e-1	1	6173	5.000000e-1	1.619958e-4	unnamed	NBN
GO Biological Process	GO:0043170	macromolecule metabolic process	165	5.266956e-1	1.000000e+0	1.000000e+0	1.898630e+0	5.266956e-1	1	5.266956e-1	1.000000e+0	170	6.104699e-1	1.000000e+0	1.000000e+0	1.330261e+0	7.517322e-1	1	6781	5.000000e-1	1.474709e-4	unnamed	NBN
GO Biological Process	GO:0044707	single-multicellular organism process	166	5.372858e-1	1.000000e+0	1.000000e+0	1.861207e+0	5.372858e-1	1	5.372858e-1	1.000000e+0	167	5.291973e-1	1.000000e+0	1.000000e+0	1.593165e+0	6.276814e-1	1	5662	5.000000e-1	1.766160e-4	unnamed	NBN
GO Biological Process	GO:0050896	response to stimulus	167	5.533212e-1	1.000000e+0	1.000000e+0	1.807268e+0	5.533212e-1	1	5.533212e-1	1.000000e+0	171	6.177696e-1	1.000000e+0	1.000000e+0	1.309787e+0	7.634832e-1	1	6887	5.000000e-1	1.452011e-4	unnamed	NBN
GO Biological Process	GO:0032501	multicellular organismal process	168	5.539872e-1	1.000000e+0	1.000000e+0	1.805096e+0	5.539872e-1	1	5.539872e-1	1.000000e+0	105	1.064675e-1	1.000000e+0	1.000000e+0	3.064549e+0	6.526246e-1	2	5887	1.000000e+0	3.397316e-4	unnamed	NBN,OSGIN2
GO Biological Process	GO:0044237	cellular metabolic process	169	6.001923e-1	1.000000e+0	1.000000e+0	1.666133e+0	6.001923e-1	1	6.001923e-1	1.000000e+0	172	7.045181e-1	1.000000e+0	1.000000e+0	1.095519e+0	9.128097e-1	1	8234	5.000000e-1	1.214477e-4	unnamed	NBN
GO Biological Process	GO:0044238	primary metabolic process	170	6.053666e-1	1.000000e+0	1.000000e+0	1.651892e+0	6.053666e-1	1	6.053666e-1	1.000000e+0	173	7.093792e-1	1.000000e+0	1.000000e+0	1.084847e+0	9.217893e-1	1	8315	5.000000e-1	1.202646e-4	unnamed	NBN
GO Biological Process	GO:0071704	organic substance metabolic process	171	6.199145e-1	1.000000e+0	1.000000e+0	1.613126e+0	6.199145e-1	1	6.199145e-1	1.000000e+0	174	7.239536e-1	1.000000e+0	1.000000e+0	1.053551e+0	9.491713e-1	1	8562	5.000000e-1	1.167951e-4	unnamed	NBN
GO Biological Process	GO:0008152	metabolic process	172	6.507895e-1	1.000000e+0	1.000000e+0	1.536595e+0	6.507895e-1	1	6.507895e-1	1.000000e+0	176	7.596471e-1	1.000000e+0	1.000000e+0	9.809156e-1	1.019456e+0	1	9196	5.000000e-1	1.087429e-4	unnamed	NBN
GO Biological Process	GO:0050794	regulation of cellular process	173	6.759845e-1	1.000000e+0	1.000000e+0	1.479324e+0	6.759845e-1	1	6.759845e-1	1.000000e+0	175	7.406997e-1	1.000000e+0	1.000000e+0	1.018805e+0	9.815420e-1	1	8854	5.000000e-1	1.129433e-4	unnamed	NBN
GO Biological Process	GO:0050789	regulation of biological process	174	6.921477e-1	1.000000e+0	1.000000e+0	1.444778e+0	6.921477e-1	1	6.921477e-1	1.000000e+0	177	7.668214e-1	1.000000e+0	1.000000e+0	9.669311e-1	1.034200e+0	1	9329	5.000000e-1	1.071926e-4	unnamed	NBN
GO Biological Process	GO:0065007	biological regulation	175	7.151977e-1	1.000000e+0	1.000000e+0	1.398215e+0	7.151977e-1	1	7.151977e-1	1.000000e+0	178	7.940293e-1	1.000000e+0	1.000000e+0	9.155080e-1	1.092290e+0	1	9853	5.000000e-1	1.014919e-4	unnamed	NBN
GO Biological Process	GO:0044763	single-organism cellular process	176	7.497126e-1	1.000000e+0	1.000000e+0	1.333844e+0	7.497126e-1	1	7.497126e-1	1.000000e+0	137	3.141478e-1	1.000000e+0	1.000000e+0	1.784118e+0	1.121002e+0	2	10112	1.000000e+0	1.977848e-4	unnamed	NBN,OSGIN2
GO Biological Process	GO:0044699	single-organism process	177	7.935590e-1	1.000000e+0	1.000000e+0	1.260146e+0	7.935590e-1	1	7.935590e-1	1.000000e+0	147	3.800402e-1	1.000000e+0	1.000000e+0	1.622100e+0	1.232969e+0	2	11122	1.000000e+0	1.798238e-4	unnamed	NBN,OSGIN2
GO Biological Process	GO:0009987	cellular process	178	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	168	5.606826e-1	1.000000e+0	1.000000e+0	1.335480e+0	1.497589e+0	2	13509	1.000000e+0	1.480494e-4	unnamed	NBN,OSGIN2
GO Cellular Component	GO:0030870	Mre11 complex	1	2.578567e-4	3.261887e-1	3.261887e-1	3.878123e+3	2.578567e-4	1	2.578567e-4	1.000000e+0	1	6.650594e-4	8.413001e-1	8.413001e-1	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	NBN
GO Cellular Component	GO:0035861	site of double-strand break	2	5.208802e-4	6.589135e-1	3.294567e-1	1.919827e+3	5.208802e-4	1	5.208802e-4	1.000000e+0	3	1.108309e-3	1.000000e+0	4.673370e-1	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	NBN
GO Cellular Component	GO:0042405	nuclear inclusion body	3	7.056133e-4	8.926008e-1	2.975336e-1	1.417207e+3	7.056133e-4	1	7.056133e-4	1.000000e+0	2	9.975062e-4	1.000000e+0	6.309227e-1	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	NBN
GO Cellular Component	GO:0000784	nuclear chromosome, telomeric region	4	1.974125e-3	1.000000e+0	6.243170e-1	5.065536e+2	1.974125e-3	1	1.974125e-3	1.000000e+0	4	2.769621e-3	1.000000e+0	8.758926e-1	3.608200e+2	2.771465e-3	1	25	5.000000e-1	4.000000e-2	unnamed	NBN
GO Cellular Component	GO:0016234	inclusion body	5	2.777964e-3	1.000000e+0	7.028249e-1	3.599758e+2	2.777964e-3	1	2.777964e-3	1.000000e+0	5	4.540164e-3	1.000000e+0	1.000000e+0	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	NBN
GO Cellular Component	GO:0000781	chromosome, telomeric region	6	3.532494e-3	1.000000e+0	7.447675e-1	2.830861e+2	3.532494e-3	1	3.532494e-3	1.000000e+0	7	5.867038e-3	1.000000e+0	1.000000e+0	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	NBN
GO Cellular Component	GO:0005657	replication fork	7	4.827270e-3	1.000000e+0	8.723567e-1	2.071564e+2	4.827270e-3	1	4.827270e-3	1.000000e+0	6	5.093135e-3	1.000000e+0	1.000000e+0	1.960978e+2	5.099496e-3	1	46	5.000000e-1	2.173913e-2	unnamed	NBN
GO Cellular Component	GO:0016605	PML body	8	7.468590e-3	1.000000e+0	1.000000e+0	1.338941e+2	7.468590e-3	1	7.468590e-3	1.000000e+0	8	9.180352e-3	1.000000e+0	1.000000e+0	1.086807e+2	9.201264e-3	1	83	5.000000e-1	1.204819e-2	unnamed	NBN
GO Cellular Component	GO:0044454	nuclear chromosome part	9	2.532385e-2	1.000000e+0	1.000000e+0	3.948846e+1	2.532385e-2	1	2.532385e-2	1.000000e+0	9	2.905334e-2	1.000000e+0	1.000000e+0	3.416856e+1	2.926667e-2	1	264	5.000000e-1	3.787879e-3	unnamed	NBN
GO Cellular Component	GO:0016604	nuclear body	10	2.621946e-2	1.000000e+0	1.000000e+0	3.813961e+1	2.621946e-2	1	2.621946e-2	1.000000e+0	10	3.287295e-2	1.000000e+0	1.000000e+0	3.016890e+1	3.314672e-2	1	299	5.000000e-1	3.344482e-3	unnamed	NBN
GO Cellular Component	GO:0000228	nuclear chromosome	11	2.961235e-2	1.000000e+0	1.000000e+0	3.376969e+1	2.961235e-2	1	2.961235e-2	1.000000e+0	11	3.374495e-2	1.000000e+0	1.000000e+0	2.938274e+1	3.403359e-2	1	307	5.000000e-1	3.257329e-3	unnamed	NBN
GO Cellular Component	GO:0044427	chromosomal part	12	4.834754e-2	1.000000e+0	1.000000e+0	2.068358e+1	4.834754e-2	1	4.834754e-2	1.000000e+0	12	6.433882e-2	1.000000e+0	1.000000e+0	1.528898e+1	6.540657e-2	1	590	5.000000e-1	1.694915e-3	unnamed	NBN
GO Cellular Component	GO:0005730	nucleolus	13	5.338243e-2	1.000000e+0	1.000000e+0	1.873275e+1	5.338243e-2	1	5.338243e-2	1.000000e+0	14	7.118934e-2	1.000000e+0	1.000000e+0	1.379281e+1	7.250152e-2	1	654	5.000000e-1	1.529052e-3	unnamed	NBN
GO Cellular Component	GO:0044451	nucleoplasm part	14	5.637067e-2	1.000000e+0	1.000000e+0	1.773972e+1	5.637067e-2	1	5.637067e-2	1.000000e+0	13	6.958601e-2	1.000000e+0	1.000000e+0	1.411659e+1	7.083865e-2	1	639	5.000000e-1	1.564945e-3	unnamed	NBN
GO Cellular Component	GO:0005694	chromosome	15	5.644203e-2	1.000000e+0	1.000000e+0	1.771729e+1	5.644203e-2	1	5.644203e-2	1.000000e+0	15	7.535154e-2	1.000000e+0	1.000000e+0	1.301659e+1	7.682501e-2	1	693	5.000000e-1	1.443001e-3	unnamed	NBN
GO Cellular Component	GO:0005654	nucleoplasm	16	1.212700e-1	1.000000e+0	1.000000e+0	8.246060e+0	1.212700e-1	1	1.212700e-1	1.000000e+0	16	1.512280e-1	1.000000e+0	1.000000e+0	6.352465e+0	1.574192e-1	1	1420	5.000000e-1	7.042254e-4	unnamed	NBN
GO Cellular Component	GO:0031981	nuclear lumen	17	1.748307e-1	1.000000e+0	1.000000e+0	5.719819e+0	1.748307e-1	1	1.748307e-1	1.000000e+0	17	2.174952e-1	1.000000e+0	1.000000e+0	4.332613e+0	2.308076e-1	1	2082	5.000000e-1	4.803074e-4	unnamed	NBN
GO Cellular Component	GO:0044428	nuclear part	18	2.070089e-1	1.000000e+0	1.000000e+0	4.830709e+0	2.070089e-1	1	2.070089e-1	1.000000e+0	18	2.552742e-1	1.000000e+0	1.000000e+0	3.649070e+0	2.740425e-1	1	2472	5.000000e-1	4.045307e-4	unnamed	NBN
GO Cellular Component	GO:0070013	intracellular organelle lumen	19	2.178720e-1	1.000000e+0	1.000000e+0	4.589852e+0	2.178720e-1	1	2.178720e-1	1.000000e+0	19	2.759844e-1	1.000000e+0	1.000000e+0	3.353346e+0	2.982096e-1	1	2690	5.000000e-1	3.717472e-4	unnamed	NBN
GO Cellular Component	GO:0043233	organelle lumen	20	2.231770e-1	1.000000e+0	1.000000e+0	4.480748e+0	2.231770e-1	1	2.231770e-1	1.000000e+0	20	2.816332e-1	1.000000e+0	1.000000e+0	3.280182e+0	3.048611e-1	1	2750	5.000000e-1	3.636364e-4	unnamed	NBN
GO Cellular Component	GO:0031974	membrane-enclosed lumen	21	2.255118e-1	1.000000e+0	1.000000e+0	4.434357e+0	2.255118e-1	1	2.255118e-1	1.000000e+0	21	2.863237e-1	1.000000e+0	1.000000e+0	3.221607e+0	3.104041e-1	1	2800	5.000000e-1	3.571429e-4	unnamed	NBN
GO Cellular Component	GO:0043232	intracellular non-membrane-bounded organelle	22	2.709879e-1	1.000000e+0	1.000000e+0	3.690202e+0	2.709879e-1	1	2.709879e-1	1.000000e+0	22	3.348266e-1	1.000000e+0	1.000000e+0	2.711301e+0	3.688266e-1	1	3327	5.000000e-1	3.005711e-4	unnamed	NBN
GO Cellular Component	GO:0043234	protein complex	23	3.027166e-1	1.000000e+0	1.000000e+0	3.303419e+0	3.027166e-1	1	3.027166e-1	1.000000e+0	23	3.630030e-1	1.000000e+0	1.000000e+0	2.476798e+0	4.037470e-1	1	3642	5.000000e-1	2.745744e-4	unnamed	NBN
GO Cellular Component	GO:0032991	macromolecular complex	24	3.347910e-1	1.000000e+0	1.000000e+0	2.986938e+0	3.347910e-1	1	3.347910e-1	1.000000e+0	24	4.132884e-1	1.000000e+0	1.000000e+0	2.136547e+0	4.680450e-1	1	4222	5.000000e-1	2.368546e-4	unnamed	NBN
GO Cellular Component	GO:0044446	intracellular organelle part	25	4.732075e-1	1.000000e+0	1.000000e+0	2.113238e+0	4.732075e-1	1	4.732075e-1	1.000000e+0	26	5.897910e-1	1.000000e+0	1.000000e+0	1.390765e+0	7.190289e-1	1	6486	5.000000e-1	1.541782e-4	unnamed	NBN
GO Cellular Component	GO:0005634	nucleus	26	4.766312e-1	1.000000e+0	1.000000e+0	2.098058e+0	4.766312e-1	1	4.766312e-1	1.000000e+0	25	5.600157e-1	1.000000e+0	1.000000e+0	1.485100e+0	6.733551e-1	1	6074	5.000000e-1	1.646362e-4	unnamed	NBN
GO Cellular Component	GO:0044422	organelle part	27	4.814989e-1	1.000000e+0	1.000000e+0	2.076848e+0	4.814989e-1	1	4.814989e-1	1.000000e+0	27	5.977049e-1	1.000000e+0	1.000000e+0	1.367157e+0	7.314450e-1	1	6598	5.000000e-1	1.515611e-4	unnamed	NBN
GO Cellular Component	GO:0043231	intracellular membrane-bounded organelle	28	6.973299e-1	1.000000e+0	1.000000e+0	1.434041e+0	6.973299e-1	1	6.973299e-1	1.000000e+0	28	8.019514e-1	1.000000e+0	1.000000e+0	9.009688e-1	1.109916e+0	1	10012	5.000000e-1	9.988014e-5	unnamed	NBN
GO Cellular Component	GO:0043227	membrane-bounded organelle	29	6.992039e-1	1.000000e+0	1.000000e+0	1.430198e+0	6.992039e-1	1	6.992039e-1	1.000000e+0	29	8.036253e-1	1.000000e+0	1.000000e+0	8.979196e-1	1.113685e+0	1	10046	5.000000e-1	9.954211e-5	unnamed	NBN
GO Cellular Component	GO:0043229	intracellular organelle	30	7.399473e-1	1.000000e+0	1.000000e+0	1.351448e+0	7.399473e-1	1	7.399473e-1	1.000000e+0	30	8.473502e-1	1.000000e+0	1.000000e+0	8.206423e-1	1.218558e+0	1	10992	5.000000e-1	9.097525e-5	unnamed	NBN
GO Cellular Component	GO:0043226	organelle	31	7.415866e-1	1.000000e+0	1.000000e+0	1.348460e+0	7.415866e-1	1	7.415866e-1	1.000000e+0	31	8.487331e-1	1.000000e+0	1.000000e+0	8.182602e-1	1.222105e+0	1	11024	5.000000e-1	9.071118e-5	unnamed	NBN
GO Cellular Component	GO:0044424	intracellular part	32	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	32	9.083176e-1	1.000000e+0	1.000000e+0	7.171649e-1	1.394379e+0	1	12578	5.000000e-1	7.950390e-5	unnamed	NBN
GO Cellular Component	GO:0005622	intracellular	33	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	33	9.139354e-1	1.000000e+0	1.000000e+0	7.076012e-1	1.413225e+0	1	12748	5.000000e-1	7.844368e-5	unnamed	NBN
GO Cellular Component	GO:0044464	cell part	34	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	34	9.677154e-1	1.000000e+0	1.000000e+0	6.095344e-1	1.640596e+0	1	14799	5.000000e-1	6.757213e-5	unnamed	NBN
GO Cellular Component	GO:0005623	cell	35	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	35	9.677354e-1	1.000000e+0	1.000000e+0	6.094932e-1	1.640707e+0	1	14800	5.000000e-1	6.756757e-5	unnamed	NBN
Mouse Phenotype	MP:0009592	Leydig cell tumor	1	1.361886e-4	1.000000e+0	1.000000e+0	7.342761e+3	1.361886e-4	1	1.361886e-4	1.000000e+0	1	4.433975e-4	1.000000e+0	1.000000e+0	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	NBN
Mouse Phenotype	MP:0003496	increased thyroid adenoma incidence	2	2.794779e-4	1.000000e+0	1.000000e+0	3.578100e+3	2.794779e-4	1	2.794779e-4	1.000000e+0	3	7.758812e-4	1.000000e+0	1.000000e+0	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	NBN
Mouse Phenotype	MP:0009591	liver adenocarcinoma	3	6.193459e-4	1.000000e+0	1.000000e+0	1.614607e+3	6.193459e-4	1	6.193459e-4	1.000000e+0	2	6.650594e-4	1.000000e+0	1.000000e+0	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	NBN
Mouse Phenotype	MP:0002583	absent extraembryonic ectoderm	4	7.953839e-4	1.000000e+0	1.000000e+0	1.257255e+3	7.953839e-4	1	7.953839e-4	1.000000e+0	5	1.219107e-3	1.000000e+0	1.000000e+0	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	NBN
Mouse Phenotype	MP:0011198	absent proamniotic cavity	5	8.796106e-4	1.000000e+0	1.000000e+0	1.136867e+3	8.796106e-4	1	8.796106e-4	1.000000e+0	6	1.329898e-3	1.000000e+0	1.000000e+0	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	NBN
Mouse Phenotype	MP:0004500	increased incidence of tumors by ionizing radiation induction	6	1.071102e-3	1.000000e+0	1.000000e+0	9.336178e+2	1.071102e-3	1	1.071102e-3	1.000000e+0	8	1.883760e-3	1.000000e+0	1.000000e+0	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	NBN
Mouse Phenotype	MP:0011184	absent embryonic epiblast	7	1.281113e-3	1.000000e+0	1.000000e+0	7.805714e+2	1.281113e-3	1	1.281113e-3	1.000000e+0	4	1.108309e-3	1.000000e+0	1.000000e+0	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	NBN
Mouse Phenotype	MP:0003324	increased liver adenoma incidence	8	1.542576e-3	1.000000e+0	1.000000e+0	6.482664e+2	1.542576e-3	1	1.542576e-3	1.000000e+0	12	2.216004e-3	1.000000e+0	1.000000e+0	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	NBN
Mouse Phenotype	MP:0010316	increased thyroid tumor incidence	9	1.574984e-3	1.000000e+0	1.000000e+0	6.349273e+2	1.574984e-3	1	1.574984e-3	1.000000e+0	9	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	NBN
Mouse Phenotype	MP:0002690	akinesia	10	1.653210e-3	1.000000e+0	1.000000e+0	6.048840e+2	1.653210e-3	1	1.653210e-3	1.000000e+0	12	2.216004e-3	1.000000e+0	1.000000e+0	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	NBN
Mouse Phenotype	MP:0012113	decreased inner cell mass proliferation	11	1.979832e-3	1.000000e+0	1.000000e+0	5.050932e+2	1.979832e-3	1	1.979832e-3	1.000000e+0	9	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	NBN
Mouse Phenotype	MP:0002627	teratoma	12	2.033227e-3	1.000000e+0	1.000000e+0	4.918289e+2	2.033227e-3	1	2.033227e-3	1.000000e+0	9	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	NBN
Mouse Phenotype	MP:0010736	abnormal extraembryonic ectoderm morphology	13	2.279432e-3	1.000000e+0	1.000000e+0	4.387058e+2	2.279432e-3	1	2.279432e-3	1.000000e+0	14	2.548193e-3	1.000000e+0	1.000000e+0	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	NBN
Mouse Phenotype	MP:0001658	increased mortality induced by gamma-irradiation	14	2.464268e-3	1.000000e+0	1.000000e+0	4.058001e+2	2.464268e-3	1	2.464268e-3	1.000000e+0	22	3.323085e-3	1.000000e+0	1.000000e+0	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	NBN
Mouse Phenotype	MP:0010380	abnormal inner cell mass apoptosis	15	2.638796e-3	1.000000e+0	1.000000e+0	3.789606e+2	2.638796e-3	1	2.638796e-3	1.000000e+0	17	2.880326e-3	1.000000e+0	1.000000e+0	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	NBN
Mouse Phenotype	MP:0000853	absent cerebellar foliation	16	2.638876e-3	1.000000e+0	1.000000e+0	3.789492e+2	2.638876e-3	1	2.638876e-3	1.000000e+0	7	1.551461e-3	1.000000e+0	1.000000e+0	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	NBN
Mouse Phenotype	MP:0004228	decreased cellular sensitivity to ionizing radiation	17	2.770006e-3	1.000000e+0	1.000000e+0	3.610101e+2	2.770006e-3	1	2.770006e-3	1.000000e+0	25	3.765745e-3	1.000000e+0	1.000000e+0	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	NBN
Mouse Phenotype	MP:0012114	absent inner cell mass proliferation	18	3.095246e-3	1.000000e+0	1.000000e+0	3.230761e+2	3.095246e-3	1	3.095246e-3	1.000000e+0	27	4.540164e-3	1.000000e+0	1.000000e+0	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	NBN
Mouse Phenotype	MP:0002007	increased cellular sensitivity to gamma-irradiation	19	3.294309e-3	1.000000e+0	1.000000e+0	3.035538e+2	3.294309e-3	1	3.294309e-3	1.000000e+0	30	5.424845e-3	1.000000e+0	1.000000e+0	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	NBN
Mouse Phenotype	MP:0004965	inner cell mass degeneration	20	3.358718e-3	1.000000e+0	1.000000e+0	2.977326e+2	3.358718e-3	1	3.358718e-3	1.000000e+0	23	3.655089e-3	1.000000e+0	1.000000e+0	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	NBN
Mouse Phenotype	MP:0004805	absent oocytes	21	3.359096e-3	1.000000e+0	1.000000e+0	2.976991e+2	3.359096e-3	1	3.359096e-3	1.000000e+0	17	2.880326e-3	1.000000e+0	1.000000e+0	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	NBN
Mouse Phenotype	MP:0011197	abnormal proamniotic cavity morphology	22	3.452191e-3	1.000000e+0	1.000000e+0	2.896711e+2	3.452191e-3	1	3.452191e-3	1.000000e+0	14	2.548193e-3	1.000000e+0	1.000000e+0	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	NBN
Mouse Phenotype	MP:0010308	decreased tumor latency	23	3.702321e-3	1.000000e+0	1.000000e+0	2.701008e+2	3.702321e-3	1	3.702321e-3	1.000000e+0	26	3.987038e-3	1.000000e+0	1.000000e+0	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	NBN
Mouse Phenotype	MP:0009219	prostate intraepithelial neoplasia	24	3.718651e-3	1.000000e+0	1.000000e+0	2.689147e+2	3.718651e-3	1	3.718651e-3	1.000000e+0	14	2.548193e-3	1.000000e+0	1.000000e+0	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	NBN
Mouse Phenotype	MP:0003992	increased mortality induced by ionizing radiation	25	3.999546e-3	1.000000e+0	1.000000e+0	2.500283e+2	3.999546e-3	1	3.999546e-3	1.000000e+0	28	4.982553e-3	1.000000e+0	1.000000e+0	2.004556e+2	4.988637e-3	1	45	5.000000e-1	2.222222e-2	unnamed	NBN
Mouse Phenotype	MP:0006262	testis tumor	26	4.134420e-3	1.000000e+0	1.000000e+0	2.418719e+2	4.134420e-3	1	4.134420e-3	1.000000e+0	19	3.101718e-3	1.000000e+0	1.000000e+0	3.221607e+2	3.104041e-3	1	28	5.000000e-1	3.571429e-2	unnamed	NBN
Mouse Phenotype	MP:0004045	abnormal cell cycle checkpoint function	27	4.183364e-3	1.000000e+0	1.000000e+0	2.390421e+2	4.183364e-3	1	4.183364e-3	1.000000e+0	34	6.198618e-3	1.000000e+0	1.000000e+0	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	NBN
Mouse Phenotype	MP:0001409	increased stereotypic behavior	28	4.696122e-3	1.000000e+0	1.000000e+0	2.129417e+2	4.696122e-3	1	4.696122e-3	1.000000e+0	19	3.101718e-3	1.000000e+0	1.000000e+0	3.221607e+2	3.104041e-3	1	28	5.000000e-1	3.571429e-2	unnamed	NBN
Mouse Phenotype	MP:0003988	disorganized embryonic tissue	29	4.778496e-3	1.000000e+0	1.000000e+0	2.092708e+2	4.778496e-3	1	4.778496e-3	1.000000e+0	23	3.655089e-3	1.000000e+0	1.000000e+0	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	NBN
Mouse Phenotype	MP:0010357	increased prostate gland tumor incidence	30	4.880853e-3	1.000000e+0	1.000000e+0	2.048822e+2	4.880853e-3	1	4.880853e-3	1.000000e+0	21	3.212404e-3	1.000000e+0	1.000000e+0	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	NBN
Mouse Phenotype	MP:0004227	increased cellular sensitivity to ionizing radiation	31	4.938177e-3	1.000000e+0	1.000000e+0	2.025039e+2	4.938177e-3	1	4.938177e-3	1.000000e+0	46	8.297342e-3	1.000000e+0	1.000000e+0	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	NBN
Mouse Phenotype	MP:0001883	mammary adenocarcinoma	32	5.144080e-3	1.000000e+0	1.000000e+0	1.943982e+2	5.144080e-3	1	5.144080e-3	1.000000e+0	29	5.314281e-3	1.000000e+0	1.000000e+0	1.879271e+2	5.321213e-3	1	48	5.000000e-1	2.083333e-2	unnamed	NBN
Mouse Phenotype	MP:0002777	absent ovarian follicles	33	5.148897e-3	1.000000e+0	1.000000e+0	1.942164e+2	5.148897e-3	1	5.148897e-3	1.000000e+0	31	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	NBN
Mouse Phenotype	MP:0004028	chromosome breakage	34	5.508062e-3	1.000000e+0	1.000000e+0	1.815520e+2	5.508062e-3	1	5.508062e-3	1.000000e+0	38	7.082562e-3	1.000000e+0	1.000000e+0	1.409453e+2	7.094950e-3	1	64	5.000000e-1	1.562500e-2	unnamed	NBN
Mouse Phenotype	MP:0004966	abnormal inner cell mass proliferation	35	5.621959e-3	1.000000e+0	1.000000e+0	1.778739e+2	5.621959e-3	1	5.621959e-3	1.000000e+0	35	6.640639e-3	1.000000e+0	1.000000e+0	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	NBN
Mouse Phenotype	MP:0002023	B cell derived lymphoma	36	5.945856e-3	1.000000e+0	1.000000e+0	1.681844e+2	5.945856e-3	1	5.945856e-3	1.000000e+0	41	7.634827e-3	1.000000e+0	1.000000e+0	1.307319e+2	7.649243e-3	1	69	5.000000e-1	1.449275e-2	unnamed	NBN
Mouse Phenotype	MP:0010307	abnormal tumor latency	37	6.284847e-3	1.000000e+0	1.000000e+0	1.591129e+2	6.284847e-3	1	6.284847e-3	1.000000e+0	31	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	NBN
Mouse Phenotype	MP:0002027	lung adenocarcinoma	38	6.674635e-3	1.000000e+0	1.000000e+0	1.498209e+2	6.674635e-3	1	6.674635e-3	1.000000e+0	40	7.524386e-3	1.000000e+0	1.000000e+0	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	NBN
Mouse Phenotype	MP:0009590	gonad tumor	39	6.682982e-3	1.000000e+0	1.000000e+0	1.496338e+2	6.682982e-3	1	6.682982e-3	1.000000e+0	33	6.088097e-3	1.000000e+0	1.000000e+0	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	NBN
Mouse Phenotype	MP:0008497	decreased IgG2b level	40	6.711065e-3	1.000000e+0	1.000000e+0	1.490077e+2	6.711065e-3	1	6.711065e-3	1.000000e+0	36	6.751129e-3	1.000000e+0	1.000000e+0	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	NBN
Mouse Phenotype	MP:0008716	lung non-small cell carcinoma	41	7.123287e-3	1.000000e+0	1.000000e+0	1.403846e+2	7.123287e-3	1	7.123287e-3	1.000000e+0	46	8.297342e-3	1.000000e+0	1.000000e+0	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	NBN
Mouse Phenotype	MP:0008944	decreased sensitivity to induced cell death	42	7.276732e-3	1.000000e+0	1.000000e+0	1.374243e+2	7.276732e-3	1	7.276732e-3	1.000000e+0	46	8.297342e-3	1.000000e+0	1.000000e+0	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	NBN
Mouse Phenotype	MP:0002175	decreased brain weight	43	8.018815e-3	1.000000e+0	1.000000e+0	1.247067e+2	8.018815e-3	1	8.018815e-3	1.000000e+0	44	8.076528e-3	1.000000e+0	1.000000e+0	1.235685e+2	8.092678e-3	1	73	5.000000e-1	1.369863e-2	unnamed	NBN
Mouse Phenotype	MP:0002718	abnormal inner cell mass morphology	44	8.027305e-3	1.000000e+0	1.000000e+0	1.245748e+2	8.027305e-3	1	8.027305e-3	1.000000e+0	49	8.959636e-3	1.000000e+0	1.000000e+0	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	NBN
Mouse Phenotype	MP:0008714	lung carcinoma	45	8.130735e-3	1.000000e+0	1.000000e+0	1.229901e+2	8.130735e-3	1	8.130735e-3	1.000000e+0	53	9.842351e-3	1.000000e+0	1.000000e+0	1.013539e+2	9.866415e-3	1	89	5.000000e-1	1.123596e-2	unnamed	NBN
Mouse Phenotype	MP:0008496	decreased IgG2a level	46	8.463890e-3	1.000000e+0	1.000000e+0	1.181490e+2	8.463890e-3	1	8.463890e-3	1.000000e+0	53	9.842351e-3	1.000000e+0	1.000000e+0	1.013539e+2	9.866415e-3	1	89	5.000000e-1	1.123596e-2	unnamed	NBN
Mouse Phenotype	MP:0005431	decreased oocyte number	47	8.542522e-3	1.000000e+0	1.000000e+0	1.170614e+2	8.542522e-3	1	8.542522e-3	1.000000e+0	43	7.966112e-3	1.000000e+0	1.000000e+0	1.252847e+2	7.981819e-3	1	72	5.000000e-1	1.388889e-2	unnamed	NBN
Mouse Phenotype	MP:0003886	abnormal embryonic epiblast morphology	48	9.014780e-3	1.000000e+0	1.000000e+0	1.109289e+2	9.014780e-3	1	9.014780e-3	1.000000e+0	37	6.972090e-3	1.000000e+0	1.000000e+0	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	NBN
Mouse Phenotype	MP:0008498	decreased IgG3 level	49	9.220685e-3	1.000000e+0	1.000000e+0	1.084518e+2	9.220685e-3	1	9.220685e-3	1.000000e+0	51	9.732033e-3	1.000000e+0	1.000000e+0	1.025057e+2	9.755557e-3	1	88	5.000000e-1	1.136364e-2	unnamed	NBN
Mouse Phenotype	MP:0010299	increased mammary gland tumor incidence	50	9.402370e-3	1.000000e+0	1.000000e+0	1.063562e+2	9.402370e-3	1	9.402370e-3	1.000000e+0	51	9.732033e-3	1.000000e+0	1.000000e+0	1.025057e+2	9.755557e-3	1	88	5.000000e-1	1.136364e-2	unnamed	NBN
Mouse Phenotype	MP:0008866	chromosomal instability	51	9.832341e-3	1.000000e+0	1.000000e+0	1.017052e+2	9.832341e-3	1	9.832341e-3	1.000000e+0	66	1.248814e-2	1.000000e+0	1.000000e+0	7.982743e+1	1.252702e-2	1	113	5.000000e-1	8.849558e-3	unnamed	NBN
Mouse Phenotype	MP:0010094	abnormal chromosome stability	52	9.881449e-3	1.000000e+0	1.000000e+0	1.011997e+2	9.881449e-3	1	9.881449e-3	1.000000e+0	69	1.281861e-2	1.000000e+0	1.000000e+0	7.776293e+1	1.285960e-2	1	116	5.000000e-1	8.620690e-3	unnamed	NBN
Mouse Phenotype	MP:0012103	abnormal embryonic disc morphology	53	1.003309e-2	1.000000e+0	1.000000e+0	9.967017e+1	1.003309e-2	1	1.003309e-2	1.000000e+0	39	7.413939e-3	1.000000e+0	1.000000e+0	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	NBN
Mouse Phenotype	MP:0008943	increased sensitivity to induced cell death	54	1.087050e-2	1.000000e+0	1.000000e+0	9.199209e+1	1.087050e-2	1	1.087050e-2	1.000000e+0	85	1.667005e-2	1.000000e+0	1.000000e+0	5.973841e+1	1.673965e-2	1	151	5.000000e-1	6.622517e-3	unnamed	NBN
Mouse Phenotype	MP:0010287	increased reproductive system tumor incidence	55	1.089120e-2	1.000000e+0	1.000000e+0	9.181723e+1	1.089120e-2	1	1.089120e-2	1.000000e+0	50	9.511379e-3	1.000000e+0	1.000000e+0	1.048895e+2	9.533840e-3	1	86	5.000000e-1	1.162791e-2	unnamed	NBN
Mouse Phenotype	MP:0002024	T cell derived lymphoma	56	1.137483e-2	1.000000e+0	1.000000e+0	8.791344e+1	1.137483e-2	1	1.137483e-2	1.000000e+0	57	1.072467e-2	1.000000e+0	1.000000e+0	9.299485e+1	1.075328e-2	1	97	5.000000e-1	1.030928e-2	unnamed	NBN
Mouse Phenotype	MP:0010365	increased thymus tumor incidence	57	1.140170e-2	1.000000e+0	1.000000e+0	8.770624e+1	1.140170e-2	1	1.140170e-2	1.000000e+0	59	1.083493e-2	1.000000e+0	1.000000e+0	9.204592e+1	1.086414e-2	1	98	5.000000e-1	1.020408e-2	unnamed	NBN
Mouse Phenotype	MP:0008209	decreased pre-B cell number	58	1.141684e-2	1.000000e+0	1.000000e+0	8.758988e+1	1.141684e-2	1	1.141684e-2	1.000000e+0	55	9.952663e-3	1.000000e+0	1.000000e+0	1.002278e+2	9.977274e-3	1	90	5.000000e-1	1.111111e-2	unnamed	NBN
Mouse Phenotype	MP:0001125	abnormal oocyte morphology	59	1.155225e-2	1.000000e+0	1.000000e+0	8.656325e+1	1.155225e-2	1	1.155225e-2	1.000000e+0	60	1.127592e-2	1.000000e+0	1.000000e+0	8.843627e+1	1.130758e-2	1	102	5.000000e-1	9.803922e-3	unnamed	NBN
Mouse Phenotype	MP:0005093	decreased B cell proliferation	60	1.159433e-2	1.000000e+0	1.000000e+0	8.624903e+1	1.159433e-2	1	1.159433e-2	1.000000e+0	63	1.171681e-2	1.000000e+0	1.000000e+0	8.509906e+1	1.175101e-2	1	106	5.000000e-1	9.433962e-3	unnamed	NBN
Mouse Phenotype	MP:0008019	increased liver tumor incidence	61	1.160410e-2	1.000000e+0	1.000000e+0	8.617647e+1	1.160410e-2	1	1.160410e-2	1.000000e+0	65	1.237796e-2	1.000000e+0	1.000000e+0	8.054018e+1	1.241616e-2	1	112	5.000000e-1	8.928571e-3	unnamed	NBN
Mouse Phenotype	MP:0010297	increased hepatobiliary system tumor incidence	62	1.173767e-2	1.000000e+0	1.000000e+0	8.519581e+1	1.173767e-2	1	1.173767e-2	1.000000e+0	67	1.259830e-2	1.000000e+0	1.000000e+0	7.912719e+1	1.263788e-2	1	114	5.000000e-1	8.771930e-3	unnamed	NBN
Mouse Phenotype	MP:0002032	sarcoma	63	1.184575e-2	1.000000e+0	1.000000e+0	8.441844e+1	1.184575e-2	1	1.184575e-2	1.000000e+0	71	1.303889e-2	1.000000e+0	1.000000e+0	7.644492e+1	1.308131e-2	1	118	5.000000e-1	8.474576e-3	unnamed	NBN
Mouse Phenotype	MP:0006361	abnormal female germ cell morphology	64	1.200099e-2	1.000000e+0	1.000000e+0	8.332645e+1	1.200099e-2	1	1.200099e-2	1.000000e+0	62	1.149638e-2	1.000000e+0	1.000000e+0	8.673558e+1	1.152929e-2	1	104	5.000000e-1	9.615385e-3	unnamed	NBN
Mouse Phenotype	MP:0000872	abnormal cerebellum external granule cell layer morphology	65	1.205420e-2	1.000000e+0	1.000000e+0	8.295865e+1	1.205420e-2	1	1.205420e-2	1.000000e+0	42	7.745261e-3	1.000000e+0	1.000000e+0	1.288643e+2	7.760102e-3	1	70	5.000000e-1	1.428571e-2	unnamed	NBN
Mouse Phenotype	MP:0008871	abnormal ovarian follicle number	66	1.265762e-2	1.000000e+0	1.000000e+0	7.900377e+1	1.265762e-2	1	1.265762e-2	1.000000e+0	72	1.358950e-2	1.000000e+0	1.000000e+0	7.333740e+1	1.363561e-2	1	123	5.000000e-1	8.130081e-3	unnamed	NBN
Mouse Phenotype	MP:0005028	abnormal trophectoderm morphology	67	1.275737e-2	1.000000e+0	1.000000e+0	7.838609e+1	1.275737e-2	1	1.275737e-2	1.000000e+0	74	1.413995e-2	1.000000e+0	1.000000e+0	7.047266e+1	1.418990e-2	1	128	5.000000e-1	7.812500e-3	unnamed	NBN
Mouse Phenotype	MP:0008014	increased lung tumor incidence	68	1.298326e-2	1.000000e+0	1.000000e+0	7.702228e+1	1.298326e-2	1	1.298326e-2	1.000000e+0	73	1.391979e-2	1.000000e+0	1.000000e+0	7.159127e+1	1.396818e-2	1	126	5.000000e-1	7.936508e-3	unnamed	NBN
Mouse Phenotype	MP:0008495	decreased IgG1 level	69	1.309759e-2	1.000000e+0	1.000000e+0	7.634992e+1	1.309759e-2	1	1.309759e-2	1.000000e+0	80	1.524040e-2	1.000000e+0	1.000000e+0	6.536594e+1	1.529849e-2	1	138	5.000000e-1	7.246377e-3	unnamed	NBN
Mouse Phenotype	MP:0000433	microcephaly	70	1.334416e-2	1.000000e+0	1.000000e+0	7.493916e+1	1.334416e-2	1	1.334416e-2	1.000000e+0	45	8.186938e-3	1.000000e+0	1.000000e+0	1.218986e+2	8.203536e-3	1	74	5.000000e-1	1.351351e-2	unnamed	NBN
Mouse Phenotype	MP:0002403	abnormal pre-B cell morphology	71	1.364386e-2	1.000000e+0	1.000000e+0	7.329305e+1	1.364386e-2	1	1.364386e-2	1.000000e+0	69	1.281861e-2	1.000000e+0	1.000000e+0	7.776293e+1	1.285960e-2	1	116	5.000000e-1	8.620690e-3	unnamed	NBN
Mouse Phenotype	MP:0001931	abnormal oogenesis	72	1.410581e-2	1.000000e+0	1.000000e+0	7.089277e+1	1.410581e-2	1	1.410581e-2	1.000000e+0	78	1.480029e-2	1.000000e+0	1.000000e+0	6.731716e+1	1.485505e-2	1	134	5.000000e-1	7.462687e-3	unnamed	NBN
Mouse Phenotype	MP:0011203	abnormal parietal yolk sac morphology	73	1.463667e-2	1.000000e+0	1.000000e+0	6.832154e+1	1.463667e-2	1	1.463667e-2	1.000000e+0	82	1.634023e-2	1.000000e+0	1.000000e+0	6.094932e+1	1.640707e-2	1	148	5.000000e-1	6.756757e-3	unnamed	NBN
Mouse Phenotype	MP:0011496	abnormal head size	74	1.481709e-2	1.000000e+0	1.000000e+0	6.748963e+1	1.481709e-2	1	1.481709e-2	1.000000e+0	56	1.006297e-2	1.000000e+0	1.000000e+0	9.912637e+1	1.008813e-2	1	91	5.000000e-1	1.098901e-2	unnamed	NBN
Mouse Phenotype	MP:0009308	adenocarcinoma	75	1.492238e-2	1.000000e+0	1.000000e+0	6.701344e+1	1.492238e-2	1	1.492238e-2	1.000000e+0	87	1.677999e-2	1.000000e+0	1.000000e+0	5.934539e+1	1.685051e-2	1	152	5.000000e-1	6.578947e-3	unnamed	NBN
Mouse Phenotype	MP:0001127	small ovary	76	1.492773e-2	1.000000e+0	1.000000e+0	6.698940e+1	1.492773e-2	1	1.492773e-2	1.000000e+0	77	1.469025e-2	1.000000e+0	1.000000e+0	6.782331e+1	1.474419e-2	1	133	5.000000e-1	7.518797e-3	unnamed	NBN
Mouse Phenotype	MP:0008932	abnormal embryonic tissue physiology	77	1.493424e-2	1.000000e+0	1.000000e+0	6.696020e+1	1.493424e-2	1	1.493424e-2	1.000000e+0	61	1.138616e-2	1.000000e+0	1.000000e+0	8.757767e+1	1.141844e-2	1	103	5.000000e-1	9.708738e-3	unnamed	NBN
Mouse Phenotype	MP:0010293	increased integument system tumor incidence	78	1.498579e-2	1.000000e+0	1.000000e+0	6.672990e+1	1.498579e-2	1	1.498579e-2	1.000000e+0	85	1.667005e-2	1.000000e+0	1.000000e+0	5.973841e+1	1.673965e-2	1	151	5.000000e-1	6.622517e-3	unnamed	NBN
Mouse Phenotype	MP:0002021	increased incidence of induced tumors	79	1.567887e-2	1.000000e+0	1.000000e+0	6.378010e+1	1.567887e-2	1	1.567887e-2	1.000000e+0	79	1.513038e-2	1.000000e+0	1.000000e+0	6.584307e+1	1.518763e-2	1	137	5.000000e-1	7.299270e-3	unnamed	NBN
Mouse Phenotype	MP:0001117	absent gametes	80	1.602344e-2	1.000000e+0	1.000000e+0	6.240858e+1	1.602344e-2	1	1.602344e-2	1.000000e+0	92	1.963603e-2	1.000000e+0	1.000000e+0	5.067697e+1	1.973283e-2	1	178	5.000000e-1	5.617978e-3	unnamed	NBN
Mouse Phenotype	MP:0004853	abnormal ovary size	81	1.645908e-2	1.000000e+0	1.000000e+0	6.075672e+1	1.645908e-2	1	1.645908e-2	1.000000e+0	83	1.645017e-2	1.000000e+0	1.000000e+0	6.054027e+1	1.651793e-2	1	149	5.000000e-1	6.711409e-3	unnamed	NBN
Mouse Phenotype	MP:0002182	abnormal astrocyte morphology	82	1.662627e-2	1.000000e+0	1.000000e+0	6.014579e+1	1.662627e-2	1	1.662627e-2	1.000000e+0	89	1.721965e-2	1.000000e+0	1.000000e+0	5.782372e+1	1.729394e-2	1	156	5.000000e-1	6.410256e-3	unnamed	NBN
Mouse Phenotype	MP:0005153	abnormal B cell proliferation	83	1.684528e-2	1.000000e+0	1.000000e+0	5.936382e+1	1.684528e-2	1	1.684528e-2	1.000000e+0	90	1.842821e-2	1.000000e+0	1.000000e+0	5.401497e+1	1.851339e-2	1	167	5.000000e-1	5.988024e-3	unnamed	NBN
Mouse Phenotype	MP:0010383	increased adenoma incidence	84	1.689252e-2	1.000000e+0	1.000000e+0	5.919779e+1	1.689252e-2	1	1.689252e-2	1.000000e+0	88	1.699983e-2	1.000000e+0	1.000000e+0	5.857468e+1	1.707222e-2	1	154	5.000000e-1	6.493506e-3	unnamed	NBN
Mouse Phenotype	MP:0008942	abnormal induced cell death	85	1.726637e-2	1.000000e+0	1.000000e+0	5.791607e+1	1.726637e-2	1	1.726637e-2	1.000000e+0	100	2.314545e-2	1.000000e+0	1.000000e+0	4.295476e+1	2.328031e-2	1	210	5.000000e-1	4.761905e-3	unnamed	NBN
Mouse Phenotype	MP:0008215	decreased immature B cell number	86	1.726959e-2	1.000000e+0	1.000000e+0	5.790526e+1	1.726959e-2	1	1.726959e-2	1.000000e+0	83	1.645017e-2	1.000000e+0	1.000000e+0	6.054027e+1	1.651793e-2	1	149	5.000000e-1	6.711409e-3	unnamed	NBN
Mouse Phenotype	MP:0008217	abnormal B cell activation	87	1.794285e-2	1.000000e+0	1.000000e+0	5.573250e+1	1.794285e-2	1	1.794285e-2	1.000000e+0	93	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	NBN
Mouse Phenotype	MP:0000886	abnormal cerebellar granule layer	88	1.811551e-2	1.000000e+0	1.000000e+0	5.520132e+1	1.811551e-2	1	1.811551e-2	1.000000e+0	68	1.270846e-2	1.000000e+0	1.000000e+0	7.843913e+1	1.274874e-2	1	115	5.000000e-1	8.695652e-3	unnamed	NBN
Mouse Phenotype	MP:0001525	impaired balance	89	1.811598e-2	1.000000e+0	1.000000e+0	5.519988e+1	1.811598e-2	1	1.811598e-2	1.000000e+0	76	1.458020e-2	1.000000e+0	1.000000e+0	6.833712e+1	1.463334e-2	1	132	5.000000e-1	7.575758e-3	unnamed	NBN
Mouse Phenotype	MP:0004806	absent germ cells	90	1.845597e-2	1.000000e+0	1.000000e+0	5.418301e+1	1.845597e-2	1	1.845597e-2	1.000000e+0	96	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	NBN
Mouse Phenotype	MP:0000857	abnormal cerebellar foliation	91	1.975168e-2	1.000000e+0	1.000000e+0	5.062861e+1	1.975168e-2	1	1.975168e-2	1.000000e+0	57	1.072467e-2	1.000000e+0	1.000000e+0	9.299485e+1	1.075328e-2	1	97	5.000000e-1	1.030928e-2	unnamed	NBN
Mouse Phenotype	MP:0004957	abnormal blastocyst morphology	92	2.026522e-2	1.000000e+0	1.000000e+0	4.934563e+1	2.026522e-2	1	2.026522e-2	1.000000e+0	98	2.270712e-2	1.000000e+0	1.000000e+0	4.378883e+1	2.283687e-2	1	206	5.000000e-1	4.854369e-3	unnamed	NBN
Mouse Phenotype	MP:0001823	thymus hypoplasia	93	2.083639e-2	1.000000e+0	1.000000e+0	4.799296e+1	2.083639e-2	1	2.083639e-2	1.000000e+0	94	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	NBN
Mouse Phenotype	MP:0009964	abnormal cerebellum lobule morphology	94	2.152053e-2	1.000000e+0	1.000000e+0	4.646726e+1	2.152053e-2	1	2.152053e-2	1.000000e+0	63	1.171681e-2	1.000000e+0	1.000000e+0	8.509906e+1	1.175101e-2	1	106	5.000000e-1	9.433962e-3	unnamed	NBN
Mouse Phenotype	MP:0005022	abnormal immature B cell morphology	95	2.214945e-2	1.000000e+0	1.000000e+0	4.514786e+1	2.214945e-2	1	2.214945e-2	1.000000e+0	97	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	NBN
Mouse Phenotype	MP:0000852	small cerebellum	96	2.215338e-2	1.000000e+0	1.000000e+0	4.513983e+1	2.215338e-2	1	2.215338e-2	1.000000e+0	75	1.436009e-2	1.000000e+0	1.000000e+0	6.938846e+1	1.441162e-2	1	130	5.000000e-1	7.692308e-3	unnamed	NBN
Mouse Phenotype	MP:0002022	increased lymphoma incidence	97	2.227473e-2	1.000000e+0	1.000000e+0	4.489392e+1	2.227473e-2	1	2.227473e-2	1.000000e+0	101	2.413134e-2	1.000000e+0	1.000000e+0	4.118950e+1	2.427803e-2	1	219	5.000000e-1	4.566210e-3	unnamed	NBN
Mouse Phenotype	MP:0001805	decreased IgG level	98	2.347358e-2	1.000000e+0	1.000000e+0	4.260109e+1	2.347358e-2	1	2.347358e-2	1.000000e+0	108	2.697668e-2	1.000000e+0	1.000000e+0	3.681837e+1	2.716036e-2	1	245	5.000000e-1	4.081633e-3	unnamed	NBN
Mouse Phenotype	MP:0003077	abnormal cell cycle	99	2.376361e-2	1.000000e+0	1.000000e+0	4.208115e+1	2.376361e-2	1	2.376361e-2	1.000000e+0	109	2.850706e-2	1.000000e+0	1.000000e+0	3.482819e+1	2.871238e-2	1	259	5.000000e-1	3.861004e-3	unnamed	NBN
Mouse Phenotype	MP:0008211	decreased mature B cell number	100	2.473708e-2	1.000000e+0	1.000000e+0	4.042514e+1	2.473708e-2	1	2.473708e-2	1.000000e+0	104	2.555453e-2	1.000000e+0	1.000000e+0	3.888147e+1	2.571920e-2	1	232	5.000000e-1	4.310345e-3	unnamed	NBN
Mouse Phenotype	MP:0001131	abnormal ovarian follicle morphology	101	2.489271e-2	1.000000e+0	1.000000e+0	4.017241e+1	2.489271e-2	1	2.489271e-2	1.000000e+0	98	2.270712e-2	1.000000e+0	1.000000e+0	4.378883e+1	2.283687e-2	1	206	5.000000e-1	4.854369e-3	unnamed	NBN
Mouse Phenotype	MP:0008075	decreased CD4-positive T cell number	102	2.541417e-2	1.000000e+0	1.000000e+0	3.934812e+1	2.541417e-2	1	2.541417e-2	1.000000e+0	106	2.653920e-2	1.000000e+0	1.000000e+0	3.742946e+1	2.671692e-2	1	241	5.000000e-1	4.149378e-3	unnamed	NBN
Mouse Phenotype	MP:0000854	abnormal cerebellum development	103	2.586109e-2	1.000000e+0	1.000000e+0	3.866813e+1	2.586109e-2	1	2.586109e-2	1.000000e+0	81	1.557041e-2	1.000000e+0	1.000000e+0	6.397518e+1	1.563106e-2	1	141	5.000000e-1	7.092199e-3	unnamed	NBN
Mouse Phenotype	MP:0010296	increased hemolymphoid system tumor incidence	104	2.613114e-2	1.000000e+0	1.000000e+0	3.826852e+1	2.613114e-2	1	2.613114e-2	1.000000e+0	109	2.850706e-2	1.000000e+0	1.000000e+0	3.482819e+1	2.871238e-2	1	259	5.000000e-1	3.861004e-3	unnamed	NBN
Mouse Phenotype	MP:0006043	decreased apoptosis	105	2.648005e-2	1.000000e+0	1.000000e+0	3.776428e+1	2.648005e-2	1	2.648005e-2	1.000000e+0	105	2.577339e-2	1.000000e+0	1.000000e+0	3.854915e+1	2.594091e-2	1	234	5.000000e-1	4.273504e-3	unnamed	NBN
Mouse Phenotype	MP:0011096	complete embryonic lethality between implantation and somite formation	106	2.707518e-2	1.000000e+0	1.000000e+0	3.693420e+1	2.707518e-2	1	2.707518e-2	1.000000e+0	115	2.992705e-2	1.000000e+0	1.000000e+0	3.316360e+1	3.015354e-2	1	272	5.000000e-1	3.676471e-3	unnamed	NBN
Mouse Phenotype	MP:0002038	carcinoma	107	2.714825e-2	1.000000e+0	1.000000e+0	3.683478e+1	2.714825e-2	1	2.714825e-2	1.000000e+0	113	2.970866e-2	1.000000e+0	1.000000e+0	3.340926e+1	2.993182e-2	1	270	5.000000e-1	3.703704e-3	unnamed	NBN
Mouse Phenotype	MP:0001408	stereotypic behavior	108	2.721686e-2	1.000000e+0	1.000000e+0	3.674193e+1	2.721686e-2	1	2.721686e-2	1.000000e+0	91	1.930669e-2	1.000000e+0	1.000000e+0	5.154571e+1	1.940025e-2	1	175	5.000000e-1	5.714286e-3	unnamed	NBN
Mouse Phenotype	MP:0002460	decreased immunoglobulin level	109	2.899527e-2	1.000000e+0	1.000000e+0	3.448838e+1	2.899527e-2	1	2.899527e-2	1.000000e+0	124	3.363597e-2	1.000000e+0	1.000000e+0	2.947876e+1	3.392273e-2	1	306	5.000000e-1	3.267974e-3	unnamed	NBN
Mouse Phenotype	MP:0000875	abnormal cerebellar Purkinje cell layer	110	2.920911e-2	1.000000e+0	1.000000e+0	3.423590e+1	2.920911e-2	1	2.920911e-2	1.000000e+0	102	2.478833e-2	1.000000e+0	1.000000e+0	4.009111e+1	2.494318e-2	1	225	5.000000e-1	4.444444e-3	unnamed	NBN
Mouse Phenotype	MP:0006205	embryonic lethality between implantation and somite formation	111	2.974573e-2	1.000000e+0	1.000000e+0	3.361827e+1	2.974573e-2	1	2.974573e-2	1.000000e+0	121	3.287295e-2	1.000000e+0	1.000000e+0	3.016890e+1	3.314672e-2	1	299	5.000000e-1	3.344482e-3	unnamed	NBN
Mouse Phenotype	MP:0000774	decreased brain size	112	3.022323e-2	1.000000e+0	1.000000e+0	3.308713e+1	3.022323e-2	1	3.022323e-2	1.000000e+0	103	2.533565e-2	1.000000e+0	1.000000e+0	3.921957e+1	2.549748e-2	1	230	5.000000e-1	4.347826e-3	unnamed	NBN
Mouse Phenotype	MP:0009781	abnormal preimplantation embryo development	113	3.036362e-2	1.000000e+0	1.000000e+0	3.293415e+1	3.036362e-2	1	3.036362e-2	1.000000e+0	127	3.450762e-2	1.000000e+0	1.000000e+0	2.872771e+1	3.480960e-2	1	314	5.000000e-1	3.184713e-3	unnamed	NBN
Mouse Phenotype	MP:0006108	abnormal hindbrain development	114	3.065387e-2	1.000000e+0	1.000000e+0	3.262230e+1	3.065387e-2	1	3.065387e-2	1.000000e+0	94	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	NBN
Mouse Phenotype	MP:0010288	increased gland tumor incidence	115	3.105825e-2	1.000000e+0	1.000000e+0	3.219757e+1	3.105825e-2	1	3.105825e-2	1.000000e+0	107	2.675795e-2	1.000000e+0	1.000000e+0	3.712140e+1	2.693864e-2	1	243	5.000000e-1	4.115226e-3	unnamed	NBN
Mouse Phenotype	MP:0008171	abnormal mature B cell morphology	116	3.123786e-2	1.000000e+0	1.000000e+0	3.201244e+1	3.123786e-2	1	3.123786e-2	1.000000e+0	123	3.352698e-2	1.000000e+0	1.000000e+0	2.957541e+1	3.381187e-2	1	305	5.000000e-1	3.278689e-3	unnamed	NBN
Mouse Phenotype	MP:0000952	abnormal CNS glial cell morphology	117	3.199709e-2	1.000000e+0	1.000000e+0	3.125284e+1	3.199709e-2	1	3.199709e-2	1.000000e+0	112	2.894409e-2	1.000000e+0	1.000000e+0	3.429848e+1	2.915581e-2	1	263	5.000000e-1	3.802281e-3	unnamed	NBN
Mouse Phenotype	MP:0000745	tremors	118	3.275077e-2	1.000000e+0	1.000000e+0	3.053363e+1	3.275077e-2	1	3.275077e-2	1.000000e+0	111	2.861633e-2	1.000000e+0	1.000000e+0	3.469423e+1	2.882324e-2	1	260	5.000000e-1	3.846154e-3	unnamed	NBN
Mouse Phenotype	MP:0000706	small thymus	119	3.301004e-2	1.000000e+0	1.000000e+0	3.029381e+1	3.301004e-2	1	3.301004e-2	1.000000e+0	120	3.232775e-2	1.000000e+0	1.000000e+0	3.068197e+1	3.259243e-2	1	294	5.000000e-1	3.401361e-3	unnamed	NBN
Mouse Phenotype	MP:0008083	decreased single-positive T cell number	120	3.326596e-2	1.000000e+0	1.000000e+0	3.006076e+1	3.326596e-2	1	3.326596e-2	1.000000e+0	126	3.407184e-2	1.000000e+0	1.000000e+0	2.909839e+1	3.436617e-2	1	310	5.000000e-1	3.225806e-3	unnamed	NBN
Mouse Phenotype	MP:0001577	anemia	121	3.352421e-2	1.000000e+0	1.000000e+0	2.982919e+1	3.352421e-2	1	3.352421e-2	1.000000e+0	128	3.635858e-2	1.000000e+0	1.000000e+0	2.725227e+1	3.669420e-2	1	331	5.000000e-1	3.021148e-3	unnamed	NBN
Mouse Phenotype	MP:0002018	malignant tumors	122	3.474739e-2	1.000000e+0	1.000000e+0	2.877914e+1	3.474739e-2	1	3.474739e-2	1.000000e+0	129	3.646740e-2	1.000000e+0	1.000000e+0	2.717018e+1	3.680506e-2	1	332	5.000000e-1	3.012048e-3	unnamed	NBN
Mouse Phenotype	MP:0001126	abnormal ovary morphology	123	3.497291e-2	1.000000e+0	1.000000e+0	2.859356e+1	3.497291e-2	1	3.497291e-2	1.000000e+0	117	3.134601e-2	1.000000e+0	1.000000e+0	3.165088e+1	3.159470e-2	1	285	5.000000e-1	3.508772e-3	unnamed	NBN
Mouse Phenotype	MP:0001926	female infertility	124	3.525648e-2	1.000000e+0	1.000000e+0	2.836358e+1	3.525648e-2	1	3.525648e-2	1.000000e+0	122	3.319999e-2	1.000000e+0	1.000000e+0	2.986921e+1	3.347930e-2	1	302	5.000000e-1	3.311258e-3	unnamed	NBN
Mouse Phenotype	MP:0008073	abnormal CD4-positive T cell number	125	3.596266e-2	1.000000e+0	1.000000e+0	2.780662e+1	3.596266e-2	1	3.596266e-2	1.000000e+0	136	4.038099e-2	1.000000e+0	1.000000e+0	2.451223e+1	4.079596e-2	1	368	5.000000e-1	2.717391e-3	unnamed	NBN
Mouse Phenotype	MP:0000771	abnormal brain size	126	3.646588e-2	1.000000e+0	1.000000e+0	2.742289e+1	3.646588e-2	1	3.646588e-2	1.000000e+0	116	3.101865e-2	1.000000e+0	1.000000e+0	3.198759e+1	3.126213e-2	1	282	5.000000e-1	3.546099e-3	unnamed	NBN
Mouse Phenotype	MP:0001393	ataxia	127	3.690969e-2	1.000000e+0	1.000000e+0	2.709315e+1	3.690969e-2	1	3.690969e-2	1.000000e+0	118	3.156421e-2	1.000000e+0	1.000000e+0	3.143031e+1	3.181642e-2	1	287	5.000000e-1	3.484321e-3	unnamed	NBN
Mouse Phenotype	MP:0009956	abnormal cerebellar layer morphology	128	3.723440e-2	1.000000e+0	1.000000e+0	2.685689e+1	3.723440e-2	1	3.723440e-2	1.000000e+0	114	2.981786e-2	1.000000e+0	1.000000e+0	3.328598e+1	3.004268e-2	1	271	5.000000e-1	3.690037e-3	unnamed	NBN
Mouse Phenotype	MP:0009763	increased sensitivity to induced morbidity/mortality	129	3.731243e-2	1.000000e+0	1.000000e+0	2.680072e+1	3.731243e-2	1	3.731243e-2	1.000000e+0	137	4.114105e-2	1.000000e+0	1.000000e+0	2.405467e+1	4.157197e-2	1	375	5.000000e-1	2.666667e-3	unnamed	NBN
Mouse Phenotype	MP:0002364	abnormal thymus size	130	3.842994e-2	1.000000e+0	1.000000e+0	2.602138e+1	3.842994e-2	1	3.842994e-2	1.000000e+0	135	4.016378e-2	1.000000e+0	1.000000e+0	2.464617e+1	4.057425e-2	1	366	5.000000e-1	2.732240e-3	unnamed	NBN
Mouse Phenotype	MP:0009850	embryonic lethality between implantation and placentation	131	4.196084e-2	1.000000e+0	1.000000e+0	2.383174e+1	4.196084e-2	1	4.196084e-2	1.000000e+0	148	4.699418e-2	1.000000e+0	1.000000e+0	2.102681e+1	4.755834e-2	1	429	5.000000e-1	2.331002e-3	unnamed	NBN
Mouse Phenotype	MP:0001124	abnormal gametes	132	4.207952e-2	1.000000e+0	1.000000e+0	2.376453e+1	4.207952e-2	1	4.207952e-2	1.000000e+0	147	4.666947e-2	1.000000e+0	1.000000e+0	2.117488e+1	4.722576e-2	1	426	5.000000e-1	2.347418e-3	unnamed	NBN
Mouse Phenotype	MP:0002432	abnormal CD4-positive T cell morphology	133	4.208989e-2	1.000000e+0	1.000000e+0	2.375867e+1	4.208989e-2	1	4.208989e-2	1.000000e+0	146	4.656123e-2	1.000000e+0	1.000000e+0	2.122471e+1	4.711490e-2	1	425	5.000000e-1	2.352941e-3	unnamed	NBN
Mouse Phenotype	MP:0003634	abnormal glial cell morphology	134	4.227551e-2	1.000000e+0	1.000000e+0	2.365436e+1	4.227551e-2	1	4.227551e-2	1.000000e+0	132	3.831648e-2	1.000000e+0	1.000000e+0	2.584670e+1	3.868965e-2	1	349	5.000000e-1	2.865330e-3	unnamed	NBN
Mouse Phenotype	MP:0011092	complete embryonic lethality	135	4.260939e-2	1.000000e+0	1.000000e+0	2.346900e+1	4.260939e-2	1	4.260939e-2	1.000000e+0	133	3.842519e-2	1.000000e+0	1.000000e+0	2.577286e+1	3.880051e-2	1	350	5.000000e-1	2.857143e-3	unnamed	NBN
Mouse Phenotype	MP:0002144	abnormal B cell differentiation	136	4.316951e-2	1.000000e+0	1.000000e+0	2.316450e+1	4.316951e-2	1	4.316951e-2	1.000000e+0	143	4.461173e-2	1.000000e+0	1.000000e+0	2.216339e+1	4.511945e-2	1	407	5.000000e-1	2.457002e-3	unnamed	NBN
Mouse Phenotype	MP:0005017	decreased B cell number	137	4.371459e-2	1.000000e+0	1.000000e+0	2.287566e+1	4.371459e-2	1	4.371459e-2	1.000000e+0	140	4.320252e-2	1.000000e+0	1.000000e+0	2.289467e+1	4.367829e-2	1	394	5.000000e-1	2.538071e-3	unnamed	NBN
Mouse Phenotype	MP:0004097	abnormal cerebellar cortex morphology	138	4.448801e-2	1.000000e+0	1.000000e+0	2.247797e+1	4.448801e-2	1	4.448801e-2	1.000000e+0	124	3.363597e-2	1.000000e+0	1.000000e+0	2.947876e+1	3.392273e-2	1	306	5.000000e-1	3.267974e-3	unnamed	NBN
Mouse Phenotype	MP:0002209	decreased germ cell number	139	4.466922e-2	1.000000e+0	1.000000e+0	2.238678e+1	4.466922e-2	1	4.466922e-2	1.000000e+0	145	4.623645e-2	1.000000e+0	1.000000e+0	2.137559e+1	4.678233e-2	1	422	5.000000e-1	2.369668e-3	unnamed	NBN
Mouse Phenotype	MP:0008081	abnormal single-positive T cell number	140	4.577501e-2	1.000000e+0	1.000000e+0	2.184598e+1	4.577501e-2	1	4.577501e-2	1.000000e+0	150	4.969789e-2	1.000000e+0	1.000000e+0	1.986894e+1	5.032980e-2	1	454	5.000000e-1	2.202643e-3	unnamed	NBN
Mouse Phenotype	MP:0000352	decreased cell proliferation	141	4.619465e-2	1.000000e+0	1.000000e+0	2.164753e+1	4.619465e-2	1	4.619465e-2	1.000000e+0	149	4.850873e-2	1.000000e+0	1.000000e+0	2.036230e+1	4.911036e-2	1	443	5.000000e-1	2.257336e-3	unnamed	NBN
Mouse Phenotype	MP:0002490	abnormal immunoglobulin level	142	4.625320e-2	1.000000e+0	1.000000e+0	2.162013e+1	4.625320e-2	1	4.625320e-2	1.000000e+0	152	5.218192e-2	1.000000e+0	1.000000e+0	1.891090e+1	5.287955e-2	1	477	5.000000e-1	2.096436e-3	unnamed	NBN
Mouse Phenotype	MP:0001406	abnormal gait	143	4.719407e-2	1.000000e+0	1.000000e+0	2.118910e+1	4.719407e-2	1	4.719407e-2	1.000000e+0	131	3.712022e-2	1.000000e+0	1.000000e+0	2.668787e+1	3.747021e-2	1	338	5.000000e-1	2.958580e-3	unnamed	NBN
Mouse Phenotype	MP:0009209	abnormal internal female genitalia morphology	144	4.760230e-2	1.000000e+0	1.000000e+0	2.100739e+1	4.760230e-2	1	4.760230e-2	1.000000e+0	139	4.287718e-2	1.000000e+0	1.000000e+0	2.307033e+1	4.334571e-2	1	391	5.000000e-1	2.557545e-3	unnamed	NBN
Mouse Phenotype	MP:0011091	complete prenatal lethality	145	4.770684e-2	1.000000e+0	1.000000e+0	2.096135e+1	4.770684e-2	1	4.770684e-2	1.000000e+0	134	3.885999e-2	1.000000e+0	1.000000e+0	2.548164e+1	3.924394e-2	1	354	5.000000e-1	2.824859e-3	unnamed	NBN
Mouse Phenotype	MP:0011089	complete perinatal lethality	146	4.824623e-2	1.000000e+0	1.000000e+0	2.072701e+1	4.824623e-2	1	4.824623e-2	1.000000e+0	119	3.210963e-2	1.000000e+0	1.000000e+0	3.089212e+1	3.237071e-2	1	292	5.000000e-1	3.424658e-3	unnamed	NBN
Mouse Phenotype	MP:0001116	small gonad	147	4.956812e-2	1.000000e+0	1.000000e+0	2.017426e+1	4.956812e-2	1	4.956812e-2	1.000000e+0	153	5.272149e-2	1.000000e+0	1.000000e+0	1.871473e+1	5.343385e-2	1	482	5.000000e-1	2.074689e-3	unnamed	NBN
Mouse Phenotype	MP:0009208	abnormal female genitalia morphology	148	4.967210e-2	1.000000e+0	1.000000e+0	2.013202e+1	4.967210e-2	1	4.967210e-2	1.000000e+0	141	4.363624e-2	1.000000e+0	1.000000e+0	2.266457e+1	4.412172e-2	1	398	5.000000e-1	2.512563e-3	unnamed	NBN
Mouse Phenotype	MP:0001119	abnormal female reproductive system morphology	149	4.984565e-2	1.000000e+0	1.000000e+0	2.006193e+1	4.984565e-2	1	4.984565e-2	1.000000e+0	142	4.396146e-2	1.000000e+0	1.000000e+0	2.249501e+1	4.445430e-2	1	401	5.000000e-1	2.493766e-3	unnamed	NBN
Mouse Phenotype	MP:0001800	abnormal humoral immune response	150	5.047245e-2	1.000000e+0	1.000000e+0	1.981279e+1	5.047245e-2	1	5.047245e-2	1.000000e+0	158	5.692491e-2	1.000000e+0	1.000000e+0	1.731382e+1	5.775733e-2	1	521	5.000000e-1	1.919386e-3	unnamed	NBN
Mouse Phenotype	MP:0001657	abnormal induced morbidity/mortality	151	5.088453e-2	1.000000e+0	1.000000e+0	1.965234e+1	5.088453e-2	1	5.088453e-2	1.000000e+0	163	6.036688e-2	1.000000e+0	1.000000e+0	1.631193e+1	6.130481e-2	1	553	5.000000e-1	1.808318e-3	unnamed	NBN
Mouse Phenotype	MP:0002435	abnormal effector T cell morphology	152	5.265218e-2	1.000000e+0	1.000000e+0	1.899257e+1	5.265218e-2	1	5.265218e-2	1.000000e+0	159	5.746313e-2	1.000000e+0	1.000000e+0	1.714924e+1	5.831162e-2	1	526	5.000000e-1	1.901141e-3	unnamed	NBN
Mouse Phenotype	MP:0000703	abnormal thymus morphology	153	5.279962e-2	1.000000e+0	1.000000e+0	1.893953e+1	5.279962e-2	1	5.279962e-2	1.000000e+0	154	5.433930e-2	1.000000e+0	1.000000e+0	1.814990e+1	5.509672e-2	1	497	5.000000e-1	2.012072e-3	unnamed	NBN
Mouse Phenotype	MP:0002211	abnormal primary sex determination	154	5.292252e-2	1.000000e+0	1.000000e+0	1.889555e+1	5.292252e-2	1	5.292252e-2	1.000000e+0	154	5.433930e-2	1.000000e+0	1.000000e+0	1.814990e+1	5.509672e-2	1	497	5.000000e-1	2.012072e-3	unnamed	NBN
Mouse Phenotype	MP:0002458	abnormal B cell number	155	5.356917e-2	1.000000e+0	1.000000e+0	1.866745e+1	5.356917e-2	1	5.356917e-2	1.000000e+0	157	5.649422e-2	1.000000e+0	1.000000e+0	1.744778e+1	5.731390e-2	1	517	5.000000e-1	1.934236e-3	unnamed	NBN
Mouse Phenotype	MP:0010273	increased classified tumor incidence	156	5.452900e-2	1.000000e+0	1.000000e+0	1.833887e+1	5.452900e-2	1	5.452900e-2	1.000000e+0	156	5.563254e-2	1.000000e+0	1.000000e+0	1.772200e+1	5.642703e-2	1	509	5.000000e-1	1.964637e-3	unnamed	NBN
Mouse Phenotype	MP:0002208	abnormal germ cell morphology	157	5.558182e-2	1.000000e+0	1.000000e+0	1.799149e+1	5.558182e-2	1	5.558182e-2	1.000000e+0	162	6.004447e-2	1.000000e+0	1.000000e+0	1.640091e+1	6.097223e-2	1	550	5.000000e-1	1.818182e-3	unnamed	NBN
Mouse Phenotype	MP:0002459	abnormal B cell physiology	158	5.585276e-2	1.000000e+0	1.000000e+0	1.790422e+1	5.585276e-2	1	5.585276e-2	1.000000e+0	168	6.337345e-2	1.000000e+0	1.000000e+0	1.552582e+1	6.440885e-2	1	581	5.000000e-1	1.721170e-3	unnamed	NBN
Mouse Phenotype	MP:0000849	abnormal cerebellum morphology	159	5.650568e-2	1.000000e+0	1.000000e+0	1.769734e+1	5.650568e-2	1	5.650568e-2	1.000000e+0	138	4.190080e-2	1.000000e+0	1.000000e+0	2.361387e+1	4.234799e-2	1	382	5.000000e-1	2.617801e-3	unnamed	NBN
Mouse Phenotype	MP:0005018	decreased T cell number	160	5.651636e-2	1.000000e+0	1.000000e+0	1.769399e+1	5.651636e-2	1	5.651636e-2	1.000000e+0	164	6.133380e-2	1.000000e+0	1.000000e+0	1.605071e+1	6.230253e-2	1	562	5.000000e-1	1.779359e-3	unnamed	NBN
Mouse Phenotype	MP:0002210	abnormal sex determination	161	5.670465e-2	1.000000e+0	1.000000e+0	1.763524e+1	5.670465e-2	1	5.670465e-2	1.000000e+0	160	5.832397e-2	1.000000e+0	1.000000e+0	1.689232e+1	5.919849e-2	1	534	5.000000e-1	1.872659e-3	unnamed	NBN
Mouse Phenotype	MP:0009937	abnormal neuron differentiation	162	5.722860e-2	1.000000e+0	1.000000e+0	1.747378e+1	5.722860e-2	1	5.722860e-2	1.000000e+0	130	3.679384e-2	1.000000e+0	1.000000e+0	2.692687e+1	3.713763e-2	1	335	5.000000e-1	2.985075e-3	unnamed	NBN
Mouse Phenotype	MP:0002447	abnormal erythrocyte morphology	163	5.809647e-2	1.000000e+0	1.000000e+0	1.721275e+1	5.809647e-2	1	5.809647e-2	1.000000e+0	169	6.380257e-2	1.000000e+0	1.000000e+0	1.541966e+1	6.485228e-2	1	585	5.000000e-1	1.709402e-3	unnamed	NBN
Mouse Phenotype	MP:0010274	increased organ/body region tumor incidence	164	5.980108e-2	1.000000e+0	1.000000e+0	1.672211e+1	5.980108e-2	1	5.980108e-2	1.000000e+0	161	5.907688e-2	1.000000e+0	1.000000e+0	1.667375e+1	5.997450e-2	1	541	5.000000e-1	1.848429e-3	unnamed	NBN
Mouse Phenotype	MP:0000847	abnormal metencephalon morphology	165	6.041658e-2	1.000000e+0	1.000000e+0	1.655175e+1	6.041658e-2	1	6.041658e-2	1.000000e+0	144	4.504512e-2	1.000000e+0	1.000000e+0	2.194769e+1	4.556288e-2	1	411	5.000000e-1	2.433090e-3	unnamed	NBN
Mouse Phenotype	MP:0004939	abnormal B cell morphology	166	6.254515e-2	1.000000e+0	1.000000e+0	1.598845e+1	6.254515e-2	1	6.254515e-2	1.000000e+0	171	6.744608e-2	1.000000e+0	1.000000e+0	1.457270e+1	6.862147e-2	1	619	5.000000e-1	1.615509e-3	unnamed	NBN
Mouse Phenotype	MP:0000245	abnormal erythropoiesis	167	6.477947e-2	1.000000e+0	1.000000e+0	1.543699e+1	6.477947e-2	1	6.477947e-2	1.000000e+0	173	6.926518e-2	1.000000e+0	1.000000e+0	1.418318e+1	7.050607e-2	1	636	5.000000e-1	1.572327e-3	unnamed	NBN
Mouse Phenotype	MP:0000841	abnormal hindbrain morphology	168	6.658160e-2	1.000000e+0	1.000000e+0	1.501917e+1	6.658160e-2	1	6.658160e-2	1.000000e+0	151	5.013013e-2	1.000000e+0	1.000000e+0	1.969541e+1	5.077324e-2	1	458	5.000000e-1	2.183406e-3	unnamed	NBN
Mouse Phenotype	MP:0001929	abnormal gametogenesis	169	6.671849e-2	1.000000e+0	1.000000e+0	1.498835e+1	6.671849e-2	1	6.671849e-2	1.000000e+0	176	7.236424e-2	1.000000e+0	1.000000e+0	1.356466e+1	7.372097e-2	1	665	5.000000e-1	1.503759e-3	unnamed	NBN
Mouse Phenotype	MP:0001698	decreased embryo size	170	6.752872e-2	1.000000e+0	1.000000e+0	1.480851e+1	6.752872e-2	1	6.752872e-2	1.000000e+0	164	6.133380e-2	1.000000e+0	1.000000e+0	1.605071e+1	6.230253e-2	1	562	5.000000e-1	1.779359e-3	unnamed	NBN
Mouse Phenotype	MP:0008195	abnormal professional antigen presenting cell morphology	171	6.835128e-2	1.000000e+0	1.000000e+0	1.463030e+1	6.835128e-2	1	6.835128e-2	1.000000e+0	177	7.332497e-2	1.000000e+0	1.000000e+0	1.338353e+1	7.471870e-2	1	674	5.000000e-1	1.483680e-3	unnamed	NBN
Mouse Phenotype	MP:0001697	abnormal embryo size	172	6.914308e-2	1.000000e+0	1.000000e+0	1.446276e+1	6.914308e-2	1	6.914308e-2	1.000000e+0	167	6.230023e-2	1.000000e+0	1.000000e+0	1.579772e+1	6.330026e-2	1	571	5.000000e-1	1.751313e-3	unnamed	NBN
Mouse Phenotype	MP:0002020	increased tumor incidence	173	7.037685e-2	1.000000e+0	1.000000e+0	1.420922e+1	7.037685e-2	1	7.037685e-2	1.000000e+0	172	6.873033e-2	1.000000e+0	1.000000e+0	1.429556e+1	6.995178e-2	1	631	5.000000e-1	1.584786e-3	unnamed	NBN
Mouse Phenotype	MP:0006387	abnormal T cell number	174	7.164861e-2	1.000000e+0	1.000000e+0	1.395701e+1	7.164861e-2	1	7.164861e-2	1.000000e+0	181	7.812114e-2	1.000000e+0	1.000000e+0	1.254590e+1	7.970733e-2	1	719	5.000000e-1	1.390821e-3	unnamed	NBN
Mouse Phenotype	MP:0003312	abnormal locomotor coordination	175	7.384015e-2	1.000000e+0	1.000000e+0	1.354277e+1	7.384015e-2	1	7.384015e-2	1.000000e+0	166	6.154861e-2	1.000000e+0	1.000000e+0	1.599379e+1	6.252425e-2	1	564	5.000000e-1	1.773050e-3	unnamed	NBN
Mouse Phenotype	MP:0002019	abnormal tumor incidence	176	7.769090e-2	1.000000e+0	1.000000e+0	1.287152e+1	7.769090e-2	1	7.769090e-2	1.000000e+0	180	7.705640e-2	1.000000e+0	1.000000e+0	1.272285e+1	7.859875e-2	1	709	5.000000e-1	1.410437e-3	unnamed	NBN
Mouse Phenotype	MP:0002086	abnormal extraembryonic tissue morphology	177	7.842157e-2	1.000000e+0	1.000000e+0	1.275159e+1	7.842157e-2	1	7.842157e-2	1.000000e+0	175	7.086879e-2	1.000000e+0	1.000000e+0	1.385637e+1	7.216895e-2	1	651	5.000000e-1	1.536098e-3	unnamed	NBN
Mouse Phenotype	MP:0001924	infertility	178	7.848077e-2	1.000000e+0	1.000000e+0	1.274198e+1	7.848077e-2	1	7.848077e-2	1.000000e+0	183	7.886609e-2	1.000000e+0	1.000000e+0	1.242493e+1	8.048334e-2	1	726	5.000000e-1	1.377410e-3	unnamed	NBN
Mouse Phenotype	MP:0002166	altered tumor susceptibility	179	7.903444e-2	1.000000e+0	1.000000e+0	1.265271e+1	7.903444e-2	1	7.903444e-2	1.000000e+0	182	7.854686e-2	1.000000e+0	1.000000e+0	1.247649e+1	8.015077e-2	1	723	5.000000e-1	1.383126e-3	unnamed	NBN
Mouse Phenotype	MP:0003699	abnormal female reproductive system physiology	180	7.951923e-2	1.000000e+0	1.000000e+0	1.257558e+1	7.951923e-2	1	7.951923e-2	1.000000e+0	174	6.979987e-2	1.000000e+0	1.000000e+0	1.407254e+1	7.106036e-2	1	641	5.000000e-1	1.560062e-3	unnamed	NBN
Mouse Phenotype	MP:0002401	abnormal lymphopoiesis	181	7.968565e-2	1.000000e+0	1.000000e+0	1.254931e+1	7.968565e-2	1	7.968565e-2	1.000000e+0	190	8.523905e-2	1.000000e+0	1.000000e+0	1.147646e+1	8.713486e-2	1	786	5.000000e-1	1.272265e-3	unnamed	NBN
Mouse Phenotype	MP:0005016	decreased lymphocyte cell number	182	8.004882e-2	1.000000e+0	1.000000e+0	1.249238e+1	8.004882e-2	1	8.004882e-2	1.000000e+0	193	8.809966e-2	1.000000e+0	1.000000e+0	1.109533e+1	9.012804e-2	1	813	5.000000e-1	1.230012e-3	unnamed	NBN
Mouse Phenotype	MP:0002445	abnormal mononuclear cell differentiation	183	8.007402e-2	1.000000e+0	1.000000e+0	1.248844e+1	8.007402e-2	1	8.007402e-2	1.000000e+0	192	8.587513e-2	1.000000e+0	1.000000e+0	1.138952e+1	8.780001e-2	1	792	5.000000e-1	1.262626e-3	unnamed	NBN
Mouse Phenotype	MP:0002452	abnormal professional antigen presenting cell physiology	184	8.156256e-2	1.000000e+0	1.000000e+0	1.226053e+1	8.156256e-2	1	8.156256e-2	1.000000e+0	200	9.433504e-2	1.000000e+0	1.000000e+0	1.034461e+1	9.666870e-2	1	872	5.000000e-1	1.146789e-3	unnamed	NBN
Mouse Phenotype	MP:0001961	abnormal reflex	185	8.225642e-2	1.000000e+0	1.000000e+0	1.215711e+1	8.225642e-2	1	8.225642e-2	1.000000e+0	170	6.508932e-2	1.000000e+0	1.000000e+0	1.510972e+1	6.618258e-2	1	597	5.000000e-1	1.675042e-3	unnamed	NBN
Mouse Phenotype	MP:0000653	abnormal sex gland morphology	186	8.328551e-2	1.000000e+0	1.000000e+0	1.200689e+1	8.328551e-2	1	8.328551e-2	1.000000e+0	187	8.088659e-2	1.000000e+0	1.000000e+0	1.210805e+1	8.258966e-2	1	745	5.000000e-1	1.342282e-3	unnamed	NBN
Mouse Phenotype	MP:0006042	increased apoptosis	187	8.429662e-2	1.000000e+0	1.000000e+0	1.186287e+1	8.429662e-2	1	8.429662e-2	1.000000e+0	185	7.939802e-2	1.000000e+0	1.000000e+0	1.233995e+1	8.103764e-2	1	731	5.000000e-1	1.367989e-3	unnamed	NBN
Mouse Phenotype	MP:0010866	abnormal prenatal body size	188	8.435389e-2	1.000000e+0	1.000000e+0	1.185482e+1	8.435389e-2	1	8.435389e-2	1.000000e+0	179	7.663033e-2	1.000000e+0	1.000000e+0	1.279504e+1	7.815531e-2	1	705	5.000000e-1	1.418440e-3	unnamed	NBN
Mouse Phenotype	MP:0008037	abnormal T cell morphology	189	8.505437e-2	1.000000e+0	1.000000e+0	1.175719e+1	8.505437e-2	1	8.505437e-2	1.000000e+0	202	9.570606e-2	1.000000e+0	1.000000e+0	1.019266e+1	9.810986e-2	1	885	5.000000e-1	1.129944e-3	unnamed	NBN
Mouse Phenotype	MP:0002414	abnormal myeloblast morphology/development	190	8.539083e-2	1.000000e+0	1.000000e+0	1.171086e+1	8.539083e-2	1	8.539083e-2	1.000000e+0	196	9.264620e-2	1.000000e+0	1.000000e+0	1.053797e+1	9.489496e-2	1	856	5.000000e-1	1.168224e-3	unnamed	NBN
Mouse Phenotype	MP:0002006	tumorigenesis	191	8.579997e-2	1.000000e+0	1.000000e+0	1.165502e+1	8.579997e-2	1	8.579997e-2	1.000000e+0	191	8.576913e-2	1.000000e+0	1.000000e+0	1.140392e+1	8.768915e-2	1	791	5.000000e-1	1.264223e-3	unnamed	NBN
Mouse Phenotype	MP:0002221	abnormal lymph organ size	192	8.616517e-2	1.000000e+0	1.000000e+0	1.160562e+1	8.616517e-2	1	8.616517e-2	1.000000e+0	196	9.264620e-2	1.000000e+0	1.000000e+0	1.053797e+1	9.489496e-2	1	856	5.000000e-1	1.168224e-3	unnamed	NBN
Mouse Phenotype	MP:0005460	abnormal leukopoiesis	193	8.694600e-2	1.000000e+0	1.000000e+0	1.150139e+1	8.694600e-2	1	8.694600e-2	1.000000e+0	198	9.306856e-2	1.000000e+0	1.000000e+0	1.048895e+1	9.533840e-2	1	860	5.000000e-1	1.162791e-3	unnamed	NBN
Mouse Phenotype	MP:0003945	abnormal lymphocyte physiology	194	9.054147e-2	1.000000e+0	1.000000e+0	1.104466e+1	9.054147e-2	1	9.054147e-2	1.000000e+0	205	1.016001e-1	1.000000e+0	1.000000e+0	9.586079e+0	1.043179e-1	1	941	5.000000e-1	1.062699e-3	unnamed	NBN
Mouse Phenotype	MP:0002723	abnormal immune serum protein physiology	195	9.094959e-2	1.000000e+0	1.000000e+0	1.099510e+1	9.094959e-2	1	9.094959e-2	1.000000e+0	207	1.059032e-1	1.000000e+0	1.000000e+0	9.185845e+0	1.088631e-1	1	982	5.000000e-1	1.018330e-3	unnamed	NBN
Mouse Phenotype	MP:0000350	abnormal cell proliferation	196	9.545087e-2	1.000000e+0	1.000000e+0	1.047659e+1	9.545087e-2	1	9.545087e-2	1.000000e+0	195	9.021575e-2	1.000000e+0	1.000000e+0	1.082893e+1	9.234521e-2	1	833	5.000000e-1	1.200480e-3	unnamed	NBN
Mouse Phenotype	MP:0000221	decreased leukocyte cell number	197	9.549676e-2	1.000000e+0	1.000000e+0	1.047156e+1	9.549676e-2	1	9.549676e-2	1.000000e+0	208	1.060080e-1	1.000000e+0	1.000000e+0	9.176501e+0	1.089740e-1	1	983	5.000000e-1	1.017294e-3	unnamed	NBN
Mouse Phenotype	MP:0000913	abnormal brain development	198	9.561960e-2	1.000000e+0	1.000000e+0	1.045811e+1	9.561960e-2	1	9.561960e-2	1.000000e+0	178	7.396518e-2	1.000000e+0	1.000000e+0	1.326544e+1	7.538385e-2	1	680	5.000000e-1	1.470588e-3	unnamed	NBN
Mouse Phenotype	MP:0003492	abnormal involuntary movement	199	9.771039e-2	1.000000e+0	1.000000e+0	1.023433e+1	9.771039e-2	1	9.771039e-2	1.000000e+0	186	8.014245e-2	1.000000e+0	1.000000e+0	1.222290e+1	8.181365e-2	1	738	5.000000e-1	1.355014e-3	unnamed	NBN
Mouse Phenotype	MP:0001516	abnormal motor coordination/ balance	200	9.929128e-2	1.000000e+0	1.000000e+0	1.007138e+1	9.929128e-2	1	9.929128e-2	1.000000e+0	184	7.897249e-2	1.000000e+0	1.000000e+0	1.240784e+1	8.059420e-2	1	727	5.000000e-1	1.375516e-3	unnamed	NBN
Mouse Phenotype	MP:0002088	abnormal embryonic growth/weight/body size	201	9.953028e-2	1.000000e+0	1.000000e+0	1.004719e+1	9.953028e-2	1	9.953028e-2	1.000000e+0	194	8.947540e-2	1.000000e+0	1.000000e+0	1.092070e+1	9.156920e-2	1	826	5.000000e-1	1.210654e-3	unnamed	NBN
Mouse Phenotype	MP:0000717	abnormal lymphocyte cell number	202	9.986740e-2	1.000000e+0	1.000000e+0	1.001328e+1	9.986740e-2	1	9.986740e-2	1.000000e+0	210	1.109278e-1	1.000000e+0	1.000000e+0	8.757767e+0	1.141844e-1	1	1030	5.000000e-1	9.708738e-4	unnamed	NBN
Mouse Phenotype	MP:0002067	abnormal sensory capabilities/reflexes/nociception	203	1.044486e-1	1.000000e+0	1.000000e+0	9.574091e+0	1.044486e-1	1	1.044486e-1	1.000000e+0	189	8.216155e-2	1.000000e+0	1.000000e+0	1.191612e+1	8.391996e-2	1	757	5.000000e-1	1.321004e-3	unnamed	NBN
Mouse Phenotype	MP:0001732	postnatal growth retardation	204	1.070890e-1	1.000000e+0	1.000000e+0	9.338025e+0	1.070890e-1	1	1.070890e-1	1.000000e+0	201	9.528432e-2	1.000000e+0	1.000000e+0	1.023893e+1	9.766643e-2	1	881	5.000000e-1	1.135074e-3	unnamed	NBN
Mouse Phenotype	MP:0002398	abnormal bone marrow cell morphology/development	205	1.085064e-1	1.000000e+0	1.000000e+0	9.216047e+0	1.085064e-1	1	1.085064e-1	1.000000e+0	215	1.211425e-1	1.000000e+0	1.000000e+0	7.996897e+0	1.250485e-1	1	1128	5.000000e-1	8.865248e-4	unnamed	NBN
Mouse Phenotype	MP:0000432	abnormal head morphology	206	1.086636e-1	1.000000e+0	1.000000e+0	9.202710e+0	1.086636e-1	1	1.086636e-1	1.000000e+0	188	8.152418e-2	1.000000e+0	1.000000e+0	1.201132e+1	8.325481e-2	1	751	5.000000e-1	1.331558e-3	unnamed	NBN
Mouse Phenotype	MP:0011182	decreased hematopoietic cell number	207	1.093948e-1	1.000000e+0	1.000000e+0	9.141200e+0	1.093948e-1	1	1.093948e-1	1.000000e+0	216	1.236350e-1	1.000000e+0	1.000000e+0	7.830295e+0	1.277091e-1	1	1152	5.000000e-1	8.680556e-4	unnamed	NBN
Mouse Phenotype	MP:0001731	abnormal postnatal growth	208	1.097999e-1	1.000000e+0	1.000000e+0	9.107480e+0	1.097999e-1	1	1.097999e-1	1.000000e+0	204	9.791859e-2	1.000000e+0	1.000000e+0	9.956402e+0	1.004379e-1	1	906	5.000000e-1	1.103753e-3	unnamed	NBN
Mouse Phenotype	MP:0002722	abnormal immune system organ morphology	209	1.102968e-1	1.000000e+0	1.000000e+0	9.066446e+0	1.102968e-1	1	1.102968e-1	1.000000e+0	213	1.202068e-1	1.000000e+0	1.000000e+0	8.061215e+0	1.240508e-1	1	1119	5.000000e-1	8.936550e-4	unnamed	NBN
Mouse Phenotype	MP:0002085	abnormal embryonic tissue morphology	210	1.131386e-1	1.000000e+0	1.000000e+0	8.838720e+0	1.131386e-1	1	1.131386e-1	1.000000e+0	199	9.391298e-2	1.000000e+0	1.000000e+0	1.039228e+1	9.622526e-2	1	868	5.000000e-1	1.152074e-3	unnamed	NBN
Mouse Phenotype	MP:0002160	abnormal reproductive system morphology	211	1.137433e-1	1.000000e+0	1.000000e+0	8.791730e+0	1.137433e-1	1	1.137433e-1	1.000000e+0	211	1.128084e-1	1.000000e+0	1.000000e+0	8.607347e+0	1.161798e-1	1	1048	5.000000e-1	9.541985e-4	unnamed	NBN
Mouse Phenotype	MP:0002619	abnormal lymphocyte morphology	212	1.142540e-1	1.000000e+0	1.000000e+0	8.752430e+0	1.142540e-1	1	1.142540e-1	1.000000e+0	217	1.290234e-1	1.000000e+0	1.000000e+0	7.492110e+0	1.334738e-1	1	1204	5.000000e-1	8.305648e-4	unnamed	NBN
Mouse Phenotype	MP:0003313	abnormal locomotor activation	213	1.143198e-1	1.000000e+0	1.000000e+0	8.747388e+0	1.143198e-1	1	1.143198e-1	1.000000e+0	203	9.675999e-2	1.000000e+0	1.000000e+0	1.007877e+1	9.921845e-2	1	895	5.000000e-1	1.117318e-3	unnamed	NBN
Mouse Phenotype	MP:0004196	abnormal prenatal growth/weight/body size	214	1.174251e-1	1.000000e+0	1.000000e+0	8.516069e+0	1.174251e-1	1	1.174251e-1	1.000000e+0	206	1.056935e-1	1.000000e+0	1.000000e+0	9.204592e+0	1.086414e-1	1	980	5.000000e-1	1.020408e-3	unnamed	NBN
Mouse Phenotype	MP:0002442	abnormal leukocyte physiology	215	1.192967e-1	1.000000e+0	1.000000e+0	8.382459e+0	1.192967e-1	1	1.192967e-1	1.000000e+0	221	1.356324e-1	1.000000e+0	1.000000e+0	7.113959e+0	1.405687e-1	1	1268	5.000000e-1	7.886435e-4	unnamed	NBN
Mouse Phenotype	MP:0001819	abnormal immune cell physiology	216	1.203217e-1	1.000000e+0	1.000000e+0	8.311053e+0	1.203217e-1	1	1.203217e-1	1.000000e+0	225	1.380014e-1	1.000000e+0	1.000000e+0	6.987219e+0	1.431185e-1	1	1291	5.000000e-1	7.745933e-4	unnamed	NBN
Mouse Phenotype	MP:0002421	abnormal cell-mediated immunity	217	1.209554e-1	1.000000e+0	1.000000e+0	8.267508e+0	1.209554e-1	1	1.209554e-1	1.000000e+0	226	1.391333e-1	1.000000e+0	1.000000e+0	6.928187e+0	1.443379e-1	1	1302	5.000000e-1	7.680492e-4	unnamed	NBN
Mouse Phenotype	MP:0001648	abnormal apoptosis	218	1.225891e-1	1.000000e+0	1.000000e+0	8.157331e+0	1.225891e-1	1	1.225891e-1	1.000000e+0	214	1.205188e-1	1.000000e+0	1.000000e+0	8.039661e+0	1.243833e-1	1	1122	5.000000e-1	8.912656e-4	unnamed	NBN
Mouse Phenotype	MP:0002420	abnormal adaptive immunity	219	1.226687e-1	1.000000e+0	1.000000e+0	8.152037e+0	1.226687e-1	1	1.226687e-1	1.000000e+0	229	1.408810e-1	1.000000e+0	1.000000e+0	6.838893e+0	1.462225e-1	1	1319	5.000000e-1	7.581501e-4	unnamed	NBN
Mouse Phenotype	MP:0000217	abnormal leukocyte cell number	220	1.272684e-1	1.000000e+0	1.000000e+0	7.857411e+0	1.272684e-1	1	1.272684e-1	1.000000e+0	228	1.403671e-1	1.000000e+0	1.000000e+0	6.864916e+0	1.456682e-1	1	1314	5.000000e-1	7.610350e-4	unnamed	NBN
Mouse Phenotype	MP:0002161	abnormal fertility/fecundity	221	1.345122e-1	1.000000e+0	1.000000e+0	7.434268e+0	1.345122e-1	1	1.345122e-1	1.000000e+0	220	1.310914e-1	1.000000e+0	1.000000e+0	7.369690e+0	1.356909e-1	1	1224	5.000000e-1	8.169935e-4	unnamed	NBN
Mouse Phenotype	MP:0008247	abnormal mononuclear cell morphology	222	1.350005e-1	1.000000e+0	1.000000e+0	7.407378e+0	1.350005e-1	1	1.350005e-1	1.000000e+0	234	1.540854e-1	1.000000e+0	1.000000e+0	6.229627e+0	1.605233e-1	1	1448	5.000000e-1	6.906077e-4	unnamed	NBN
Mouse Phenotype	MP:0000313	abnormal cell death	223	1.373532e-1	1.000000e+0	1.000000e+0	7.280503e+0	1.373532e-1	1	1.373532e-1	1.000000e+0	224	1.377955e-1	1.000000e+0	1.000000e+0	6.998061e+0	1.428967e-1	1	1289	5.000000e-1	7.757952e-4	unnamed	NBN
Mouse Phenotype	MP:0000428	abnormal craniofacial morphology	224	1.404613e-1	1.000000e+0	1.000000e+0	7.119400e+0	1.404613e-1	1	1.404613e-1	1.000000e+0	209	1.066368e-1	1.000000e+0	1.000000e+0	9.120829e+0	1.096392e-1	1	989	5.000000e-1	1.011122e-3	unnamed	NBN
Mouse Phenotype	MP:0011180	abnormal hematopoietic cell number	225	1.429801e-1	1.000000e+0	1.000000e+0	6.993980e+0	1.429801e-1	1	1.429801e-1	1.000000e+0	235	1.595825e-1	1.000000e+0	1.000000e+0	6.005659e+0	1.665096e-1	1	1502	5.000000e-1	6.657790e-4	unnamed	NBN
Mouse Phenotype	MP:0002083	premature death	226	1.449089e-1	1.000000e+0	1.000000e+0	6.900889e+0	1.449089e-1	1	1.449089e-1	1.000000e+0	222	1.369718e-1	1.000000e+0	1.000000e+0	7.041764e+0	1.420099e-1	1	1281	5.000000e-1	7.806401e-4	unnamed	NBN
Mouse Phenotype	MP:0008246	abnormal leukocyte morphology	227	1.497188e-1	1.000000e+0	1.000000e+0	6.679189e+0	1.497188e-1	1	1.497188e-1	1.000000e+0	240	1.698159e-1	1.000000e+0	1.000000e+0	5.627261e+0	1.777063e-1	1	1603	5.000000e-1	6.238303e-4	unnamed	NBN
Mouse Phenotype	MP:0000716	abnormal immune system cell morphology	228	1.505458e-1	1.000000e+0	1.000000e+0	6.642496e+0	1.505458e-1	1	1.505458e-1	1.000000e+0	241	1.710276e-1	1.000000e+0	1.000000e+0	5.585449e+0	1.790366e-1	1	1615	5.000000e-1	6.191950e-4	unnamed	NBN
Mouse Phenotype	MP:0003861	abnormal nervous system development	229	1.509392e-1	1.000000e+0	1.000000e+0	6.625185e+0	1.509392e-1	1	1.509392e-1	1.000000e+0	212	1.151042e-1	1.000000e+0	1.000000e+0	8.430374e+0	1.186187e-1	1	1070	5.000000e-1	9.345794e-4	unnamed	NBN
Mouse Phenotype	MP:0001392	abnormal locomotor behavior	230	1.510711e-1	1.000000e+0	1.000000e+0	6.619401e+0	1.510711e-1	1	1.510711e-1	1.000000e+0	219	1.309881e-1	1.000000e+0	1.000000e+0	7.375715e+0	1.355801e-1	1	1223	5.000000e-1	8.176615e-4	unnamed	NBN
Mouse Phenotype	MP:0001919	abnormal reproductive system physiology	231	1.530473e-1	1.000000e+0	1.000000e+0	6.533929e+0	1.530473e-1	1	1.530473e-1	1.000000e+0	232	1.495931e-1	1.000000e+0	1.000000e+0	6.424858e+0	1.556455e-1	1	1404	5.000000e-1	7.122507e-4	unnamed	NBN
Mouse Phenotype	MP:0005076	abnormal cell differentiation	232	1.541850e-1	1.000000e+0	1.000000e+0	6.485715e+0	1.541850e-1	1	1.541850e-1	1.000000e+0	223	1.371778e-1	1.000000e+0	1.000000e+0	7.030787e+0	1.422316e-1	1	1283	5.000000e-1	7.794232e-4	unnamed	NBN
Mouse Phenotype	MP:0002163	abnormal gland morphology	233	1.548620e-1	1.000000e+0	1.000000e+0	6.457362e+0	1.548620e-1	1	1.548620e-1	1.000000e+0	231	1.460111e-1	1.000000e+0	1.000000e+0	6.589116e+0	1.517654e-1	1	1369	5.000000e-1	7.304602e-4	unnamed	NBN
Mouse Phenotype	MP:0008762	embryonic lethality	234	1.587123e-1	1.000000e+0	1.000000e+0	6.300711e+0	1.587123e-1	1	1.587123e-1	1.000000e+0	238	1.667828e-1	1.000000e+0	1.000000e+0	5.734584e+0	1.743806e-1	1	1573	5.000000e-1	6.357279e-4	unnamed	NBN
Mouse Phenotype	MP:0003491	abnormal voluntary movement	235	1.639822e-1	1.000000e+0	1.000000e+0	6.098224e+0	1.639822e-1	1	1.639822e-1	1.000000e+0	227	1.399559e-1	1.000000e+0	1.000000e+0	6.885878e+0	1.452248e-1	1	1310	5.000000e-1	7.633588e-4	unnamed	NBN
Mouse Phenotype	MP:0005379	endocrine/exocrine gland phenotype	236	1.670185e-1	1.000000e+0	1.000000e+0	5.987362e+0	1.670185e-1	1	1.670185e-1	1.000000e+0	236	1.601922e-1	1.000000e+0	1.000000e+0	5.981764e+0	1.671748e-1	1	1508	5.000000e-1	6.631300e-4	unnamed	NBN
Mouse Phenotype	MP:0001672	abnormal embryogenesis/ development	237	1.759787e-1	1.000000e+0	1.000000e+0	5.682507e+0	1.759787e-1	1	1.759787e-1	1.000000e+0	237	1.649603e-1	1.000000e+0	1.000000e+0	5.800965e+0	1.723851e-1	1	1555	5.000000e-1	6.430868e-4	unnamed	NBN
Mouse Phenotype	MP:0002081	perinatal lethality	238	1.768700e-1	1.000000e+0	1.000000e+0	5.653869e+0	1.768700e-1	1	1.768700e-1	1.000000e+0	218	1.305746e-1	1.000000e+0	1.000000e+0	7.399918e+0	1.351366e-1	1	1219	5.000000e-1	8.203445e-4	unnamed	NBN
Mouse Phenotype	MP:0005389	reproductive system phenotype	239	1.774158e-1	1.000000e+0	1.000000e+0	5.636476e+0	1.774158e-1	1	1.774158e-1	1.000000e+0	242	1.715322e-1	1.000000e+0	1.000000e+0	5.568210e+0	1.795909e-1	1	1620	5.000000e-1	6.172840e-4	unnamed	NBN
Mouse Phenotype	MP:0002123	abnormal hematopoiesis	240	1.777183e-1	1.000000e+0	1.000000e+0	5.626882e+0	1.777183e-1	1	1.777183e-1	1.000000e+0	246	2.055841e-1	1.000000e+0	1.000000e+0	4.599949e+0	2.173937e-1	1	1961	5.000000e-1	5.099439e-4	unnamed	NBN
Mouse Phenotype	MP:0002429	abnormal blood cell morphology/development	241	1.793335e-1	1.000000e+0	1.000000e+0	5.576203e+0	1.793335e-1	1	1.793335e-1	1.000000e+0	247	2.074604e-1	1.000000e+0	1.000000e+0	4.555808e+0	2.195000e-1	1	1980	5.000000e-1	5.050505e-4	unnamed	NBN
Mouse Phenotype	MP:0000685	abnormal immune system morphology	242	1.819041e-1	1.000000e+0	1.000000e+0	5.497404e+0	1.819041e-1	1	1.819041e-1	1.000000e+0	245	2.020229e-1	1.000000e+0	1.000000e+0	4.685974e+0	2.134028e-1	1	1925	5.000000e-1	5.194805e-4	unnamed	NBN
Mouse Phenotype	MP:0002882	abnormal neuron morphology	243	1.824896e-1	1.000000e+0	1.000000e+0	5.479764e+0	1.824896e-1	1	1.824896e-1	1.000000e+0	230	1.439609e-1	1.000000e+0	1.000000e+0	6.686805e+0	1.495483e-1	1	1349	5.000000e-1	7.412898e-4	unnamed	NBN
Mouse Phenotype	MP:0001262	decreased body weight	244	1.844836e-1	1.000000e+0	1.000000e+0	5.420536e+0	1.844836e-1	1	1.844836e-1	1.000000e+0	239	1.675922e-1	1.000000e+0	1.000000e+0	5.705566e+0	1.752674e-1	1	1581	5.000000e-1	6.325111e-4	unnamed	NBN
Mouse Phenotype	MP:0002152	abnormal brain morphology	245	1.867872e-1	1.000000e+0	1.000000e+0	5.353687e+0	1.867872e-1	1	1.867872e-1	1.000000e+0	233	1.513302e-1	1.000000e+0	1.000000e+0	6.347994e+0	1.575301e-1	1	1421	5.000000e-1	7.037298e-4	unnamed	NBN
Mouse Phenotype	MP:0001790	abnormal immune system physiology	246	1.911135e-1	1.000000e+0	1.000000e+0	5.232494e+0	1.911135e-1	1	1.911135e-1	1.000000e+0	250	2.153363e-1	1.000000e+0	1.000000e+0	4.378883e+0	2.283687e-1	1	2060	5.000000e-1	4.854369e-4	unnamed	NBN
Mouse Phenotype	MP:0002396	abnormal hematopoietic system morphology/development	247	2.022701e-1	1.000000e+0	1.000000e+0	4.943885e+0	2.022701e-1	1	2.022701e-1	1.000000e+0	252	2.274661e-1	1.000000e+0	1.000000e+0	4.130266e+0	2.421152e-1	1	2184	5.000000e-1	4.578755e-4	unnamed	NBN
Mouse Phenotype	MP:0005397	hematopoietic system phenotype	248	2.068614e-1	1.000000e+0	1.000000e+0	4.834154e+0	2.068614e-1	1	2.068614e-1	1.000000e+0	253	2.333986e-1	1.000000e+0	1.000000e+0	4.018040e+0	2.488776e-1	1	2245	5.000000e-1	4.454343e-4	unnamed	NBN
Mouse Phenotype	MP:0001259	abnormal body weight	249	2.081556e-1	1.000000e+0	1.000000e+0	4.804098e+0	2.081556e-1	1	2.081556e-1	1.000000e+0	244	1.952745e-1	1.000000e+0	1.000000e+0	4.857566e+0	2.058644e-1	1	1857	5.000000e-1	5.385030e-4	unnamed	NBN
Mouse Phenotype	MP:0002080	prenatal lethality	250	2.134127e-1	1.000000e+0	1.000000e+0	4.685758e+0	2.134127e-1	1	2.134127e-1	1.000000e+0	249	2.134693e-1	1.000000e+0	1.000000e+0	4.419647e+0	2.262624e-1	1	2041	5.000000e-1	4.899559e-4	unnamed	NBN
Mouse Phenotype	MP:0002066	abnormal motor capabilities/coordination/movement	251	2.177788e-1	1.000000e+0	1.000000e+0	4.591816e+0	2.177788e-1	1	2.177788e-1	1.000000e+0	243	1.858990e-1	1.000000e+0	1.000000e+0	5.116563e+0	1.954437e-1	1	1763	5.000000e-1	5.672150e-4	unnamed	NBN
Mouse Phenotype	MP:0001265	decreased body size	252	2.412513e-1	1.000000e+0	1.000000e+0	4.145055e+0	2.412513e-1	1	2.412513e-1	1.000000e+0	248	2.125842e-1	1.000000e+0	1.000000e+0	4.439222e+0	2.252647e-1	1	2032	5.000000e-1	4.921260e-4	unnamed	NBN
Mouse Phenotype	MP:0005387	immune system phenotype	253	2.446842e-1	1.000000e+0	1.000000e+0	4.086901e+0	2.446842e-1	1	2.446842e-1	1.000000e+0	258	2.754183e-1	1.000000e+0	1.000000e+0	3.360842e+0	2.975445e-1	1	2684	5.000000e-1	3.725782e-4	unnamed	NBN
Mouse Phenotype	MP:0003956	abnormal body size	254	2.623454e-1	1.000000e+0	1.000000e+0	3.811768e+0	2.623454e-1	1	2.623454e-1	1.000000e+0	255	2.384377e-1	1.000000e+0	1.000000e+0	3.927079e+0	2.546422e-1	1	2297	5.000000e-1	4.353505e-4	unnamed	NBN
Mouse Phenotype	MP:0010832	lethality during fetal growth through weaning	255	2.758093e-1	1.000000e+0	1.000000e+0	3.625694e+0	2.758093e-1	1	2.758093e-1	1.000000e+0	251	2.188676e-1	1.000000e+0	1.000000e+0	4.303674e+0	2.323596e-1	1	2096	5.000000e-1	4.770992e-4	unnamed	NBN
Mouse Phenotype	MP:0002089	abnormal postnatal growth/weight/body size	256	2.800528e-1	1.000000e+0	1.000000e+0	3.570755e+0	2.800528e-1	1	2.800528e-1	1.000000e+0	257	2.591915e-1	1.000000e+0	1.000000e+0	3.589534e+0	2.785877e-1	1	2513	5.000000e-1	3.979308e-4	unnamed	NBN
Mouse Phenotype	MP:0003632	abnormal nervous system morphology	257	2.827167e-1	1.000000e+0	1.000000e+0	3.537110e+0	2.827167e-1	1	2.827167e-1	1.000000e+0	254	2.350478e-1	1.000000e+0	1.000000e+0	3.987843e+0	2.507622e-1	1	2262	5.000000e-1	4.420866e-4	unnamed	NBN
Mouse Phenotype	MP:0004924	abnormal behavior	258	2.945352e-1	1.000000e+0	1.000000e+0	3.395180e+0	2.945352e-1	1	2.945352e-1	1.000000e+0	256	2.543172e-1	1.000000e+0	1.000000e+0	3.663891e+0	2.729339e-1	1	2462	5.000000e-1	4.061738e-4	unnamed	NBN
Mouse Phenotype	MP:0005621	abnormal cell physiology	259	3.078333e-1	1.000000e+0	1.000000e+0	3.248512e+0	3.078333e-1	1	3.078333e-1	1.000000e+0	260	3.046545e-1	1.000000e+0	1.000000e+0	3.009843e+0	3.322432e-1	1	2997	5.000000e-1	3.336670e-4	unnamed	NBN
Mouse Phenotype	MP:0005384	cellular phenotype	260	3.121556e-1	1.000000e+0	1.000000e+0	3.203530e+0	3.121556e-1	1	3.121556e-1	1.000000e+0	261	3.123982e-1	1.000000e+0	1.000000e+0	2.927783e+0	3.415553e-1	1	3081	5.000000e-1	3.245699e-4	unnamed	NBN
Mouse Phenotype	MP:0003631	nervous system phenotype	261	3.410385e-1	1.000000e+0	1.000000e+0	2.932220e+0	3.410385e-1	1	3.410385e-1	1.000000e+0	259	2.844493e-1	1.000000e+0	1.000000e+0	3.244784e+0	3.081869e-1	1	2780	5.000000e-1	3.597122e-4	unnamed	NBN
Mouse Phenotype	MP:0005378	growth/size phenotype	262	3.447235e-1	1.000000e+0	1.000000e+0	2.900875e+0	3.447235e-1	1	3.447235e-1	1.000000e+0	262	3.172618e-1	1.000000e+0	1.000000e+0	2.878271e+0	3.474309e-1	1	3134	5.000000e-1	3.190810e-4	unnamed	NBN
Mouse Phenotype	MP:0010770	preweaning lethality	263	3.585301e-1	1.000000e+0	1.000000e+0	2.789166e+0	3.585301e-1	1	3.585301e-1	1.000000e+0	263	3.286641e-1	1.000000e+0	1.000000e+0	2.767874e+0	3.612882e-1	1	3259	5.000000e-1	3.068426e-4	unnamed	NBN
Mouse Phenotype	MP:0010769	abnormal survival	264	3.982821e-1	1.000000e+0	1.000000e+0	2.510783e+0	3.982821e-1	1	3.982821e-1	1.000000e+0	264	3.748920e-1	1.000000e+0	1.000000e+0	2.388271e+0	4.187129e-1	1	3777	5.000000e-1	2.647604e-4	unnamed	NBN
Mouse Phenotype	MP:0010768	mortality/aging	265	4.155501e-1	1.000000e+0	1.000000e+0	2.406449e+0	4.155501e-1	1	4.155501e-1	1.000000e+0	265	3.982479e-1	1.000000e+0	1.000000e+0	2.229486e+0	4.485339e-1	1	4046	5.000000e-1	2.471577e-4	unnamed	NBN
Mouse Phenotype	MP:0000001	mammalian phenotype	266	6.422596e-1	1.000000e+0	1.000000e+0	1.557003e+0	6.422596e-1	1	6.422596e-1	1.000000e+0	266	6.601828e-1	1.000000e+0	1.000000e+0	1.198897e+0	8.341001e-1	1	7524	5.000000e-1	1.329080e-4	unnamed	NBN
Human Phenotype	HP:0005602	Progressive vitiligo	1	3.245707e-5	1.994812e-1	1.994812e-1	3.080993e+4	3.245707e-5	1	3.245707e-5	1.000000e+0	1	1.108586e-4	6.813370e-1	6.813370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	NBN
Human Phenotype	HP:0002961	Dysgammaglobulinemia	2	1.278117e-4	7.855307e-1	3.927654e-1	7.824008e+3	1.278117e-4	1	1.278117e-4	1.000000e+0	2	3.325574e-4	1.000000e+0	1.000000e+0	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	NBN
Human Phenotype	HP:0010620	Malar prominence	3	2.511623e-4	1.000000e+0	5.145478e-1	3.981489e+3	2.511623e-4	1	2.511623e-4	1.000000e+0	4	4.433975e-4	1.000000e+0	6.812803e-1	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	NBN
Human Phenotype	HP:0001587	Primary ovarian failure	4	2.668640e-4	1.000000e+0	4.100365e-1	3.747227e+3	2.668640e-4	1	2.668640e-4	1.000000e+0	4	4.433975e-4	1.000000e+0	6.812803e-1	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	NBN
Human Phenotype	HP:0004798	Recurrent infection of the gastrointestinal tract	5	3.132984e-4	1.000000e+0	3.851064e-1	3.191846e+3	3.132984e-4	1	3.132984e-4	1.000000e+0	6	5.542315e-4	1.000000e+0	5.677178e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	NBN
Human Phenotype	HP:0000265	Mastoiditis	6	4.109373e-4	1.000000e+0	4.209368e-1	2.433461e+3	4.109373e-4	1	4.109373e-4	1.000000e+0	2	3.325574e-4	1.000000e+0	1.000000e+0	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	NBN
Human Phenotype	HP:0001045	Vitiligo	7	5.001169e-4	1.000000e+0	4.391026e-1	1.999533e+3	5.001169e-4	1	5.001169e-4	1.000000e+0	7	6.650594e-4	1.000000e+0	5.839222e-1	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	NBN
Human Phenotype	HP:0001890	Autoimmune hemolytic anemia	8	7.658447e-4	1.000000e+0	5.883602e-1	1.305748e+3	7.658447e-4	1	7.658447e-4	1.000000e+0	10	1.108309e-3	1.000000e+0	6.811667e-1	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	NBN
Human Phenotype	HP:0009733	Glioma	9	7.683865e-4	1.000000e+0	5.247226e-1	1.301428e+3	7.683865e-4	1	7.683865e-4	1.000000e+0	14	1.440682e-3	1.000000e+0	6.324594e-1	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	NBN
Human Phenotype	HP:0002837	Recurrent bronchitis	10	8.749240e-4	1.000000e+0	5.377283e-1	1.142956e+3	8.749240e-4	1	8.749240e-4	1.000000e+0	17	1.773000e-3	1.000000e+0	6.409916e-1	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	NBN
Human Phenotype	HP:0010976	B lymphocytopenia	11	9.057168e-4	1.000000e+0	5.060487e-1	1.104098e+3	9.057168e-4	1	9.057168e-4	1.000000e+0	8	7.758812e-4	1.000000e+0	5.960707e-1	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	NBN
Human Phenotype	HP:0010975	Abnormality of B cell number	12	9.532231e-4	1.000000e+0	4.882091e-1	1.049072e+3	9.532231e-4	1	9.532231e-4	1.000000e+0	9	8.866967e-4	1.000000e+0	6.055153e-1	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	NBN
Human Phenotype	HP:0002885	Medulloblastoma	13	1.002871e-3	1.000000e+0	4.741266e-1	9.971376e+2	1.002871e-3	1	1.002871e-3	1.000000e+0	12	1.329898e-3	1.000000e+0	6.811294e-1	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	NBN
Human Phenotype	HP:0012387	Bronchitis	14	1.228314e-3	1.000000e+0	5.392298e-1	8.141244e+2	1.228314e-3	1	1.228314e-3	1.000000e+0	22	2.658910e-3	1.000000e+0	7.428028e-1	3.758542e+2	2.660606e-3	1	24	5.000000e-1	4.166667e-2	unnamed	NBN
Human Phenotype	HP:0002180	Neurodegeneration	15	1.268813e-3	1.000000e+0	5.198750e-1	7.881382e+2	1.268813e-3	1	1.268813e-3	1.000000e+0	12	1.329898e-3	1.000000e+0	6.811294e-1	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	NBN
Human Phenotype	HP:0005403	T lymphocytopenia	16	1.486168e-3	1.000000e+0	5.708743e-1	6.728712e+2	1.486168e-3	1	1.486168e-3	1.000000e+0	19	1.883760e-3	1.000000e+0	6.093468e-1	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	NBN
Human Phenotype	HP:0002859	Rhabdomyosarcoma	17	1.501022e-3	1.000000e+0	5.426636e-1	6.662129e+2	1.501022e-3	1	1.501022e-3	1.000000e+0	14	1.440682e-3	1.000000e+0	6.324594e-1	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	NBN
Human Phenotype	HP:0009728	Neoplasm of striated muscle	18	1.722749e-3	1.000000e+0	5.882231e-1	5.804677e+2	1.722749e-3	1	1.722749e-3	1.000000e+0	17	1.773000e-3	1.000000e+0	6.409916e-1	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	NBN
Human Phenotype	HP:0011839	Abnormality of T cell number	19	1.752687e-3	1.000000e+0	5.669481e-1	5.705526e+2	1.752687e-3	1	1.752687e-3	1.000000e+0	21	2.216004e-3	1.000000e+0	6.485505e-1	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	NBN
Human Phenotype	HP:0006532	Recurrent pneumonia	20	1.915783e-3	1.000000e+0	5.887201e-1	5.219797e+2	1.915783e-3	1	1.915783e-3	1.000000e+0	23	2.769621e-3	1.000000e+0	7.400909e-1	3.608200e+2	2.771465e-3	1	25	5.000000e-1	4.000000e-2	unnamed	NBN
Human Phenotype	HP:0002002	Deep philtrum	21	2.020549e-3	1.000000e+0	5.913473e-1	4.949150e+2	2.020549e-3	1	2.020549e-3	1.000000e+0	20	2.105263e-3	1.000000e+0	6.469473e-1	4.747632e+2	2.106313e-3	1	19	5.000000e-1	5.263158e-2	unnamed	NBN
Human Phenotype	HP:0002110	Bronchiectasis	22	2.056449e-3	1.000000e+0	5.744971e-1	4.862752e+2	2.056449e-3	1	2.056449e-3	1.000000e+0	28	3.544427e-3	1.000000e+0	7.780017e-1	2.818906e+2	3.547475e-3	1	32	5.000000e-1	3.125000e-2	unnamed	NBN
Human Phenotype	HP:0003189	Long nose	23	2.409059e-3	1.000000e+0	6.437425e-1	4.150999e+2	2.409059e-3	1	2.409059e-3	1.000000e+0	11	1.219107e-3	1.000000e+0	6.811483e-1	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	NBN
Human Phenotype	HP:0002783	Recurrent lower respiratory tract infections	24	2.581910e-3	1.000000e+0	6.611841e-1	3.873102e+2	2.581910e-3	1	2.581910e-3	1.000000e+0	32	4.097676e-3	1.000000e+0	7.870099e-1	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	NBN
Human Phenotype	HP:0010515	Aplasia/Hypoplasia of the thymus	25	2.750859e-3	1.000000e+0	6.762712e-1	3.635228e+2	2.750859e-3	1	2.750859e-3	1.000000e+0	23	2.769621e-3	1.000000e+0	7.400909e-1	3.608200e+2	2.771465e-3	1	25	5.000000e-1	4.000000e-2	unnamed	NBN
Human Phenotype	HP:0002025	Anal stenosis	26	2.915185e-3	1.000000e+0	6.891049e-1	3.430315e+2	2.915185e-3	1	2.915185e-3	1.000000e+0	16	1.662234e-3	1.000000e+0	6.385056e-1	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	NBN
Human Phenotype	HP:0002843	Abnormality of T cells	27	2.994732e-3	1.000000e+0	6.816897e-1	3.339197e+2	2.994732e-3	1	2.994732e-3	1.000000e+0	32	4.097676e-3	1.000000e+0	7.870099e-1	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	NBN
Human Phenotype	HP:0003220	Abnormality of chromosome stability	28	2.996418e-3	1.000000e+0	6.577138e-1	3.337319e+2	2.996418e-3	1	2.996418e-3	1.000000e+0	25	2.991025e-3	1.000000e+0	7.353136e-1	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	NBN
Human Phenotype	HP:0001480	Freckling	29	3.374996e-3	1.000000e+0	7.152664e-1	2.962966e+2	3.374996e-3	1	3.374996e-3	1.000000e+0	27	3.433759e-3	1.000000e+0	7.816253e-1	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	NBN
Human Phenotype	HP:0001878	Hemolytic anemia	30	3.437660e-3	1.000000e+0	7.042619e-1	2.908956e+2	3.437660e-3	1	3.437660e-3	1.000000e+0	59	7.634827e-3	1.000000e+0	7.953160e-1	1.307319e+2	7.649243e-3	1	69	5.000000e-1	1.449275e-2	unnamed	NBN
Human Phenotype	HP:0000777	Abnormality of the thymus	31	3.691951e-3	1.000000e+0	7.319591e-1	2.708595e+2	3.691951e-3	1	3.691951e-3	1.000000e+0	28	3.544427e-3	1.000000e+0	7.780017e-1	2.818906e+2	3.547475e-3	1	32	5.000000e-1	3.125000e-2	unnamed	NBN
Human Phenotype	HP:0002788	Recurrent upper respiratory tract infections	32	3.899312e-3	1.000000e+0	7.489116e-1	2.564555e+2	3.899312e-3	1	3.899312e-3	1.000000e+0	48	6.751129e-3	1.000000e+0	8.644258e-1	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	NBN
Human Phenotype	HP:0100836	Malignant neoplasm of the central nervous system	33	3.920200e-3	1.000000e+0	7.301076e-1	2.550890e+2	3.920200e-3	1	3.920200e-3	1.000000e+0	30	3.876395e-3	1.000000e+0	7.941441e-1	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	NBN
Human Phenotype	HP:0000294	Low anterior hairline	34	3.947082e-3	1.000000e+0	7.134931e-1	2.533517e+2	3.947082e-3	1	3.947082e-3	1.000000e+0	25	2.991025e-3	1.000000e+0	7.353136e-1	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	NBN
Human Phenotype	HP:0000444	Convex nasal ridge	35	3.950776e-3	1.000000e+0	6.937563e-1	2.531148e+2	3.950776e-3	1	3.950776e-3	1.000000e+0	32	4.097676e-3	1.000000e+0	7.870099e-1	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	NBN
Human Phenotype	HP:0000246	Sinusitis	36	4.061936e-3	1.000000e+0	6.934627e-1	2.461880e+2	4.061936e-3	1	4.061936e-3	1.000000e+0	57	7.082562e-3	1.000000e+0	7.636741e-1	1.409453e+2	7.094950e-3	1	64	5.000000e-1	1.562500e-2	unnamed	NBN
Human Phenotype	HP:0002960	Autoimmunity	37	4.274459e-3	1.000000e+0	7.100223e-1	2.339477e+2	4.274459e-3	1	4.274459e-3	1.000000e+0	52	6.972090e-3	1.000000e+0	8.240474e-1	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	NBN
Human Phenotype	HP:0002090	Pneumonia	38	4.301347e-3	1.000000e+0	6.956863e-1	2.324853e+2	4.301347e-3	1	4.301347e-3	1.000000e+0	41	5.867038e-3	1.000000e+0	8.794833e-1	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	NBN
Human Phenotype	HP:0002109	Abnormality of the bronchi	39	4.409381e-3	1.000000e+0	6.948732e-1	2.267892e+2	4.409381e-3	1	4.409381e-3	1.000000e+0	44	6.309133e-3	1.000000e+0	8.812712e-1	1.582544e+2	6.318940e-3	1	57	5.000000e-1	1.754386e-2	unnamed	NBN
Human Phenotype	HP:0000992	Cutaneous photosensitivity	40	4.532305e-3	1.000000e+0	6.963887e-1	2.206383e+2	4.532305e-3	1	4.532305e-3	1.000000e+0	37	5.645954e-3	1.000000e+0	9.378387e-1	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	NBN
Human Phenotype	HP:0100335	Non-midline cleft lip	41	4.775981e-3	1.000000e+0	7.159312e-1	2.093811e+2	4.775981e-3	1	4.775981e-3	1.000000e+0	35	4.208307e-3	1.000000e+0	7.389787e-1	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	NBN
Human Phenotype	HP:0000010	Recurrent urinary tract infections	42	4.848235e-3	1.000000e+0	7.094584e-1	2.062606e+2	4.848235e-3	1	4.848235e-3	1.000000e+0	42	5.977571e-3	1.000000e+0	8.747179e-1	1.670463e+2	5.986364e-3	1	54	5.000000e-1	1.851852e-2	unnamed	NBN
Human Phenotype	HP:0000957	Cafe-au-lait spot	43	5.182813e-3	1.000000e+0	7.407807e-1	1.929454e+2	5.182813e-3	1	5.182813e-3	1.000000e+0	52	6.972090e-3	1.000000e+0	8.240474e-1	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	NBN
Human Phenotype	HP:0100577	Urinary bladder inflammation	44	5.396092e-3	1.000000e+0	7.537359e-1	1.853193e+2	5.396092e-3	1	5.396092e-3	1.000000e+0	47	6.640639e-3	1.000000e+0	8.683695e-1	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	NBN
Human Phenotype	HP:0002665	Lymphoma	45	5.521516e-3	1.000000e+0	7.541164e-1	1.811097e+2	5.521516e-3	1	5.521516e-3	1.000000e+0	52	6.972090e-3	1.000000e+0	8.240474e-1	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	NBN
Human Phenotype	HP:0000599	Abnormality of the frontal hairline	46	5.673204e-3	1.000000e+0	7.579894e-1	1.762672e+2	5.673204e-3	1	5.673204e-3	1.000000e+0	36	4.318932e-3	1.000000e+0	7.373377e-1	2.312949e+2	4.323485e-3	1	39	5.000000e-1	2.564103e-2	unnamed	NBN
Human Phenotype	HP:0100705	Abnormality of the glial cells	47	5.741252e-3	1.000000e+0	7.507603e-1	1.741780e+2	5.741252e-3	1	5.741252e-3	1.000000e+0	58	7.524386e-3	1.000000e+0	7.973255e-1	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	NBN
Human Phenotype	HP:0004313	Hypogammaglobulinemia	48	5.960668e-3	1.000000e+0	7.632139e-1	1.677664e+2	5.960668e-3	1	5.960668e-3	1.000000e+0	62	7.966112e-3	1.000000e+0	7.896730e-1	1.252847e+2	7.981819e-3	1	72	5.000000e-1	1.388889e-2	unnamed	NBN
Human Phenotype	HP:0002023	Anal atresia	49	6.036033e-3	1.000000e+0	7.570910e-1	1.656717e+2	6.036033e-3	1	6.036033e-3	1.000000e+0	31	3.987038e-3	1.000000e+0	7.904624e-1	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	NBN
Human Phenotype	HP:0000340	Sloping forehead	50	6.112222e-3	1.000000e+0	7.513143e-1	1.636066e+2	6.112222e-3	1	6.112222e-3	1.000000e+0	48	6.751129e-3	1.000000e+0	8.644258e-1	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	NBN
Human Phenotype	HP:0000245	Abnormality of the sinuses	51	6.448248e-3	1.000000e+0	7.770771e-1	1.550809e+2	6.448248e-3	1	6.448248e-3	1.000000e+0	65	8.518131e-3	1.000000e+0	8.054220e-1	1.171494e+2	8.536112e-3	1	77	5.000000e-1	1.298701e-2	unnamed	NBN
Human Phenotype	HP:0002488	Acute leukemia	52	6.713221e-3	1.000000e+0	7.934511e-1	1.489598e+2	6.713221e-3	1	6.713221e-3	1.000000e+0	50	6.861613e-3	1.000000e+0	8.434295e-1	1.454919e+2	6.873233e-3	1	62	5.000000e-1	1.612903e-2	unnamed	NBN
Human Phenotype	HP:0100006	Neoplasm of the central nervous system	53	6.795571e-3	1.000000e+0	7.880298e-1	1.471547e+2	6.795571e-3	1	6.795571e-3	1.000000e+0	44	6.309133e-3	1.000000e+0	8.812712e-1	1.582544e+2	6.318940e-3	1	57	5.000000e-1	1.754386e-2	unnamed	NBN
Human Phenotype	HP:0007018	Attention deficit hyperactivity disorder	54	7.014625e-3	1.000000e+0	7.983682e-1	1.425593e+2	7.014625e-3	1	7.014625e-3	1.000000e+0	42	5.977571e-3	1.000000e+0	8.747179e-1	1.670463e+2	5.986364e-3	1	54	5.000000e-1	1.851852e-2	unnamed	NBN
Human Phenotype	HP:0000453	Choanal atresia	55	7.023138e-3	1.000000e+0	7.848037e-1	1.423865e+2	7.023138e-3	1	7.023138e-3	1.000000e+0	46	6.419641e-3	1.000000e+0	8.577199e-1	1.555259e+2	6.429799e-3	1	58	5.000000e-1	1.724138e-2	unnamed	NBN
Human Phenotype	HP:0010701	Abnormal immunoglobulin level	56	7.055509e-3	1.000000e+0	7.743421e-1	1.417332e+2	7.055509e-3	1	7.055509e-3	1.000000e+0	74	1.072467e-2	1.000000e+0	8.907273e-1	9.299485e+1	1.075328e-2	1	97	5.000000e-1	1.030928e-2	unnamed	NBN
Human Phenotype	HP:0005372	Abnormality of B cell physiology	57	7.105981e-3	1.000000e+0	7.661993e-1	1.407265e+2	7.105981e-3	1	7.105981e-3	1.000000e+0	77	1.094519e-2	1.000000e+0	8.736252e-1	9.111616e+1	1.097500e-2	1	99	5.000000e-1	1.010101e-2	unnamed	NBN
Human Phenotype	HP:0100242	Sarcoma	58	7.244055e-3	1.000000e+0	7.676200e-1	1.380442e+2	7.244055e-3	1	7.244055e-3	1.000000e+0	50	6.861613e-3	1.000000e+0	8.434295e-1	1.454919e+2	6.873233e-3	1	62	5.000000e-1	1.612903e-2	unnamed	NBN
Human Phenotype	HP:0002846	Abnormality of B cells	59	7.276330e-3	1.000000e+0	7.579716e-1	1.374319e+2	7.276330e-3	1	7.276330e-3	1.000000e+0	78	1.105544e-2	1.000000e+0	8.711120e-1	9.020500e+1	1.108586e-2	1	100	5.000000e-1	1.000000e-2	unnamed	NBN
Human Phenotype	HP:0001739	Abnormality of the nasopharynx	60	7.372579e-3	1.000000e+0	7.551978e-1	1.356378e+2	7.372579e-3	1	7.372579e-3	1.000000e+0	65	8.518131e-3	1.000000e+0	8.054220e-1	1.171494e+2	8.536112e-3	1	77	5.000000e-1	1.298701e-2	unnamed	NBN
Human Phenotype	HP:0000388	Otitis media	61	7.575208e-3	1.000000e+0	7.632333e-1	1.320096e+2	7.575208e-3	1	7.575208e-3	1.000000e+0	76	1.083493e-2	1.000000e+0	8.762037e-1	9.204592e+1	1.086414e-2	1	98	5.000000e-1	1.020408e-2	unnamed	NBN
Human Phenotype	HP:0000415	Abnormality of the choanae	62	7.865364e-3	1.000000e+0	7.796859e-1	1.271397e+2	7.865364e-3	1	7.865364e-3	1.000000e+0	52	6.972090e-3	1.000000e+0	8.240474e-1	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	NBN
Human Phenotype	HP:0000600	Abnormality of the pharynx	63	7.873454e-3	1.000000e+0	7.680992e-1	1.270091e+2	7.873454e-3	1	7.873454e-3	1.000000e+0	74	1.072467e-2	1.000000e+0	8.907273e-1	9.299485e+1	1.075328e-2	1	97	5.000000e-1	1.030928e-2	unnamed	NBN
Human Phenotype	HP:0005368	Abnormality of humoral immunity	64	7.880175e-3	1.000000e+0	7.567431e-1	1.269007e+2	7.880175e-3	1	7.880175e-3	1.000000e+0	83	1.215761e-2	1.000000e+0	9.002490e-1	8.200455e+1	1.219445e-2	1	110	5.000000e-1	9.090909e-3	unnamed	NBN
Human Phenotype	HP:0001034	Hypermelanotic macule	65	8.294523e-3	1.000000e+0	7.842791e-1	1.205615e+2	8.294523e-3	1	8.294523e-3	1.000000e+0	79	1.116569e-2	1.000000e+0	8.686624e-1	8.931188e+1	1.119672e-2	1	101	5.000000e-1	9.900990e-3	unnamed	NBN
Human Phenotype	HP:0000736	Short attention span	66	8.714628e-3	1.000000e+0	8.115167e-1	1.147496e+2	8.714628e-3	1	8.714628e-3	1.000000e+0	52	6.972090e-3	1.000000e+0	8.240474e-1	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	NBN
Human Phenotype	HP:0000126	Hydronephrosis	67	8.715330e-3	1.000000e+0	7.994689e-1	1.147404e+2	8.715330e-3	1	8.715330e-3	1.000000e+0	37	5.645954e-3	1.000000e+0	9.378387e-1	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	NBN
Human Phenotype	HP:0004378	Abnormality of the anus	68	9.044339e-3	1.000000e+0	8.174486e-1	1.105664e+2	9.044339e-3	1	9.044339e-3	1.000000e+0	39	5.756499e-3	1.000000e+0	9.071652e-1	1.734712e+2	5.764647e-3	1	52	5.000000e-1	1.923077e-2	unnamed	NBN
Human Phenotype	HP:0010944	Abnormality of the renal pelvis	69	9.046580e-3	1.000000e+0	8.058012e-1	1.105390e+2	9.046580e-3	1	9.046580e-3	1.000000e+0	39	5.756499e-3	1.000000e+0	9.071652e-1	1.734712e+2	5.764647e-3	1	52	5.000000e-1	1.923077e-2	unnamed	NBN
Human Phenotype	HP:0004375	Neoplasm of the nervous system	70	9.050370e-3	1.000000e+0	7.946225e-1	1.104927e+2	9.050370e-3	1	9.050370e-3	1.000000e+0	63	8.186938e-3	1.000000e+0	7.986813e-1	1.218986e+2	8.203536e-3	1	74	5.000000e-1	1.351351e-2	unnamed	NBN
Human Phenotype	HP:0001909	Leukemia	71	9.306101e-3	1.000000e+0	8.055676e-1	1.074564e+2	9.306101e-3	1	9.306101e-3	1.000000e+0	70	1.039385e-2	1.000000e+0	9.125800e-1	9.596277e+1	1.042071e-2	1	94	5.000000e-1	1.063830e-2	unnamed	NBN
Human Phenotype	HP:0100589	Urogenital fistula	72	9.397482e-3	1.000000e+0	8.021795e-1	1.064115e+2	9.397482e-3	1	9.397482e-3	1.000000e+0	60	7.745261e-3	1.000000e+0	7.933729e-1	1.288643e+2	7.760102e-3	1	70	5.000000e-1	1.428571e-2	unnamed	NBN
Human Phenotype	HP:0008713	Genitourinary tract malformation	73	9.449157e-3	1.000000e+0	7.955414e-1	1.058295e+2	9.449157e-3	1	9.449157e-3	1.000000e+0	61	7.855690e-3	1.000000e+0	7.914930e-1	1.270493e+2	7.870961e-3	1	71	5.000000e-1	1.408451e-2	unnamed	NBN
Human Phenotype	HP:0009553	Abnormality of the hairline	74	9.514245e-3	1.000000e+0	7.901966e-1	1.051056e+2	9.514245e-3	1	9.514245e-3	1.000000e+0	64	8.297342e-3	1.000000e+0	7.968041e-1	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	NBN
Human Phenotype	HP:0004332	Abnormality of lymphocytes	75	9.846524e-3	1.000000e+0	8.068898e-1	1.015587e+2	9.846524e-3	1	9.846524e-3	1.000000e+0	87	1.413995e-2	1.000000e+0	9.988981e-1	7.047266e+1	1.418990e-2	1	128	5.000000e-1	7.812500e-3	unnamed	NBN
Human Phenotype	HP:0011361	Congenital abnormal hair pattern	76	1.061369e-2	1.000000e+0	8.583124e-1	9.421791e+1	1.061369e-2	1	1.061369e-2	1.000000e+0	67	9.180352e-3	1.000000e+0	8.421260e-1	1.086807e+2	9.201264e-3	1	83	5.000000e-1	1.204819e-2	unnamed	NBN
Human Phenotype	HP:0007400	Irregular hyperpigmentation	77	1.068274e-2	1.000000e+0	8.526769e-1	9.360890e+1	1.068274e-2	1	1.068274e-2	1.000000e+0	88	1.436009e-2	1.000000e+0	1.000000e+0	6.938846e+1	1.441162e-2	1	130	5.000000e-1	7.692308e-3	unnamed	NBN
Human Phenotype	HP:0010720	Abnormal hair pattern	78	1.072794e-2	1.000000e+0	8.453067e-1	9.321451e+1	1.072794e-2	1	1.072794e-2	1.000000e+0	69	9.511379e-3	1.000000e+0	8.472020e-1	1.048895e+2	9.533840e-3	1	86	5.000000e-1	1.162791e-2	unnamed	NBN
Human Phenotype	HP:0002024	Malabsorption	79	1.118208e-2	1.000000e+0	8.699375e-1	8.942881e+1	1.118208e-2	1	1.118208e-2	1.000000e+0	88	1.436009e-2	1.000000e+0	1.000000e+0	6.938846e+1	1.441162e-2	1	130	5.000000e-1	7.692308e-3	unnamed	NBN
Human Phenotype	HP:0000400	Macrotia	80	1.169440e-2	1.000000e+0	8.984223e-1	8.551101e+1	1.169440e-2	1	1.169440e-2	1.000000e+0	68	9.290700e-3	1.000000e+0	8.397153e-1	1.073869e+2	9.312122e-3	1	84	5.000000e-1	1.190476e-2	unnamed	NBN
Human Phenotype	HP:0011017	Abnormality of cell physiology	81	1.169780e-2	1.000000e+0	8.875886e-1	8.548614e+1	1.169780e-2	1	1.169780e-2	1.000000e+0	85	1.347939e-2	1.000000e+0	9.746392e-1	7.393852e+1	1.352475e-2	1	122	5.000000e-1	8.196721e-3	unnamed	NBN
Human Phenotype	HP:0002014	Diarrhea	82	1.175835e-2	1.000000e+0	8.813027e-1	8.504597e+1	1.175835e-2	1	1.175835e-2	1.000000e+0	86	1.391979e-2	1.000000e+0	9.947794e-1	7.159127e+1	1.396818e-2	1	126	5.000000e-1	7.936508e-3	unnamed	NBN
Human Phenotype	HP:0000582	Upslanted palpebral fissure	83	1.180838e-2	1.000000e+0	8.743892e-1	8.468565e+1	1.180838e-2	1	1.180838e-2	1.000000e+0	72	1.061440e-2	1.000000e+0	9.060570e-1	9.396354e+1	1.064243e-2	1	96	5.000000e-1	1.041667e-2	unnamed	NBN
Human Phenotype	HP:0000137	Abnormality of the ovary	84	1.185914e-2	1.000000e+0	8.676937e-1	8.432312e+1	1.185914e-2	1	1.185914e-2	1.000000e+0	70	1.039385e-2	1.000000e+0	9.125800e-1	9.596277e+1	1.042071e-2	1	94	5.000000e-1	1.063830e-2	unnamed	NBN
Human Phenotype	HP:0100037	Abnormality of the scalp hair	85	1.190356e-2	1.000000e+0	8.606974e-1	8.400852e+1	1.190356e-2	1	1.190356e-2	1.000000e+0	79	1.116569e-2	1.000000e+0	8.686624e-1	8.931188e+1	1.119672e-2	1	101	5.000000e-1	9.900990e-3	unnamed	NBN
Human Phenotype	HP:0001965	Abnormality of the scalp	86	1.221386e-2	1.000000e+0	8.728649e-1	8.187421e+1	1.221386e-2	1	1.221386e-2	1.000000e+0	81	1.138616e-2	1.000000e+0	8.639425e-1	8.757767e+1	1.141844e-2	1	103	5.000000e-1	9.708738e-3	unnamed	NBN
Human Phenotype	HP:0001873	Thrombocytopenia	87	1.287046e-2	1.000000e+0	9.092166e-1	7.769728e+1	1.287046e-2	1	1.287046e-2	1.000000e+0	92	1.710974e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	NBN
Human Phenotype	HP:0011873	Abnormal platelet count	88	1.307528e-2	1.000000e+0	9.131894e-1	7.648017e+1	1.307528e-2	1	1.307528e-2	1.000000e+0	95	1.754933e-2	1.000000e+0	1.000000e+0	5.673270e+1	1.762652e-2	1	159	5.000000e-1	6.289308e-3	unnamed	NBN
Human Phenotype	HP:0000953	Hyperpigmentation of the skin	89	1.310828e-2	1.000000e+0	9.052077e-1	7.628765e+1	1.310828e-2	1	1.310828e-2	1.000000e+0	91	1.699983e-2	1.000000e+0	1.000000e+0	5.857468e+1	1.707222e-2	1	154	5.000000e-1	6.493506e-3	unnamed	NBN
Human Phenotype	HP:0000752	Hyperactivity	90	1.367399e-2	1.000000e+0	9.337816e-1	7.313156e+1	1.367399e-2	1	1.367399e-2	1.000000e+0	72	1.061440e-2	1.000000e+0	9.060570e-1	9.396354e+1	1.064243e-2	1	96	5.000000e-1	1.041667e-2	unnamed	NBN
Human Phenotype	HP:0011792	Neoplasm by histology	91	1.405119e-2	1.000000e+0	9.489958e-1	7.116836e+1	1.405119e-2	1	1.405119e-2	1.000000e+0	84	1.248814e-2	1.000000e+0	9.137156e-1	7.982743e+1	1.252702e-2	1	113	5.000000e-1	8.849558e-3	unnamed	NBN
Human Phenotype	HP:0000204	Cleft upper lip	92	1.408341e-2	1.000000e+0	9.408330e-1	7.100554e+1	1.408341e-2	1	1.408341e-2	1.000000e+0	82	1.149638e-2	1.000000e+0	8.616677e-1	8.673558e+1	1.152929e-2	1	104	5.000000e-1	9.615385e-3	unnamed	NBN
Human Phenotype	HP:0005607	Abnormality of the tracheobronchial system	93	1.499531e-2	1.000000e+0	9.909804e-1	6.668753e+1	1.499531e-2	1	1.499531e-2	1.000000e+0	90	1.480029e-2	1.000000e+0	1.000000e+0	6.731716e+1	1.485505e-2	1	134	5.000000e-1	7.462687e-3	unnamed	NBN
Human Phenotype	HP:0004377	Hematological neoplasm	94	1.500982e-2	1.000000e+0	9.813867e-1	6.662306e+1	1.500982e-2	1	1.500982e-2	1.000000e+0	96	1.765921e-2	1.000000e+0	1.000000e+0	5.637812e+1	1.773738e-2	1	160	5.000000e-1	6.250000e-3	unnamed	NBN
Human Phenotype	HP:0001872	Abnormality of thrombocytes	95	1.595131e-2	1.000000e+0	1.000000e+0	6.269078e+1	1.595131e-2	1	1.595131e-2	1.000000e+0	102	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	NBN
Human Phenotype	HP:0002269	Abnormality of neuronal migration	96	1.636024e-2	1.000000e+0	1.000000e+0	6.112379e+1	1.636024e-2	1	1.636024e-2	1.000000e+0	93	1.721965e-2	1.000000e+0	1.000000e+0	5.782372e+1	1.729394e-2	1	156	5.000000e-1	6.410256e-3	unnamed	NBN
Human Phenotype	HP:0000009	Functional abnormality of the bladder	97	1.698759e-2	1.000000e+0	1.000000e+0	5.886651e+1	1.698759e-2	1	1.698759e-2	1.000000e+0	98	1.776908e-2	1.000000e+0	1.000000e+0	5.602795e+1	1.784823e-2	1	161	5.000000e-1	6.211180e-3	unnamed	NBN
Human Phenotype	HP:0000014	Abnormality of the bladder	98	1.747012e-2	1.000000e+0	1.000000e+0	5.724060e+1	1.747012e-2	1	1.747012e-2	1.000000e+0	100	1.853804e-2	1.000000e+0	1.000000e+0	5.369345e+1	1.862424e-2	1	168	5.000000e-1	5.952381e-3	unnamed	NBN
Human Phenotype	HP:0000470	Short neck	99	1.756682e-2	1.000000e+0	1.000000e+0	5.692549e+1	1.756682e-2	1	1.756682e-2	1.000000e+0	93	1.721965e-2	1.000000e+0	1.000000e+0	5.782372e+1	1.729394e-2	1	156	5.000000e-1	6.410256e-3	unnamed	NBN
Human Phenotype	HP:0003319	Abnormality of the cervical spine	100	1.857663e-2	1.000000e+0	1.000000e+0	5.383108e+1	1.857663e-2	1	1.857663e-2	1.000000e+0	101	1.864787e-2	1.000000e+0	1.000000e+0	5.337574e+1	1.873510e-2	1	169	5.000000e-1	5.917160e-3	unnamed	NBN
Human Phenotype	HP:0002205	Recurrent respiratory infections	101	1.903666e-2	1.000000e+0	1.000000e+0	5.253023e+1	1.903666e-2	1	1.903666e-2	1.000000e+0	107	2.489780e-2	1.000000e+0	1.000000e+0	3.991372e+1	2.505404e-2	1	226	5.000000e-1	4.424779e-3	unnamed	NBN
Human Phenotype	HP:0001903	Anemia	102	1.958596e-2	1.000000e+0	1.000000e+0	5.105699e+1	1.958596e-2	1	1.958596e-2	1.000000e+0	112	2.839779e-2	1.000000e+0	1.000000e+0	3.496318e+1	2.860152e-2	1	258	5.000000e-1	3.875969e-3	unnamed	NBN
Human Phenotype	HP:0011947	Respiratory tract infection	103	2.044241e-2	1.000000e+0	1.000000e+0	4.891792e+1	2.044241e-2	1	2.044241e-2	1.000000e+0	109	2.632043e-2	1.000000e+0	1.000000e+0	3.774268e+1	2.649521e-2	1	239	5.000000e-1	4.184100e-3	unnamed	NBN
Human Phenotype	HP:0001511	Intrauterine growth retardation	104	2.092991e-2	1.000000e+0	1.000000e+0	4.777851e+1	2.092991e-2	1	2.092991e-2	1.000000e+0	104	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	NBN
Human Phenotype	HP:0012369	Malar anomaly	105	2.213915e-2	1.000000e+0	1.000000e+0	4.516886e+1	2.213915e-2	1	2.213915e-2	1.000000e+0	99	1.809867e-2	1.000000e+0	1.000000e+0	5.500305e+1	1.818081e-2	1	164	5.000000e-1	6.097561e-3	unnamed	NBN
Human Phenotype	HP:0001877	Abnormality of erythrocytes	106	2.240890e-2	1.000000e+0	1.000000e+0	4.462513e+1	2.240890e-2	1	2.240890e-2	1.000000e+0	119	3.101865e-2	1.000000e+0	1.000000e+0	3.198759e+1	3.126213e-2	1	282	5.000000e-1	3.546099e-3	unnamed	NBN
Human Phenotype	HP:0000370	Abnormality of the middle ear	107	2.356312e-2	1.000000e+0	1.000000e+0	4.243920e+1	2.356312e-2	1	2.356312e-2	1.000000e+0	108	2.555453e-2	1.000000e+0	1.000000e+0	3.888147e+1	2.571920e-2	1	232	5.000000e-1	4.310345e-3	unnamed	NBN
Human Phenotype	HP:0001000	Abnormality of skin pigmentation	108	2.462739e-2	1.000000e+0	1.000000e+0	4.060519e+1	2.462739e-2	1	2.462739e-2	1.000000e+0	113	2.872559e-2	1.000000e+0	1.000000e+0	3.456130e+1	2.893409e-2	1	261	5.000000e-1	3.831418e-3	unnamed	NBN
Human Phenotype	HP:0000177	Abnormality of upper lip	109	2.521996e-2	1.000000e+0	1.000000e+0	3.965114e+1	2.521996e-2	1	2.521996e-2	1.000000e+0	96	1.765921e-2	1.000000e+0	1.000000e+0	5.637812e+1	1.773738e-2	1	160	5.000000e-1	6.250000e-3	unnamed	NBN
Human Phenotype	HP:0007367	Atrophy/Degeneration affecting the central nervous system	110	2.578991e-2	1.000000e+0	1.000000e+0	3.877485e+1	2.578991e-2	1	2.578991e-2	1.000000e+0	110	2.686732e-2	1.000000e+0	1.000000e+0	3.696926e+1	2.704950e-2	1	244	5.000000e-1	4.098361e-3	unnamed	NBN
Human Phenotype	HP:0000288	Abnormality of the philtrum	111	2.625076e-2	1.000000e+0	1.000000e+0	3.809414e+1	2.625076e-2	1	2.625076e-2	1.000000e+0	103	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	NBN
Human Phenotype	HP:0003202	Amyotrophy	112	2.705294e-2	1.000000e+0	1.000000e+0	3.696455e+1	2.705294e-2	1	2.705294e-2	1.000000e+0	121	3.167331e-2	1.000000e+0	1.000000e+0	3.132118e+1	3.192728e-2	1	288	5.000000e-1	3.472222e-3	unnamed	NBN
Human Phenotype	HP:0005280	Depressed nasal bridge	113	2.733450e-2	1.000000e+0	1.000000e+0	3.658380e+1	2.733450e-2	1	2.733450e-2	1.000000e+0	105	2.193980e-2	1.000000e+0	1.000000e+0	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	NBN
Human Phenotype	HP:0001881	Abnormality of leukocytes	114	2.780174e-2	1.000000e+0	1.000000e+0	3.596897e+1	2.780174e-2	1	2.780174e-2	1.000000e+0	131	3.516110e-2	1.000000e+0	1.000000e+0	2.818906e+1	3.547475e-2	1	320	5.000000e-1	3.125000e-3	unnamed	NBN
Human Phenotype	HP:0002093	Respiratory insufficiency	115	2.790110e-2	1.000000e+0	1.000000e+0	3.584089e+1	2.790110e-2	1	2.790110e-2	1.000000e+0	127	3.439869e-2	1.000000e+0	1.000000e+0	2.881949e+1	3.469874e-2	1	313	5.000000e-1	3.194888e-3	unnamed	NBN
Human Phenotype	HP:0002719	Recurrent infections	116	2.831519e-2	1.000000e+0	1.000000e+0	3.531673e+1	2.831519e-2	1	2.831519e-2	1.000000e+0	133	3.624975e-2	1.000000e+0	1.000000e+0	2.733485e+1	3.658334e-2	1	330	5.000000e-1	3.030303e-3	unnamed	NBN
Human Phenotype	HP:0100763	Abnormality of the lymphatic system	117	2.916890e-2	1.000000e+0	1.000000e+0	3.428309e+1	2.916890e-2	1	2.916890e-2	1.000000e+0	132	3.581436e-2	1.000000e+0	1.000000e+0	2.767025e+1	3.613990e-2	1	326	5.000000e-1	3.067485e-3	unnamed	NBN
Human Phenotype	HP:0200006	Slanting of the palpebral fissure	118	2.961857e-2	1.000000e+0	1.000000e+0	3.376261e+1	2.961857e-2	1	2.961857e-2	1.000000e+0	106	2.478833e-2	1.000000e+0	1.000000e+0	4.009111e+1	2.494318e-2	1	225	5.000000e-1	4.444444e-3	unnamed	NBN
Human Phenotype	HP:0000464	Abnormality of the neck	119	2.976377e-2	1.000000e+0	1.000000e+0	3.359790e+1	2.976377e-2	1	2.976377e-2	1.000000e+0	114	2.894409e-2	1.000000e+0	1.000000e+0	3.429848e+1	2.915581e-2	1	263	5.000000e-1	3.802281e-3	unnamed	NBN
Human Phenotype	HP:0000309	Abnormality of the midface	120	2.981411e-2	1.000000e+0	1.000000e+0	3.354116e+1	2.981411e-2	1	2.981411e-2	1.000000e+0	111	2.752338e-2	1.000000e+0	1.000000e+0	3.608200e+1	2.771465e-2	1	250	5.000000e-1	4.000000e-3	unnamed	NBN
Human Phenotype	HP:0000008	Abnormality of female internal genitalia	121	3.365925e-2	1.000000e+0	1.000000e+0	2.970951e+1	3.365925e-2	1	3.365925e-2	1.000000e+0	116	2.981786e-2	1.000000e+0	1.000000e+0	3.328598e+1	3.004268e-2	1	271	5.000000e-1	3.690037e-3	unnamed	NBN
Human Phenotype	HP:0000175	Cleft palate	122	3.555289e-2	1.000000e+0	1.000000e+0	2.812711e+1	3.555289e-2	1	3.555289e-2	1.000000e+0	115	2.959946e-2	1.000000e+0	1.000000e+0	3.353346e+1	2.982096e-2	1	269	5.000000e-1	3.717472e-3	unnamed	NBN
Human Phenotype	HP:0000377	Abnormality of the pinna	123	3.568518e-2	1.000000e+0	1.000000e+0	2.802284e+1	3.568518e-2	1	3.568518e-2	1.000000e+0	120	3.112777e-2	1.000000e+0	1.000000e+0	3.187456e+1	3.137298e-2	1	283	5.000000e-1	3.533569e-3	unnamed	NBN
Human Phenotype	HP:0011362	Abnormal hair quantity	124	3.605802e-2	1.000000e+0	1.000000e+0	2.773308e+1	3.605802e-2	1	3.605802e-2	1.000000e+0	130	3.505220e-2	1.000000e+0	1.000000e+0	2.827743e+1	3.536389e-2	1	319	5.000000e-1	3.134796e-3	unnamed	NBN
Human Phenotype	HP:0002087	Abnormality of the upper respiratory tract	125	3.607184e-2	1.000000e+0	1.000000e+0	2.772246e+1	3.607184e-2	1	3.607184e-2	1.000000e+0	129	3.450762e-2	1.000000e+0	1.000000e+0	2.872771e+1	3.480960e-2	1	314	5.000000e-1	3.184713e-3	unnamed	NBN
Human Phenotype	HP:0011355	Localized skin lesion	126	3.611249e-2	1.000000e+0	1.000000e+0	2.769125e+1	3.611249e-2	1	3.611249e-2	1.000000e+0	135	3.766407e-2	1.000000e+0	1.000000e+0	2.629883e+1	3.802450e-2	1	343	5.000000e-1	2.915452e-3	unnamed	NBN
Human Phenotype	HP:0100737	Abnormality of the hard palate	127	3.615159e-2	1.000000e+0	1.000000e+0	2.766130e+1	3.615159e-2	1	3.615159e-2	1.000000e+0	116	2.981786e-2	1.000000e+0	1.000000e+0	3.328598e+1	3.004268e-2	1	271	5.000000e-1	3.690037e-3	unnamed	NBN
Human Phenotype	HP:0010936	Abnormality of the lower urinary tract	128	3.624123e-2	1.000000e+0	1.000000e+0	2.759288e+1	3.624123e-2	1	3.624123e-2	1.000000e+0	123	3.396288e-2	1.000000e+0	1.000000e+0	2.919256e+1	3.425531e-2	1	309	5.000000e-1	3.236246e-3	unnamed	NBN
Human Phenotype	HP:0008050	Abnormality of the palpebral fissures	129	3.743654e-2	1.000000e+0	1.000000e+0	2.671187e+1	3.743654e-2	1	3.743654e-2	1.000000e+0	118	3.047293e-2	1.000000e+0	1.000000e+0	3.256498e+1	3.070783e-2	1	277	5.000000e-1	3.610108e-3	unnamed	NBN
Human Phenotype	HP:0000347	Micrognathia	130	3.790993e-2	1.000000e+0	1.000000e+0	2.637831e+1	3.790993e-2	1	3.790993e-2	1.000000e+0	126	3.428974e-2	1.000000e+0	1.000000e+0	2.891186e+1	3.458788e-2	1	312	5.000000e-1	3.205128e-3	unnamed	NBN
Human Phenotype	HP:0009118	Aplasia/Hypoplasia of the mandible	131	3.793557e-2	1.000000e+0	1.000000e+0	2.636049e+1	3.793557e-2	1	3.793557e-2	1.000000e+0	127	3.439869e-2	1.000000e+0	1.000000e+0	2.881949e+1	3.469874e-2	1	313	5.000000e-1	3.194888e-3	unnamed	NBN
Human Phenotype	HP:0010460	Abnormality of the female genitalia	132	3.799718e-2	1.000000e+0	1.000000e+0	2.631774e+1	3.799718e-2	1	3.799718e-2	1.000000e+0	125	3.418080e-2	1.000000e+0	1.000000e+0	2.900482e+1	3.447702e-2	1	311	5.000000e-1	3.215434e-3	unnamed	NBN
Human Phenotype	HP:0001324	Muscle weakness	133	3.916358e-2	1.000000e+0	1.000000e+0	2.553393e+1	3.916358e-2	1	3.916358e-2	1.000000e+0	145	4.688595e-2	1.000000e+0	1.000000e+0	2.107593e+1	4.744748e-2	1	428	5.000000e-1	2.336449e-3	unnamed	NBN
Human Phenotype	HP:0002242	Abnormality of the intestine	134	3.988204e-2	1.000000e+0	1.000000e+0	2.507394e+1	3.988204e-2	1	3.988204e-2	1.000000e+0	136	4.027239e-2	1.000000e+0	1.000000e+0	2.457902e+1	4.068511e-2	1	367	5.000000e-1	2.724796e-3	unnamed	NBN
Human Phenotype	HP:0009116	Aplasia/Hypoplasia involving bones of the skull	135	4.031629e-2	1.000000e+0	1.000000e+0	2.480387e+1	4.031629e-2	1	4.031629e-2	1.000000e+0	134	3.657622e-2	1.000000e+0	1.000000e+0	2.708859e+1	3.691591e-2	1	333	5.000000e-1	3.003003e-3	unnamed	NBN
Human Phenotype	HP:0000202	Oral cleft	136	4.063484e-2	1.000000e+0	1.000000e+0	2.460943e+1	4.063484e-2	1	4.063484e-2	1.000000e+0	123	3.396288e-2	1.000000e+0	1.000000e+0	2.919256e+1	3.425531e-2	1	309	5.000000e-1	3.236246e-3	unnamed	NBN
Human Phenotype	HP:0002795	Functional respiratory abnormality	137	4.088885e-2	1.000000e+0	1.000000e+0	2.445654e+1	4.088885e-2	1	4.088885e-2	1.000000e+0	144	4.666947e-2	1.000000e+0	1.000000e+0	2.117488e+1	4.722576e-2	1	426	5.000000e-1	2.347418e-3	unnamed	NBN
Human Phenotype	HP:0010978	Abnormality of immune system physiology	138	4.120940e-2	1.000000e+0	1.000000e+0	2.426631e+1	4.120940e-2	1	4.120940e-2	1.000000e+0	153	5.336878e-2	1.000000e+0	1.000000e+0	1.848463e+1	5.409900e-2	1	488	5.000000e-1	2.049180e-3	unnamed	NBN
Human Phenotype	HP:0000159	Abnormality of the lip	139	4.273885e-2	1.000000e+0	1.000000e+0	2.339791e+1	4.273885e-2	1	4.273885e-2	1.000000e+0	122	3.374495e-2	1.000000e+0	1.000000e+0	2.938274e+1	3.403359e-2	1	307	5.000000e-1	3.257329e-3	unnamed	NBN
Human Phenotype	HP:0009122	Aplasia/Hypoplasia affecting bones of the axial skeleton	140	4.547088e-2	1.000000e+0	1.000000e+0	2.199210e+1	4.547088e-2	1	4.547088e-2	1.000000e+0	138	4.124960e-2	1.000000e+0	1.000000e+0	2.399069e+1	4.168283e-2	1	376	5.000000e-1	2.659574e-3	unnamed	NBN
Human Phenotype	HP:0000290	Abnormality of the forehead	141	4.611275e-2	1.000000e+0	1.000000e+0	2.168598e+1	4.611275e-2	1	4.611275e-2	1.000000e+0	137	4.059818e-2	1.000000e+0	1.000000e+0	2.437973e+1	4.101768e-2	1	370	5.000000e-1	2.702703e-3	unnamed	NBN
Human Phenotype	HP:0004325	Decreased body weight	142	4.649404e-2	1.000000e+0	1.000000e+0	2.150813e+1	4.649404e-2	1	4.649404e-2	1.000000e+0	147	4.872500e-2	1.000000e+0	1.000000e+0	2.027079e+1	4.933208e-2	1	445	5.000000e-1	2.247191e-3	unnamed	NBN
Human Phenotype	HP:0000252	Microcephaly	143	4.655716e-2	1.000000e+0	1.000000e+0	2.147897e+1	4.655716e-2	1	4.655716e-2	1.000000e+0	142	4.656123e-2	1.000000e+0	1.000000e+0	2.122471e+1	4.711490e-2	1	425	5.000000e-1	2.352941e-3	unnamed	NBN
Human Phenotype	HP:0012210	Abnormal renal morphology	144	4.761321e-2	1.000000e+0	1.000000e+0	2.100257e+1	4.761321e-2	1	4.761321e-2	1.000000e+0	140	4.439500e-2	1.000000e+0	1.000000e+0	2.227284e+1	4.489773e-2	1	405	5.000000e-1	2.469136e-3	unnamed	NBN
Human Phenotype	HP:0011793	Neoplasm by anatomical site	145	4.811988e-2	1.000000e+0	1.000000e+0	2.078143e+1	4.811988e-2	1	4.811988e-2	1.000000e+0	142	4.656123e-2	1.000000e+0	1.000000e+0	2.122471e+1	4.711490e-2	1	425	5.000000e-1	2.352941e-3	unnamed	NBN
Human Phenotype	HP:0000277	Abnormality of the mandible	146	4.858944e-2	1.000000e+0	1.000000e+0	2.058060e+1	4.858944e-2	1	4.858944e-2	1.000000e+0	139	4.222631e-2	1.000000e+0	1.000000e+0	2.342987e+1	4.268056e-2	1	385	5.000000e-1	2.597403e-3	unnamed	NBN
Human Phenotype	HP:0002664	Neoplasm	147	5.084040e-2	1.000000e+0	1.000000e+0	1.966940e+1	5.084040e-2	1	5.084040e-2	1.000000e+0	150	4.991402e-2	1.000000e+0	1.000000e+0	1.978180e+1	5.055152e-2	1	456	5.000000e-1	2.192982e-3	unnamed	NBN
Human Phenotype	HP:0011821	Abnormality of facial skeleton	148	5.308301e-2	1.000000e+0	1.000000e+0	1.883842e+1	5.308301e-2	1	5.308301e-2	1.000000e+0	151	5.034621e-2	1.000000e+0	1.000000e+0	1.960978e+1	5.099496e-2	1	460	5.000000e-1	2.173913e-3	unnamed	NBN
Human Phenotype	HP:0011121	Abnormality of skin morphology	149	5.311577e-2	1.000000e+0	1.000000e+0	1.882680e+1	5.311577e-2	1	5.311577e-2	1.000000e+0	162	6.187077e-2	1.000000e+0	1.000000e+0	1.590917e+1	6.285683e-2	1	567	5.000000e-1	1.763668e-3	unnamed	NBN
Human Phenotype	HP:0000422	Abnormality of the nasal bridge	150	5.330993e-2	1.000000e+0	1.000000e+0	1.875823e+1	5.330993e-2	1	5.330993e-2	1.000000e+0	141	4.515346e-2	1.000000e+0	1.000000e+0	2.189442e+1	4.567374e-2	1	412	5.000000e-1	2.427184e-3	unnamed	NBN
Human Phenotype	HP:0005105	Abnormal nasal morphology	151	5.425388e-2	1.000000e+0	1.000000e+0	1.843186e+1	5.425388e-2	1	5.425388e-2	1.000000e+0	148	4.948174e-2	1.000000e+0	1.000000e+0	1.995686e+1	5.010809e-2	1	452	5.000000e-1	2.212389e-3	unnamed	NBN
Human Phenotype	HP:0000174	Abnormality of the palate	152	5.471904e-2	1.000000e+0	1.000000e+0	1.827517e+1	5.471904e-2	1	5.471904e-2	1.000000e+0	146	4.840059e-2	1.000000e+0	1.000000e+0	2.040837e+1	4.899950e-2	1	442	5.000000e-1	2.262443e-3	unnamed	NBN
Human Phenotype	HP:0007364	Aplasia/Hypoplasia of the cerebrum	153	5.539730e-2	1.000000e+0	1.000000e+0	1.805142e+1	5.539730e-2	1	5.539730e-2	1.000000e+0	157	5.681724e-2	1.000000e+0	1.000000e+0	1.734712e+1	5.764647e-2	1	520	5.000000e-1	1.923077e-3	unnamed	NBN
Human Phenotype	HP:0001595	Abnormality of the hair	154	5.637295e-2	1.000000e+0	1.000000e+0	1.773901e+1	5.637295e-2	1	5.637295e-2	1.000000e+0	155	5.509380e-2	1.000000e+0	1.000000e+0	1.789782e+1	5.587273e-2	1	504	5.000000e-1	1.984127e-3	unnamed	NBN
Human Phenotype	HP:0000492	Abnormality of the eyelid	155	5.671593e-2	1.000000e+0	1.000000e+0	1.763173e+1	5.671593e-2	1	5.671593e-2	1.000000e+0	149	4.969789e-2	1.000000e+0	1.000000e+0	1.986894e+1	5.032980e-2	1	454	5.000000e-1	2.202643e-3	unnamed	NBN
Human Phenotype	HP:0011458	Abdominal symptom	156	5.682180e-2	1.000000e+0	1.000000e+0	1.759888e+1	5.682180e-2	1	5.682180e-2	1.000000e+0	160	6.004447e-2	1.000000e+0	1.000000e+0	1.640091e+1	6.097223e-2	1	550	5.000000e-1	1.818182e-3	unnamed	NBN
Human Phenotype	HP:0000356	Abnormality of the outer ear	157	5.750419e-2	1.000000e+0	1.000000e+0	1.739004e+1	5.750419e-2	1	5.750419e-2	1.000000e+0	152	5.196604e-2	1.000000e+0	1.000000e+0	1.899053e+1	5.265783e-2	1	475	5.000000e-1	2.105263e-3	unnamed	NBN
Human Phenotype	HP:0001871	Abnormality of  blood and blood-forming tissues	158	5.831227e-2	1.000000e+0	1.000000e+0	1.714905e+1	5.831227e-2	1	5.831227e-2	1.000000e+0	180	7.577790e-2	1.000000e+0	1.000000e+0	1.294189e+1	7.726844e-2	1	697	5.000000e-1	1.434720e-3	unnamed	NBN
Human Phenotype	HP:0002088	Abnormality of the lung	159	5.867133e-2	1.000000e+0	1.000000e+0	1.704410e+1	5.867133e-2	1	5.867133e-2	1.000000e+0	174	6.990679e-2	1.000000e+0	1.000000e+0	1.405062e+1	7.117122e-2	1	642	5.000000e-1	1.557632e-3	unnamed	NBN
Human Phenotype	HP:0000077	Abnormality of the kidney	160	5.877112e-2	1.000000e+0	1.000000e+0	1.701516e+1	5.877112e-2	1	5.877112e-2	1.000000e+0	156	5.541706e-2	1.000000e+0	1.000000e+0	1.779191e+1	5.620531e-2	1	507	5.000000e-1	1.972387e-3	unnamed	NBN
Human Phenotype	HP:0000708	Behavioural/Psychiatric Abnormality	161	6.042589e-2	1.000000e+0	1.000000e+0	1.654920e+1	6.042589e-2	1	6.042589e-2	1.000000e+0	162	6.187077e-2	1.000000e+0	1.000000e+0	1.590917e+1	6.285683e-2	1	567	5.000000e-1	1.763668e-3	unnamed	NBN
Human Phenotype	HP:0009115	Aplasia/Hypoplasia involving the skeleton	162	6.091633e-2	1.000000e+0	1.000000e+0	1.641596e+1	6.091633e-2	1	6.091633e-2	1.000000e+0	154	5.412367e-2	1.000000e+0	1.000000e+0	1.822323e+1	5.487501e-2	1	495	5.000000e-1	2.020202e-3	unnamed	NBN
Human Phenotype	HP:0010935	Abnormality of the upper urinary tract	163	6.180045e-2	1.000000e+0	1.000000e+0	1.618111e+1	6.180045e-2	1	6.180045e-2	1.000000e+0	159	5.961449e-2	1.000000e+0	1.000000e+0	1.652106e+1	6.052880e-2	1	546	5.000000e-1	1.831502e-3	unnamed	NBN
Human Phenotype	HP:0004322	Short stature	164	6.307451e-2	1.000000e+0	1.000000e+0	1.585427e+1	6.307451e-2	1	6.307451e-2	1.000000e+0	164	6.197814e-2	1.000000e+0	1.000000e+0	1.588116e+1	6.296768e-2	1	568	5.000000e-1	1.760563e-3	unnamed	NBN
Human Phenotype	HP:0011805	Abnormality of muscle morphology	165	6.379056e-2	1.000000e+0	1.000000e+0	1.567630e+1	6.379056e-2	1	6.379056e-2	1.000000e+0	173	6.937213e-2	1.000000e+0	1.000000e+0	1.416091e+1	7.061693e-2	1	637	5.000000e-1	1.569859e-3	unnamed	NBN
Human Phenotype	HP:0000240	Abnormality of skull size	166	6.394702e-2	1.000000e+0	1.000000e+0	1.563795e+1	6.394702e-2	1	6.394702e-2	1.000000e+0	165	6.305155e-2	1.000000e+0	1.000000e+0	1.560640e+1	6.407627e-2	1	578	5.000000e-1	1.730104e-3	unnamed	NBN
Human Phenotype	HP:0000606	Abnormality of the periorbital region	167	6.436496e-2	1.000000e+0	1.000000e+0	1.553640e+1	6.436496e-2	1	6.436496e-2	1.000000e+0	158	5.724786e-2	1.000000e+0	1.000000e+0	1.721469e+1	5.808991e-2	1	524	5.000000e-1	1.908397e-3	unnamed	NBN
Human Phenotype	HP:0004323	Abnormality of body weight	168	6.465988e-2	1.000000e+0	1.000000e+0	1.546554e+1	6.465988e-2	1	6.465988e-2	1.000000e+0	166	6.541088e-2	1.000000e+0	1.000000e+0	1.503417e+1	6.651516e-2	1	600	5.000000e-1	1.666667e-3	unnamed	NBN
Human Phenotype	HP:0000812	Abnormal internal genitalia	169	6.482038e-2	1.000000e+0	1.000000e+0	1.542725e+1	6.482038e-2	1	6.482038e-2	1.000000e+0	161	6.068925e-2	1.000000e+0	1.000000e+0	1.622392e+1	6.163738e-2	1	556	5.000000e-1	1.798561e-3	unnamed	NBN
Human Phenotype	HP:0011024	Abnormality of the gastrointestinal tract	170	6.745114e-2	1.000000e+0	1.000000e+0	1.482555e+1	6.745114e-2	1	6.745114e-2	1.000000e+0	169	6.626808e-2	1.000000e+0	1.000000e+0	1.483635e+1	6.740203e-2	1	608	5.000000e-1	1.644737e-3	unnamed	NBN
Human Phenotype	HP:0002977	Aplasia/Hypoplasia involving the central nervous system	171	6.843249e-2	1.000000e+0	1.000000e+0	1.461294e+1	6.843249e-2	1	6.843249e-2	1.000000e+0	175	7.150984e-2	1.000000e+0	1.000000e+0	1.372983e+1	7.283410e-2	1	657	5.000000e-1	1.522070e-3	unnamed	NBN
Human Phenotype	HP:0000002	Abnormality of body height	172	6.858327e-2	1.000000e+0	1.000000e+0	1.458081e+1	6.858327e-2	1	6.858327e-2	1.000000e+0	170	6.637520e-2	1.000000e+0	1.000000e+0	1.481199e+1	6.751289e-2	1	609	5.000000e-1	1.642036e-3	unnamed	NBN
Human Phenotype	HP:0011138	Abnormality of skin adnexa	173	6.863693e-2	1.000000e+0	1.000000e+0	1.456942e+1	6.863693e-2	1	6.863693e-2	1.000000e+0	172	6.798130e-2	1.000000e+0	1.000000e+0	1.445593e+1	6.917577e-2	1	624	5.000000e-1	1.602564e-3	unnamed	NBN
Human Phenotype	HP:0000925	Abnormality of the vertebral column	174	6.929502e-2	1.000000e+0	1.000000e+0	1.443105e+1	6.929502e-2	1	6.929502e-2	1.000000e+0	167	6.551805e-2	1.000000e+0	1.000000e+0	1.500915e+1	6.662602e-2	1	601	5.000000e-1	1.663894e-3	unnamed	NBN
Human Phenotype	HP:0100022	Abnormality of movement	175	7.002976e-2	1.000000e+0	1.000000e+0	1.427964e+1	7.002976e-2	1	7.002976e-2	1.000000e+0	176	7.172348e-2	1.000000e+0	1.000000e+0	1.368816e+1	7.305582e-2	1	659	5.000000e-1	1.517451e-3	unnamed	NBN
Human Phenotype	HP:0002715	Abnormality of the immune system	176	7.036261e-2	1.000000e+0	1.000000e+0	1.421209e+1	7.036261e-2	1	7.036261e-2	1.000000e+0	185	8.555712e-2	1.000000e+0	1.000000e+0	1.143283e+1	8.746744e-2	1	789	5.000000e-1	1.267427e-3	unnamed	NBN
Human Phenotype	HP:0001249	Intellectual disability	177	7.044946e-2	1.000000e+0	1.000000e+0	1.419457e+1	7.044946e-2	1	7.044946e-2	1.000000e+0	167	6.551805e-2	1.000000e+0	1.000000e+0	1.500915e+1	6.662602e-2	1	601	5.000000e-1	1.663894e-3	unnamed	NBN
Human Phenotype	HP:0012243	Abnormal genital system morphology	178	7.339808e-2	1.000000e+0	1.000000e+0	1.362434e+1	7.339808e-2	1	7.339808e-2	1.000000e+0	171	6.712488e-2	1.000000e+0	1.000000e+0	1.464367e+1	6.828890e-2	1	616	5.000000e-1	1.623377e-3	unnamed	NBN
Human Phenotype	HP:0000364	Hearing abnormality	179	7.499185e-2	1.000000e+0	1.000000e+0	1.333478e+1	7.499185e-2	1	7.499185e-2	1.000000e+0	178	7.449852e-2	1.000000e+0	1.000000e+0	1.316861e+1	7.593814e-2	1	685	5.000000e-1	1.459854e-3	unnamed	NBN
Human Phenotype	HP:0002060	Abnormality of the cerebrum	180	7.579775e-2	1.000000e+0	1.000000e+0	1.319300e+1	7.579775e-2	1	7.579775e-2	1.000000e+0	182	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	NBN
Human Phenotype	HP:0100547	Abnormality of the forebrain	181	7.625082e-2	1.000000e+0	1.000000e+0	1.311461e+1	7.625082e-2	1	7.625082e-2	1.000000e+0	184	7.918527e-2	1.000000e+0	1.000000e+0	1.237380e+1	8.081592e-2	1	729	5.000000e-1	1.371742e-3	unnamed	NBN
Human Phenotype	HP:0001510	Growth delay	182	7.829812e-2	1.000000e+0	1.000000e+0	1.277170e+1	7.829812e-2	1	7.829812e-2	1.000000e+0	182	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	NBN
Human Phenotype	HP:0000078	Abnormality of the genital system	183	7.832480e-2	1.000000e+0	1.000000e+0	1.276735e+1	7.832480e-2	1	7.832480e-2	1.000000e+0	179	7.513832e-2	1.000000e+0	1.000000e+0	1.305427e+1	7.660329e-2	1	691	5.000000e-1	1.447178e-3	unnamed	NBN
Human Phenotype	HP:0011354	Generalized abnormality of skin	184	7.852036e-2	1.000000e+0	1.000000e+0	1.273555e+1	7.852036e-2	1	7.852036e-2	1.000000e+0	189	9.349082e-2	1.000000e+0	1.000000e+0	1.044039e+1	9.578183e-2	1	864	5.000000e-1	1.157407e-3	unnamed	NBN
Human Phenotype	HP:0012252	Abnormal respiratory system morphology	185	8.040224e-2	1.000000e+0	1.000000e+0	1.243746e+1	8.040224e-2	1	8.040224e-2	1.000000e+0	187	8.661694e-2	1.000000e+0	1.000000e+0	1.128974e+1	8.857602e-2	1	799	5.000000e-1	1.251564e-3	unnamed	NBN
Human Phenotype	HP:0000284	Abnormality of the ocular region	186	8.041999e-2	1.000000e+0	1.000000e+0	1.243472e+1	8.041999e-2	1	8.041999e-2	1.000000e+0	177	7.204389e-2	1.000000e+0	1.000000e+0	1.362613e+1	7.338839e-2	1	662	5.000000e-1	1.510574e-3	unnamed	NBN
Human Phenotype	HP:0000366	Abnormality of the nose	187	8.197813e-2	1.000000e+0	1.000000e+0	1.219838e+1	8.197813e-2	1	8.197813e-2	1.000000e+0	181	7.833401e-2	1.000000e+0	1.000000e+0	1.251110e+1	7.992905e-2	1	721	5.000000e-1	1.386963e-3	unnamed	NBN
Human Phenotype	HP:0002086	Abnormality of the respiratory system	188	8.717457e-2	1.000000e+0	1.000000e+0	1.147124e+1	8.717457e-2	1	8.717457e-2	1.000000e+0	190	9.359637e-2	1.000000e+0	1.000000e+0	1.042832e+1	9.589269e-2	1	865	5.000000e-1	1.156069e-3	unnamed	NBN
Human Phenotype	HP:0000079	Abnormality of the urinary system	189	8.807497e-2	1.000000e+0	1.000000e+0	1.135396e+1	8.807497e-2	1	8.807497e-2	1.000000e+0	188	9.053295e-2	1.000000e+0	1.000000e+0	1.079007e+1	9.267779e-2	1	836	5.000000e-1	1.196172e-3	unnamed	NBN
Human Phenotype	HP:0000163	Abnormality of the oral cavity	190	8.862539e-2	1.000000e+0	1.000000e+0	1.128345e+1	8.862539e-2	1	8.862539e-2	1.000000e+0	186	8.576913e-2	1.000000e+0	1.000000e+0	1.140392e+1	8.768915e-2	1	791	5.000000e-1	1.264223e-3	unnamed	NBN
Human Phenotype	HP:0012443	Abnormality of the brain	191	9.259756e-2	1.000000e+0	1.000000e+0	1.079942e+1	9.259756e-2	1	9.259756e-2	1.000000e+0	192	9.833972e-2	1.000000e+0	1.000000e+0	9.912637e+0	1.008813e-1	1	910	5.000000e-1	1.098901e-3	unnamed	NBN
Human Phenotype	HP:0002012	Abnormality of the abdominal organs	192	9.395144e-2	1.000000e+0	1.000000e+0	1.064380e+1	9.395144e-2	1	9.395144e-2	1.000000e+0	195	1.060080e-1	1.000000e+0	1.000000e+0	9.176501e+0	1.089740e-1	1	983	5.000000e-1	1.017294e-3	unnamed	NBN
Human Phenotype	HP:0011804	Abnormality of muscle physiology	193	9.636400e-2	1.000000e+0	1.000000e+0	1.037732e+1	9.636400e-2	1	9.636400e-2	1.000000e+0	194	1.050644e-1	1.000000e+0	1.000000e+0	9.261294e+0	1.079763e-1	1	974	5.000000e-1	1.026694e-3	unnamed	NBN
Human Phenotype	HP:0000951	Abnormality of the skin	194	9.900756e-2	1.000000e+0	1.000000e+0	1.010024e+1	9.900756e-2	1	9.900756e-2	1.000000e+0	197	1.100914e-1	1.000000e+0	1.000000e+0	8.826321e+0	1.132975e-1	1	1022	5.000000e-1	9.784736e-4	unnamed	NBN
Human Phenotype	HP:0000929	Abnormality of the skull	195	1.006699e-1	1.000000e+0	1.000000e+0	9.933458e+0	1.006699e-1	1	1.006699e-1	1.000000e+0	193	1.002336e-1	1.000000e+0	1.000000e+0	9.720366e+0	1.028768e-1	1	928	5.000000e-1	1.077586e-3	unnamed	NBN
Human Phenotype	HP:0000153	Abnormality of the mouth	196	1.037371e-1	1.000000e+0	1.000000e+0	9.639755e+0	1.037371e-1	1	1.037371e-1	1.000000e+0	191	9.823445e-2	1.000000e+0	1.000000e+0	9.923542e+0	1.007705e-1	1	909	5.000000e-1	1.100110e-3	unnamed	NBN
Human Phenotype	HP:0000598	Abnormality of the ear	197	1.055161e-1	1.000000e+0	1.000000e+0	9.477228e+0	1.055161e-1	1	1.055161e-1	1.000000e+0	196	1.062177e-1	1.000000e+0	1.000000e+0	9.157868e+0	1.091957e-1	1	985	5.000000e-1	1.015228e-3	unnamed	NBN
Human Phenotype	HP:0001507	Growth abnormality	198	1.155115e-1	1.000000e+0	1.000000e+0	8.657146e+0	1.155115e-1	1	1.155115e-1	1.000000e+0	198	1.160425e-1	1.000000e+0	1.000000e+0	8.360056e+0	1.196164e-1	1	1079	5.000000e-1	9.267841e-4	unnamed	NBN
Human Phenotype	HP:0000119	Abnormality of the genitourinary system	199	1.156102e-1	1.000000e+0	1.000000e+0	8.649757e+0	1.156102e-1	1	1.156102e-1	1.000000e+0	199	1.209346e-1	1.000000e+0	1.000000e+0	8.011101e+0	1.248268e-1	1	1126	5.000000e-1	8.880995e-4	unnamed	NBN
Human Phenotype	HP:0001939	Abnormality of metabolism/homeostasis	200	1.159749e-1	1.000000e+0	1.000000e+0	8.622554e+0	1.159749e-1	1	1.159749e-1	1.000000e+0	207	1.414974e-1	1.000000e+0	1.000000e+0	6.807925e+0	1.468876e-1	1	1325	5.000000e-1	7.547170e-4	unnamed	NBN
Human Phenotype	HP:0003011	Abnormality of the musculature	201	1.167900e-1	1.000000e+0	1.000000e+0	8.562375e+0	1.167900e-1	1	1.167900e-1	1.000000e+0	201	1.247763e-1	1.000000e+0	1.000000e+0	7.756234e+0	1.289286e-1	1	1163	5.000000e-1	8.598452e-4	unnamed	NBN
Human Phenotype	HP:0001438	Abnormality of the abdomen	202	1.198484e-1	1.000000e+0	1.000000e+0	8.343876e+0	1.198484e-1	1	1.198484e-1	1.000000e+0	203	1.315047e-1	1.000000e+0	1.000000e+0	7.345684e+0	1.361344e-1	1	1228	5.000000e-1	8.143322e-4	unnamed	NBN
Human Phenotype	HP:0001574	Abnormality of the integument	203	1.221743e-1	1.000000e+0	1.000000e+0	8.185030e+0	1.221743e-1	1	1.221743e-1	1.000000e+0	202	1.310914e-1	1.000000e+0	1.000000e+0	7.369690e+0	1.356909e-1	1	1224	5.000000e-1	8.169935e-4	unnamed	NBN
Human Phenotype	HP:0007319	Morphological abnormality of the central nervous system	204	1.231213e-1	1.000000e+0	1.000000e+0	8.122074e+0	1.231213e-1	1	1.231213e-1	1.000000e+0	204	1.321245e-1	1.000000e+0	1.000000e+0	7.309968e+0	1.367995e-1	1	1234	5.000000e-1	8.103728e-4	unnamed	NBN
Human Phenotype	HP:0009121	Abnormal axial skeleton morphology	205	1.232157e-1	1.000000e+0	1.000000e+0	8.115849e+0	1.232157e-1	1	1.232157e-1	1.000000e+0	200	1.216620e-1	1.000000e+0	1.000000e+0	7.961606e+0	1.256028e-1	1	1133	5.000000e-1	8.826125e-4	unnamed	NBN
Human Phenotype	HP:0100543	Cognitive impairment	206	1.275944e-1	1.000000e+0	1.000000e+0	7.837337e+0	1.275944e-1	1	1.275944e-1	1.000000e+0	205	1.328473e-1	1.000000e+0	1.000000e+0	7.268735e+0	1.375755e-1	1	1241	5.000000e-1	8.058018e-4	unnamed	NBN
Human Phenotype	HP:0000271	Abnormality of the face	207	1.330333e-1	1.000000e+0	1.000000e+0	7.516916e+0	1.330333e-1	1	1.330333e-1	1.000000e+0	206	1.358386e-1	1.000000e+0	1.000000e+0	7.102756e+0	1.407904e-1	1	1270	5.000000e-1	7.874016e-4	unnamed	NBN
Human Phenotype	HP:0000007	Autosomal recessive inheritance	208	1.382544e-1	1.000000e+0	1.000000e+0	7.233043e+0	1.382544e-1	1	1.382544e-1	1.000000e+0	213	1.705229e-1	1.000000e+0	1.000000e+0	5.602795e+0	1.784823e-1	1	1610	5.000000e-1	6.211180e-4	unnamed	NBN
Human Phenotype	HP:0011446	Abnormality of higher mental function	209	1.446140e-1	1.000000e+0	1.000000e+0	6.914961e+0	1.446140e-1	1	1.446140e-1	1.000000e+0	208	1.507173e-1	1.000000e+0	1.000000e+0	6.374912e+0	1.568649e-1	1	1415	5.000000e-1	7.067138e-4	unnamed	NBN
Human Phenotype	HP:0000234	Abnormality of the head	210	1.454011e-1	1.000000e+0	1.000000e+0	6.877527e+0	1.454011e-1	1	1.454011e-1	1.000000e+0	210	1.516365e-1	1.000000e+0	1.000000e+0	6.334621e+0	1.578626e-1	1	1424	5.000000e-1	7.022472e-4	unnamed	NBN
Human Phenotype	HP:0000152	Abnormality of head and neck	211	1.484435e-1	1.000000e+0	1.000000e+0	6.736568e+0	1.484435e-1	1	1.484435e-1	1.000000e+0	211	1.541874e-1	1.000000e+0	1.000000e+0	6.225328e+0	1.606341e-1	1	1449	5.000000e-1	6.901311e-4	unnamed	NBN
Human Phenotype	HP:0011842	Abnormality of skeletal morphology	212	1.489554e-1	1.000000e+0	1.000000e+0	6.713421e+0	1.489554e-1	1	1.489554e-1	1.000000e+0	209	1.514323e-1	1.000000e+0	1.000000e+0	6.343530e+0	1.576409e-1	1	1422	5.000000e-1	7.032349e-4	unnamed	NBN
Human Phenotype	HP:0000924	Abnormality of the skeletal system	213	1.521487e-1	1.000000e+0	1.000000e+0	6.572520e+0	1.521487e-1	1	1.521487e-1	1.000000e+0	212	1.555123e-1	1.000000e+0	1.000000e+0	6.169973e+0	1.620753e-1	1	1462	5.000000e-1	6.839945e-4	unnamed	NBN
Human Phenotype	HP:0002011	Abnormality of the central nervous system	214	1.748665e-1	1.000000e+0	1.000000e+0	5.718647e+0	1.748665e-1	1	1.748665e-1	1.000000e+0	214	1.821938e-1	1.000000e+0	1.000000e+0	5.226246e+0	1.913419e-1	1	1726	5.000000e-1	5.793743e-4	unnamed	NBN
Human Phenotype	HP:0000707	Abnormality of the nervous system	215	1.846645e-1	1.000000e+0	1.000000e+0	5.415226e+0	1.846645e-1	1	1.846645e-1	1.000000e+0	215	1.902943e-1	1.000000e+0	1.000000e+0	4.991976e+0	2.003215e-1	1	1807	5.000000e-1	5.534034e-4	unnamed	NBN
Human Phenotype	HP:0000005	Mode of inheritance	216	2.495240e-1	1.000000e+0	1.000000e+0	4.007630e+0	2.495240e-1	1	2.495240e-1	1.000000e+0	216	2.693662e-1	1.000000e+0	1.000000e+0	3.442939e+0	2.904495e-1	1	2620	5.000000e-1	3.816794e-4	unnamed	NBN
Human Phenotype	HP:0000118	Phenotypic abnormality	217	2.682332e-1	1.000000e+0	1.000000e+0	3.728099e+0	2.682332e-1	1	2.682332e-1	1.000000e+0	217	2.856679e-1	1.000000e+0	1.000000e+0	3.229681e+0	3.096281e-1	1	2793	5.000000e-1	3.580380e-4	unnamed	NBN
Human Phenotype	HP:0000001	All	218	2.696410e-1	1.000000e+0	1.000000e+0	3.708635e+0	2.696410e-1	1	2.696410e-1	1.000000e+0	218	2.883826e-1	1.000000e+0	1.000000e+0	3.196492e+0	3.128430e-1	1	2822	5.000000e-1	3.543586e-4	unnamed	NBN
Disease Ontology	DOID:7400	Nijmegen Breakage syndrome	1	7.392020e-4	1.000000e+0	1.000000e+0	1.352810e+3	7.392020e-4	1	7.392020e-4	1.000000e+0	1	8.866967e-4	1.000000e+0	1.000000e+0	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	NBN
Disease Ontology	DOID:5688	Werner syndrome	2	9.090547e-4	1.000000e+0	1.000000e+0	1.100044e+3	9.090547e-4	1	9.090547e-4	1.000000e+0	2	1.329898e-3	1.000000e+0	1.000000e+0	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	NBN
Disease Ontology	DOID:614	lymphopenia	3	1.450986e-3	1.000000e+0	1.000000e+0	6.891865e+2	1.450986e-3	1	1.450986e-3	1.000000e+0	2	1.329898e-3	1.000000e+0	1.000000e+0	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	NBN
Disease Ontology	DOID:12704	ataxia telangiectasia	4	1.671305e-3	1.000000e+0	9.338417e-1	5.983349e+2	1.671305e-3	1	1.671305e-3	1.000000e+0	4	2.769621e-3	1.000000e+0	1.000000e+0	3.608200e+2	2.771465e-3	1	25	5.000000e-1	4.000000e-2	unnamed	NBN
Disease Ontology	DOID:1272	telangiectasis	5	2.460500e-3	1.000000e+0	1.000000e+0	4.064214e+2	2.460500e-3	1	2.460500e-3	1.000000e+0	6	3.765745e-3	1.000000e+0	1.000000e+0	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	NBN
Disease Ontology	DOID:8029	sporadic breast cancer	6	2.468438e-3	1.000000e+0	9.194932e-1	4.051144e+2	2.468438e-3	1	2.468438e-3	1.000000e+0	5	3.433759e-3	1.000000e+0	1.000000e+0	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	NBN
Disease Ontology	DOID:615	leukopenia	7	4.962836e-3	1.000000e+0	1.000000e+0	2.014977e+2	4.962836e-3	1	4.962836e-3	1.000000e+0	7	5.535402e-3	1.000000e+0	1.000000e+0	1.804100e+2	5.542930e-3	1	50	5.000000e-1	2.000000e-2	unnamed	NBN
Disease Ontology	DOID:2893	cervix carcinoma	8	5.784062e-3	1.000000e+0	1.000000e+0	1.728889e+2	5.784062e-3	1	5.784062e-3	1.000000e+0	8	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	NBN
Disease Ontology	DOID:0050298	Adenoviridae infectious disease	9	1.139786e-2	1.000000e+0	1.000000e+0	8.773575e+1	1.139786e-2	1	1.139786e-2	1.000000e+0	10	1.226779e-2	1.000000e+0	1.000000e+0	8.126577e+1	1.230530e-2	1	111	5.000000e-1	9.009009e-3	unnamed	NBN
Disease Ontology	DOID:9500	leukocyte disease	10	1.184141e-2	1.000000e+0	1.000000e+0	8.444942e+1	1.184141e-2	1	1.184141e-2	1.000000e+0	9	1.094519e-2	1.000000e+0	1.000000e+0	9.111616e+1	1.097500e-2	1	99	5.000000e-1	1.010101e-2	unnamed	NBN
Disease Ontology	DOID:9540	vascular skin disease	11	1.340056e-2	1.000000e+0	1.000000e+0	7.462374e+1	1.340056e-2	1	1.340056e-2	1.000000e+0	16	1.732955e-2	1.000000e+0	1.000000e+0	5.745541e+1	1.740480e-2	1	157	5.000000e-1	6.369427e-3	unnamed	NBN
Disease Ontology	DOID:768	retinoblastoma	12	1.512580e-2	1.000000e+0	1.000000e+0	6.611220e+1	1.512580e-2	1	1.512580e-2	1.000000e+0	10	1.226779e-2	1.000000e+0	1.000000e+0	8.126577e+1	1.230530e-2	1	111	5.000000e-1	9.009009e-3	unnamed	NBN
Disease Ontology	DOID:4645	retinal neoplasm	13	1.518894e-2	1.000000e+0	1.000000e+0	6.583736e+1	1.518894e-2	1	1.518894e-2	1.000000e+0	12	1.248814e-2	1.000000e+0	1.000000e+0	7.982743e+1	1.252702e-2	1	113	5.000000e-1	8.849558e-3	unnamed	NBN
Disease Ontology	DOID:9985	malignant eye neoplasm	14	1.533717e-2	1.000000e+0	1.000000e+0	6.520110e+1	1.533717e-2	1	1.533717e-2	1.000000e+0	13	1.259830e-2	1.000000e+0	1.000000e+0	7.912719e+1	1.263788e-2	1	114	5.000000e-1	8.771930e-3	unnamed	NBN
Disease Ontology	DOID:2174	eye neoplasm	15	1.540031e-2	1.000000e+0	1.000000e+0	6.493376e+1	1.540031e-2	1	1.540031e-2	1.000000e+0	14	1.281861e-2	1.000000e+0	1.000000e+0	7.776293e+1	1.285960e-2	1	116	5.000000e-1	8.620690e-3	unnamed	NBN
Disease Ontology	DOID:612	primary immunodeficiency disease	16	1.743835e-2	1.000000e+0	1.000000e+0	5.734487e+1	1.743835e-2	1	1.743835e-2	1.000000e+0	20	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	NBN
Disease Ontology	DOID:5520	head and neck squamous cell carcinoma	17	1.765121e-2	1.000000e+0	1.000000e+0	5.665335e+1	1.765121e-2	1	1.765121e-2	1.000000e+0	17	1.831837e-2	1.000000e+0	1.000000e+0	5.434036e+1	1.840253e-2	1	166	5.000000e-1	6.024096e-3	unnamed	NBN
Disease Ontology	DOID:3858	medulloblastoma	18	1.823395e-2	1.000000e+0	1.000000e+0	5.484276e+1	1.823395e-2	1	1.823395e-2	1.000000e+0	15	1.458020e-2	1.000000e+0	1.000000e+0	6.833712e+1	1.463334e-2	1	132	5.000000e-1	7.575758e-3	unnamed	NBN
Disease Ontology	DOID:341	peripheral vascular disease	19	1.937384e-2	1.000000e+0	1.000000e+0	5.161599e+1	1.937384e-2	1	1.937384e-2	1.000000e+0	22	2.413134e-2	1.000000e+0	1.000000e+0	4.118950e+1	2.427803e-2	1	219	5.000000e-1	4.566210e-3	unnamed	NBN
Disease Ontology	DOID:2355	anemia	20	1.971202e-2	1.000000e+0	1.000000e+0	5.073048e+1	1.971202e-2	1	1.971202e-2	1.000000e+0	23	2.555453e-2	1.000000e+0	1.000000e+0	3.888147e+1	2.571920e-2	1	232	5.000000e-1	4.310345e-3	unnamed	NBN
Disease Ontology	DOID:2786	cerebellar disease	21	2.300199e-2	1.000000e+0	1.000000e+0	4.347450e+1	2.300199e-2	1	2.300199e-2	1.000000e+0	18	1.908711e-2	1.000000e+0	1.000000e+0	5.214162e+1	1.917854e-2	1	173	5.000000e-1	5.780347e-3	unnamed	NBN
Disease Ontology	DOID:5683	hereditary breast ovarian cancer	22	2.305275e-2	1.000000e+0	1.000000e+0	4.337877e+1	2.305275e-2	1	2.305275e-2	1.000000e+0	21	2.380277e-2	1.000000e+0	1.000000e+0	4.176157e+1	2.394546e-2	1	216	5.000000e-1	4.629630e-3	unnamed	NBN
Disease Ontology	DOID:0070003	blastoma	23	2.525493e-2	1.000000e+0	1.000000e+0	3.959623e+1	2.525493e-2	1	2.525493e-2	1.000000e+0	18	1.908711e-2	1.000000e+0	1.000000e+0	5.214162e+1	1.917854e-2	1	173	5.000000e-1	5.780347e-3	unnamed	NBN
Disease Ontology	DOID:9074	systemic lupus erythematosus	24	2.739422e-2	1.000000e+0	1.000000e+0	3.650406e+1	2.739422e-2	1	2.739422e-2	1.000000e+0	24	3.178240e-2	1.000000e+0	1.000000e+0	3.121280e+1	3.203814e-2	1	289	5.000000e-1	3.460208e-3	unnamed	NBN
Disease Ontology	DOID:8857	lupus erythematosus	25	3.295243e-2	1.000000e+0	1.000000e+0	3.034678e+1	3.295243e-2	1	3.295243e-2	1.000000e+0	26	3.929468e-2	1.000000e+0	1.000000e+0	2.519693e+1	3.968738e-2	1	358	5.000000e-1	2.793296e-3	unnamed	NBN
Disease Ontology	DOID:4450	renal cell carcinoma	26	3.398104e-2	1.000000e+0	1.000000e+0	2.942817e+1	3.398104e-2	1	3.398104e-2	1.000000e+0	25	3.505220e-2	1.000000e+0	1.000000e+0	2.827743e+1	3.536389e-2	1	319	5.000000e-1	3.134796e-3	unnamed	NBN
Disease Ontology	DOID:0050498	dsDNA virus infectious disease	27	3.739700e-2	1.000000e+0	1.000000e+0	2.674011e+1	3.739700e-2	1	3.739700e-2	1.000000e+0	35	4.753523e-2	1.000000e+0	1.000000e+0	2.078456e+1	4.811263e-2	1	434	5.000000e-1	2.304147e-3	unnamed	NBN
Disease Ontology	DOID:4451	renal carcinoma	28	3.907764e-2	1.000000e+0	1.000000e+0	2.559008e+1	3.907764e-2	1	3.907764e-2	1.000000e+0	27	3.940334e-2	1.000000e+0	1.000000e+0	2.512674e+1	3.979824e-2	1	359	5.000000e-1	2.785515e-3	unnamed	NBN
Disease Ontology	DOID:3069	astrocytoma	29	4.313016e-2	1.000000e+0	1.000000e+0	2.318563e+1	4.313016e-2	1	4.313016e-2	1.000000e+0	28	4.157523e-2	1.000000e+0	1.000000e+0	2.380079e+1	4.201541e-2	1	379	5.000000e-1	2.638522e-3	unnamed	NBN
Disease Ontology	DOID:2126	primary brain tumor	30	4.334785e-2	1.000000e+0	1.000000e+0	2.306920e+1	4.334785e-2	1	4.334785e-2	1.000000e+0	29	4.168376e-2	1.000000e+0	1.000000e+0	2.373816e+1	4.212627e-2	1	380	5.000000e-1	2.631579e-3	unnamed	NBN
Disease Ontology	DOID:911	malignant neoplasm of brain	31	4.364353e-2	1.000000e+0	1.000000e+0	2.291290e+1	4.364353e-2	1	4.364353e-2	1.000000e+0	30	4.222631e-2	1.000000e+0	1.000000e+0	2.342987e+1	4.268056e-2	1	385	5.000000e-1	2.597403e-3	unnamed	NBN
Disease Ontology	DOID:3459	breast carcinoma	32	4.496474e-2	1.000000e+0	1.000000e+0	2.223965e+1	4.496474e-2	1	4.496474e-2	1.000000e+0	31	4.287718e-2	1.000000e+0	1.000000e+0	2.307033e+1	4.334571e-2	1	391	5.000000e-1	2.557545e-3	unnamed	NBN
Disease Ontology	DOID:368	neoplasm of cerebrum	33	4.511970e-2	1.000000e+0	1.000000e+0	2.216327e+1	4.511970e-2	1	4.511970e-2	1.000000e+0	33	4.298563e-2	1.000000e+0	1.000000e+0	2.301148e+1	4.345657e-2	1	392	5.000000e-1	2.551020e-3	unnamed	NBN
Disease Ontology	DOID:1659	supratentorial neoplasm	34	4.529725e-2	1.000000e+0	1.000000e+0	2.207640e+1	4.529725e-2	1	4.529725e-2	1.000000e+0	34	4.320252e-2	1.000000e+0	1.000000e+0	2.289467e+1	4.367829e-2	1	394	5.000000e-1	2.538071e-3	unnamed	NBN
Disease Ontology	DOID:5679	retinal disease	35	4.769824e-2	1.000000e+0	1.000000e+0	2.096514e+1	4.769824e-2	1	4.769824e-2	1.000000e+0	36	4.850873e-2	1.000000e+0	1.000000e+0	2.036230e+1	4.911036e-2	1	443	5.000000e-1	2.257336e-3	unnamed	NBN
Disease Ontology	DOID:1037	lymphoblastic leukemia	36	4.801529e-2	1.000000e+0	1.000000e+0	2.082670e+1	4.801529e-2	1	4.801529e-2	1.000000e+0	31	4.287718e-2	1.000000e+0	1.000000e+0	2.307033e+1	4.334571e-2	1	391	5.000000e-1	2.557545e-3	unnamed	NBN
Disease Ontology	DOID:937	DNA virus infectious disease	37	5.023839e-2	1.000000e+0	1.000000e+0	1.990510e+1	5.023839e-2	1	5.023839e-2	1.000000e+0	45	6.187077e-2	1.000000e+0	1.000000e+0	1.590917e+1	6.285683e-2	1	567	5.000000e-1	1.763668e-3	unnamed	NBN
Disease Ontology	DOID:449	head neoplasm	38	5.090150e-2	1.000000e+0	1.000000e+0	1.964579e+1	5.090150e-2	1	5.090150e-2	1.000000e+0	40	5.045424e-2	1.000000e+0	1.000000e+0	1.956725e+1	5.110581e-2	1	461	5.000000e-1	2.169197e-3	unnamed	NBN
Disease Ontology	DOID:37	skin disease	39	5.172018e-2	1.000000e+0	1.000000e+0	1.933481e+1	5.172018e-2	1	5.172018e-2	1.000000e+0	49	6.733902e-2	1.000000e+0	1.000000e+0	1.459628e+1	6.851061e-2	1	618	5.000000e-1	1.618123e-3	unnamed	NBN
Disease Ontology	DOID:16	integumentary system disease	40	5.565040e-2	1.000000e+0	1.000000e+0	1.796932e+1	5.565040e-2	1	5.565040e-2	1.000000e+0	52	6.979987e-2	1.000000e+0	1.000000e+0	1.407254e+1	7.106036e-2	1	641	5.000000e-1	1.560062e-3	unnamed	NBN
Disease Ontology	DOID:0050177	simple genetic disease	41	5.697693e-2	1.000000e+0	1.000000e+0	1.755096e+1	5.697693e-2	1	5.697693e-2	1.000000e+0	46	6.337345e-2	1.000000e+0	1.000000e+0	1.552582e+1	6.440885e-2	1	581	5.000000e-1	1.721170e-3	unnamed	NBN
Disease Ontology	DOID:769	neuroblastoma	42	5.857072e-2	1.000000e+0	1.000000e+0	1.707338e+1	5.857072e-2	1	5.857072e-2	1.000000e+0	37	4.861687e-2	1.000000e+0	1.000000e+0	2.031644e+1	4.922122e-2	1	444	5.000000e-1	2.252252e-3	unnamed	NBN
Disease Ontology	DOID:3369	Ewings sarcoma	43	5.884188e-2	1.000000e+0	1.000000e+0	1.699470e+1	5.884188e-2	1	5.884188e-2	1.000000e+0	38	4.883312e-2	1.000000e+0	1.000000e+0	2.022534e+1	4.944294e-2	1	446	5.000000e-1	2.242152e-3	unnamed	NBN
Disease Ontology	DOID:2438	tumor of dermis	44	6.071436e-2	1.000000e+0	1.000000e+0	1.647057e+1	6.071436e-2	1	6.071436e-2	1.000000e+0	39	5.002208e-2	1.000000e+0	1.000000e+0	1.973851e+1	5.066238e-2	1	457	5.000000e-1	2.188184e-3	unnamed	NBN
Disease Ontology	DOID:4159	skin cancer	45	6.228896e-2	1.000000e+0	1.000000e+0	1.605421e+1	6.228896e-2	1	6.228896e-2	1.000000e+0	42	5.261359e-2	1.000000e+0	1.000000e+0	1.875364e+1	5.332299e-2	1	481	5.000000e-1	2.079002e-3	unnamed	NBN
Disease Ontology	DOID:1192	peripheral nervous system neoplasm	46	6.432174e-2	1.000000e+0	1.000000e+0	1.554684e+1	6.432174e-2	1	6.432174e-2	1.000000e+0	41	5.228984e-2	1.000000e+0	1.000000e+0	1.887134e+1	5.299041e-2	1	478	5.000000e-1	2.092050e-3	unnamed	NBN
Disease Ontology	DOID:630	genetic disease	47	6.499915e-2	1.000000e+0	1.000000e+0	1.538482e+1	6.499915e-2	1	6.499915e-2	1.000000e+0	51	6.926518e-2	1.000000e+0	1.000000e+0	1.418318e+1	7.050607e-2	1	636	5.000000e-1	1.572327e-3	unnamed	NBN
Disease Ontology	DOID:5614	eye disease	48	6.845790e-2	1.000000e+0	1.000000e+0	1.460752e+1	6.845790e-2	1	6.845790e-2	1.000000e+0	50	6.883732e-2	1.000000e+0	1.000000e+0	1.427294e+1	7.006264e-2	1	632	5.000000e-1	1.582278e-3	unnamed	NBN
Disease Ontology	DOID:168	primitive neuroectodermal tumor	49	6.935969e-2	1.000000e+0	1.000000e+0	1.441760e+1	6.935969e-2	1	6.935969e-2	1.000000e+0	43	5.789360e-2	1.000000e+0	1.000000e+0	1.701981e+1	5.875506e-2	1	530	5.000000e-1	1.886792e-3	unnamed	NBN
Disease Ontology	DOID:688	embryonal cancer	50	7.040036e-2	1.000000e+0	1.000000e+0	1.420447e+1	7.040036e-2	1	7.040036e-2	1.000000e+0	44	5.961449e-2	1.000000e+0	1.000000e+0	1.652106e+1	6.052880e-2	1	546	5.000000e-1	1.831502e-3	unnamed	NBN
Disease Ontology	DOID:1749	squamous cell carcinoma	51	7.192071e-2	1.000000e+0	1.000000e+0	1.390420e+1	7.192071e-2	1	7.192071e-2	1.000000e+0	55	7.652380e-2	1.000000e+0	1.000000e+0	1.281321e+1	7.804445e-2	1	704	5.000000e-1	1.420455e-3	unnamed	NBN
Disease Ontology	DOID:2428	epithelioma	52	7.206581e-2	1.000000e+0	1.000000e+0	1.387621e+1	7.206581e-2	1	7.206581e-2	1.000000e+0	56	7.673686e-2	1.000000e+0	1.000000e+0	1.277691e+1	7.826617e-2	1	706	5.000000e-1	1.416431e-3	unnamed	NBN
Disease Ontology	DOID:353	lymphoma	53	7.370780e-2	1.000000e+0	1.000000e+0	1.356708e+1	7.370780e-2	1	7.370780e-2	1.000000e+0	58	7.694989e-2	1.000000e+0	1.000000e+0	1.274082e+1	7.848789e-2	1	708	5.000000e-1	1.412429e-3	unnamed	NBN
Disease Ontology	DOID:2144	malignant neoplasm of ovary	54	7.395274e-2	1.000000e+0	1.000000e+0	1.352215e+1	7.395274e-2	1	7.395274e-2	1.000000e+0	60	7.737589e-2	1.000000e+0	1.000000e+0	1.266924e+1	7.893132e-2	1	712	5.000000e-1	1.404494e-3	unnamed	NBN
Disease Ontology	DOID:417	autoimmune disease	55	7.426329e-2	1.000000e+0	1.000000e+0	1.346560e+1	7.426329e-2	1	7.426329e-2	1.000000e+0	71	8.820552e-2	1.000000e+0	1.000000e+0	1.108170e+1	9.023890e-2	1	814	5.000000e-1	1.228501e-3	unnamed	NBN
Disease Ontology	DOID:1244	malignant neoplasm of female genital organ	56	7.450734e-2	1.000000e+0	1.000000e+0	1.342150e+1	7.450734e-2	1	7.450734e-2	1.000000e+0	61	7.812114e-2	1.000000e+0	1.000000e+0	1.254590e+1	7.970733e-2	1	719	5.000000e-1	1.390821e-3	unnamed	NBN
Disease Ontology	DOID:1281	female reproductive cancer	57	7.531950e-2	1.000000e+0	1.000000e+0	1.327677e+1	7.531950e-2	1	7.531950e-2	1.000000e+0	64	7.886609e-2	1.000000e+0	1.000000e+0	1.242493e+1	8.048334e-2	1	726	5.000000e-1	1.377410e-3	unnamed	NBN
Disease Ontology	DOID:3347	osteosarcoma	58	7.547113e-2	1.000000e+0	1.000000e+0	1.325010e+1	7.547113e-2	1	7.547113e-2	1.000000e+0	47	6.498213e-2	1.000000e+0	1.000000e+0	1.513507e+1	6.607173e-2	1	596	5.000000e-1	1.677852e-3	unnamed	NBN
Disease Ontology	DOID:2394	ovarian neoplasm	59	7.564403e-2	1.000000e+0	1.000000e+0	1.321981e+1	7.564403e-2	1	7.564403e-2	1.000000e+0	63	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	NBN
Disease Ontology	DOID:183	bone tissue neoplasm	60	7.606199e-2	1.000000e+0	1.000000e+0	1.314717e+1	7.606199e-2	1	7.606199e-2	1.000000e+0	48	6.551805e-2	1.000000e+0	1.000000e+0	1.500915e+1	6.662602e-2	1	601	5.000000e-1	1.663894e-3	unnamed	NBN
Disease Ontology	DOID:0050155	sensory system disease	61	7.608032e-2	1.000000e+0	1.000000e+0	1.314400e+1	7.608032e-2	1	7.608032e-2	1.000000e+0	56	7.673686e-2	1.000000e+0	1.000000e+0	1.277691e+1	7.826617e-2	1	706	5.000000e-1	1.416431e-3	unnamed	NBN
Disease Ontology	DOID:1909	melanoma	62	8.029886e-2	1.000000e+0	1.000000e+0	1.245348e+1	8.029886e-2	1	8.029886e-2	1.000000e+0	53	7.599104e-2	1.000000e+0	1.000000e+0	1.290486e+1	7.749016e-2	1	699	5.000000e-1	1.430615e-3	unnamed	NBN
Disease Ontology	DOID:191	melanocytic neoplasm	63	8.062511e-2	1.000000e+0	1.000000e+0	1.240308e+1	8.062511e-2	1	8.062511e-2	1.000000e+0	54	7.631072e-2	1.000000e+0	1.000000e+0	1.284972e+1	7.782274e-2	1	702	5.000000e-1	1.424501e-3	unnamed	NBN
Disease Ontology	DOID:9256	colorectal cancer	64	8.071500e-2	1.000000e+0	1.000000e+0	1.238927e+1	8.071500e-2	1	8.071500e-2	1.000000e+0	62	7.833401e-2	1.000000e+0	1.000000e+0	1.251110e+1	7.992905e-2	1	721	5.000000e-1	1.386963e-3	unnamed	NBN
Disease Ontology	DOID:3168	squamous cell neoplasm	65	8.073938e-2	1.000000e+0	1.000000e+0	1.238553e+1	8.073938e-2	1	8.073938e-2	1.000000e+0	67	8.492093e-2	1.000000e+0	1.000000e+0	1.152043e+1	8.680228e-2	1	783	5.000000e-1	1.277139e-3	unnamed	NBN
Disease Ontology	DOID:934	viral infectious disease	66	8.111120e-2	1.000000e+0	1.000000e+0	1.232875e+1	8.111120e-2	1	8.111120e-2	1.000000e+0	75	9.991807e-2	1.000000e+0	1.000000e+0	9.751892e+0	1.025442e-1	1	925	5.000000e-1	1.081081e-3	unnamed	NBN
Disease Ontology	DOID:120	female genital cancer	67	8.268050e-2	1.000000e+0	1.000000e+0	1.209475e+1	8.268050e-2	1	8.268050e-2	1.000000e+0	68	8.545110e-2	1.000000e+0	1.000000e+0	1.144734e+1	8.735658e-2	1	788	5.000000e-1	1.269036e-3	unnamed	NBN
Disease Ontology	DOID:201	connective tissue neoplasm	68	8.800066e-2	1.000000e+0	1.000000e+0	1.136355e+1	8.800066e-2	1	8.800066e-2	1.000000e+0	59	7.716290e-2	1.000000e+0	1.000000e+0	1.270493e+1	7.870961e-2	1	710	5.000000e-1	1.408451e-3	unnamed	NBN
Disease Ontology	DOID:1994	large Intestine carcinoma	69	8.851868e-2	1.000000e+0	1.000000e+0	1.129705e+1	8.851868e-2	1	8.851868e-2	1.000000e+0	69	8.587513e-2	1.000000e+0	1.000000e+0	1.138952e+1	8.780001e-2	1	792	5.000000e-1	1.262626e-3	unnamed	NBN
Disease Ontology	DOID:284	malignant neoplasm of abdomen	70	9.133327e-2	1.000000e+0	1.000000e+0	1.094891e+1	9.133327e-2	1	9.133327e-2	1.000000e+0	73	9.063867e-2	1.000000e+0	1.000000e+0	1.077718e+1	9.278865e-2	1	837	5.000000e-1	1.194743e-3	unnamed	NBN
Disease Ontology	DOID:1318	malignant neoplasm of central nervous system	71	9.457325e-2	1.000000e+0	1.000000e+0	1.057381e+1	9.457325e-2	1	9.457325e-2	1.000000e+0	65	8.396623e-2	1.000000e+0	1.000000e+0	1.165439e+1	8.580456e-2	1	774	5.000000e-1	1.291990e-3	unnamed	NBN
Disease Ontology	DOID:4695	malignant neoplasm of nervous system	72	9.564362e-2	1.000000e+0	1.000000e+0	1.045548e+1	9.564362e-2	1	9.564362e-2	1.000000e+0	66	8.439060e-2	1.000000e+0	1.000000e+0	1.159447e+1	8.624799e-2	1	778	5.000000e-1	1.285347e-3	unnamed	NBN
Disease Ontology	DOID:1033	lymphoid cancer	73	9.576498e-2	1.000000e+0	1.000000e+0	1.044223e+1	9.576498e-2	1	9.576498e-2	1.000000e+0	74	9.602230e-2	1.000000e+0	1.000000e+0	1.015822e+1	9.844244e-2	1	888	5.000000e-1	1.126126e-3	unnamed	NBN
Disease Ontology	DOID:169	neuroendocrine tumor	74	9.840882e-2	1.000000e+0	1.000000e+0	1.016169e+1	9.840882e-2	1	9.840882e-2	1.000000e+0	72	8.926381e-2	1.000000e+0	1.000000e+0	1.094721e+1	9.134749e-2	1	824	5.000000e-1	1.213592e-3	unnamed	NBN
Disease Ontology	DOID:3070	malignant glioma	75	9.870456e-2	1.000000e+0	1.000000e+0	1.013124e+1	9.870456e-2	1	9.870456e-2	1.000000e+0	70	8.714662e-2	1.000000e+0	1.000000e+0	1.121953e+1	8.913031e-2	1	804	5.000000e-1	1.243781e-3	unnamed	NBN
Disease Ontology	DOID:619	lymphoproliferative disease	76	9.974272e-2	1.000000e+0	1.000000e+0	1.002579e+1	9.974272e-2	1	9.974272e-2	1.000000e+0	76	1.010747e-1	1.000000e+0	1.000000e+0	9.637286e+0	1.037636e-1	1	936	5.000000e-1	1.068376e-3	unnamed	NBN
Disease Ontology	DOID:2916	immunoproliferative disease	77	9.975771e-2	1.000000e+0	1.000000e+0	1.002429e+1	9.975771e-2	1	9.975771e-2	1.000000e+0	77	1.011798e-1	1.000000e+0	1.000000e+0	9.627001e+0	1.038745e-1	1	937	5.000000e-1	1.067236e-3	unnamed	NBN
Disease Ontology	DOID:75	lymphatic system disease	78	1.035697e-1	1.000000e+0	1.000000e+0	9.655335e+0	1.035697e-1	1	1.035697e-1	1.000000e+0	78	1.052741e-1	1.000000e+0	1.000000e+0	9.242316e+0	1.081980e-1	1	976	5.000000e-1	1.024590e-3	unnamed	NBN
Disease Ontology	DOID:1265	genitourinary cancer	79	1.098597e-1	1.000000e+0	1.000000e+0	9.102521e+0	1.098597e-1	1	1.098597e-1	1.000000e+0	83	1.099868e-1	1.000000e+0	1.000000e+0	8.834966e+0	1.131866e-1	1	1021	5.000000e-1	9.794319e-4	unnamed	NBN
Disease Ontology	DOID:1240	leukemia	80	1.114394e-1	1.000000e+0	1.000000e+0	8.973483e+0	1.114394e-1	1	1.114394e-1	1.000000e+0	85	1.125996e-1	1.000000e+0	1.000000e+0	8.623805e+0	1.159581e-1	1	1046	5.000000e-1	9.560229e-4	unnamed	NBN
Disease Ontology	DOID:122	abdominal cancer	81	1.132547e-1	1.000000e+0	1.000000e+0	8.829653e+0	1.132547e-1	1	1.132547e-1	1.000000e+0	86	1.128084e-1	1.000000e+0	1.000000e+0	8.607347e+0	1.161798e-1	1	1048	5.000000e-1	9.541985e-4	unnamed	NBN
Disease Ontology	DOID:170	endocrine gland cancer	82	1.163017e-1	1.000000e+0	1.000000e+0	8.598327e+0	1.163017e-1	1	1.163017e-1	1.000000e+0	79	1.061128e-1	1.000000e+0	1.000000e+0	9.167175e+0	1.090849e-1	1	984	5.000000e-1	1.016260e-3	unnamed	NBN
Disease Ontology	DOID:3165	skin neoplasm	83	1.200813e-1	1.000000e+0	1.000000e+0	8.327690e+0	1.200813e-1	1	1.200813e-1	1.000000e+0	81	1.090453e-1	1.000000e+0	1.000000e+0	8.913538e+0	1.121889e-1	1	1012	5.000000e-1	9.881423e-4	unnamed	NBN
Disease Ontology	DOID:178	vascular disease	84	1.205522e-1	1.000000e+0	1.000000e+0	8.295164e+0	1.205522e-1	1	1.205522e-1	1.000000e+0	91	1.288165e-1	1.000000e+0	1.000000e+0	7.504576e+0	1.332520e-1	1	1202	5.000000e-1	8.319468e-4	unnamed	NBN
Disease Ontology	DOID:0050117	disease by infectious agent	85	1.209421e-1	1.000000e+0	1.000000e+0	8.268418e+0	1.209421e-1	1	1.209421e-1	1.000000e+0	96	1.508194e-1	1.000000e+0	1.000000e+0	6.370410e+0	1.569758e-1	1	1416	5.000000e-1	7.062147e-4	unnamed	NBN
Disease Ontology	DOID:65	connective tissue disease	86	1.230503e-1	1.000000e+0	1.000000e+0	8.126760e+0	1.230503e-1	1	1.230503e-1	1.000000e+0	89	1.217659e-1	1.000000e+0	1.000000e+0	7.954586e+0	1.257137e-1	1	1134	5.000000e-1	8.818342e-4	unnamed	NBN
Disease Ontology	DOID:2627	glioma	87	1.253026e-1	1.000000e+0	1.000000e+0	7.980682e+0	1.253026e-1	1	1.253026e-1	1.000000e+0	80	1.084173e-1	1.000000e+0	1.000000e+0	8.966700e+0	1.115238e-1	1	1006	5.000000e-1	9.940358e-4	unnamed	NBN
Disease Ontology	DOID:1319	brain neoplasm	88	1.265868e-1	1.000000e+0	1.000000e+0	7.899721e+0	1.265868e-1	1	1.265868e-1	1.000000e+0	82	1.094638e-1	1.000000e+0	1.000000e+0	8.878445e+0	1.126323e-1	1	1016	5.000000e-1	9.842520e-4	unnamed	NBN
Disease Ontology	DOID:3620	central nervous system neoplasm	89	1.271973e-1	1.000000e+0	1.000000e+0	7.861801e+0	1.271973e-1	1	1.271973e-1	1.000000e+0	84	1.101959e-1	1.000000e+0	1.000000e+0	8.817693e+0	1.134083e-1	1	1023	5.000000e-1	9.775171e-4	unnamed	NBN
Disease Ontology	DOID:2227	malignant neoplasm of lymphatic and hemopoietic tissue	90	1.308045e-1	1.000000e+0	1.000000e+0	7.644994e+0	1.308045e-1	1	1.308045e-1	1.000000e+0	92	1.334666e-1	1.000000e+0	1.000000e+0	7.233761e+0	1.382407e-1	1	1247	5.000000e-1	8.019246e-4	unnamed	NBN
Disease Ontology	DOID:171	neuroectodermal tumor	91	1.311969e-1	1.000000e+0	1.000000e+0	7.622132e+0	1.311969e-1	1	1.311969e-1	1.000000e+0	87	1.187505e-1	1.000000e+0	1.000000e+0	8.163348e+0	1.224988e-1	1	1105	5.000000e-1	9.049774e-4	unnamed	NBN
Disease Ontology	DOID:3095	germ cell and embryonal cancer	92	1.321992e-1	1.000000e+0	1.000000e+0	7.564342e+0	1.321992e-1	1	1.321992e-1	1.000000e+0	88	1.204148e-1	1.000000e+0	1.000000e+0	8.046833e+0	1.242725e-1	1	1121	5.000000e-1	8.920607e-4	unnamed	NBN
Disease Ontology	DOID:2994	germ cell cancer	93	1.346344e-1	1.000000e+0	1.000000e+0	7.427520e+0	1.346344e-1	1	1.346344e-1	1.000000e+0	90	1.229084e-1	1.000000e+0	1.000000e+0	7.878166e+0	1.269331e-1	1	1145	5.000000e-1	8.733624e-4	unnamed	NBN
Disease Ontology	DOID:177	soft tissue neoplasm	94	1.450676e-1	1.000000e+0	1.000000e+0	6.893336e+0	1.450676e-1	1	1.450676e-1	1.000000e+0	93	1.364568e-1	1.000000e+0	1.000000e+0	7.069357e+0	1.414556e-1	1	1276	5.000000e-1	7.836991e-4	unnamed	NBN
Disease Ontology	DOID:3350	mesenchymal cell neoplasm	95	1.453323e-1	1.000000e+0	1.000000e+0	6.880783e+0	1.453323e-1	1	1.453323e-1	1.000000e+0	94	1.369718e-1	1.000000e+0	1.000000e+0	7.041764e+0	1.420099e-1	1	1281	5.000000e-1	7.806401e-4	unnamed	NBN
Disease Ontology	DOID:2531	hematologic cancer	96	1.484252e-1	1.000000e+0	1.000000e+0	6.737401e+0	1.484252e-1	1	1.484252e-1	1.000000e+0	97	1.514323e-1	1.000000e+0	1.000000e+0	6.343530e+0	1.576409e-1	1	1422	5.000000e-1	7.032349e-4	unnamed	NBN
Disease Ontology	DOID:1115	sarcoma	97	1.495909e-1	1.000000e+0	1.000000e+0	6.684897e+0	1.495909e-1	1	1.495909e-1	1.000000e+0	95	1.416001e-1	1.000000e+0	1.000000e+0	6.802790e+0	1.469985e-1	1	1326	5.000000e-1	7.541478e-4	unnamed	NBN
Disease Ontology	DOID:74	hematopoietic system disease	98	1.634383e-1	1.000000e+0	1.000000e+0	6.118517e+0	1.634383e-1	1	1.634383e-1	1.000000e+0	106	1.726418e-1	1.000000e+0	1.000000e+0	5.530656e+0	1.808104e-1	1	1631	5.000000e-1	6.131208e-4	unnamed	NBN
Disease Ontology	DOID:3094	neuroepithelial neoplasm	99	1.687017e-1	1.000000e+0	1.000000e+0	5.927623e+0	1.687017e-1	1	1.687017e-1	1.000000e+0	98	1.534735e-1	1.000000e+0	1.000000e+0	6.255548e+0	1.598581e-1	1	1442	5.000000e-1	6.934813e-4	unnamed	NBN
Disease Ontology	DOID:4241	malignant neoplasm of breast	100	1.689834e-1	1.000000e+0	1.000000e+0	5.917740e+0	1.689834e-1	1	1.689834e-1	1.000000e+0	101	1.624258e-1	1.000000e+0	1.000000e+0	5.895752e+0	1.696137e-1	1	1530	5.000000e-1	6.535948e-4	unnamed	NBN
Disease Ontology	DOID:3937	malignant neoplasm of thorax	101	1.691008e-1	1.000000e+0	1.000000e+0	5.913634e+0	1.691008e-1	1	1.691008e-1	1.000000e+0	102	1.626287e-1	1.000000e+0	1.000000e+0	5.888055e+0	1.698354e-1	1	1532	5.000000e-1	6.527415e-4	unnamed	NBN
Disease Ontology	DOID:3195	neural neoplasm	102	1.692055e-1	1.000000e+0	1.000000e+0	5.909975e+0	1.692055e-1	1	1.692055e-1	1.000000e+0	99	1.541874e-1	1.000000e+0	1.000000e+0	6.225328e+0	1.606341e-1	1	1449	5.000000e-1	6.901311e-4	unnamed	NBN
Disease Ontology	DOID:5093	thoracic cancer	103	1.702657e-1	1.000000e+0	1.000000e+0	5.873173e+0	1.702657e-1	1	1.702657e-1	1.000000e+0	103	1.639470e-1	1.000000e+0	1.000000e+0	5.838511e+0	1.712765e-1	1	1545	5.000000e-1	6.472492e-4	unnamed	NBN
Disease Ontology	DOID:299	adenocarcinoma	104	1.706462e-1	1.000000e+0	1.000000e+0	5.860077e+0	1.706462e-1	1	1.706462e-1	1.000000e+0	105	1.699169e-1	1.000000e+0	1.000000e+0	5.623753e+0	1.778172e-1	1	1604	5.000000e-1	6.234414e-4	unnamed	NBN
Disease Ontology	DOID:3093	nervous system cancer	105	1.722624e-1	1.000000e+0	1.000000e+0	5.805099e+0	1.722624e-1	1	1.722624e-1	1.000000e+0	100	1.573451e-1	1.000000e+0	1.000000e+0	6.094932e+0	1.640707e-1	1	1480	5.000000e-1	6.756757e-4	unnamed	NBN
Disease Ontology	DOID:1612	mammary cancer	106	1.772500e-1	1.000000e+0	1.000000e+0	5.641748e+0	1.772500e-1	1	1.772500e-1	1.000000e+0	104	1.677945e-1	1.000000e+0	1.000000e+0	5.698358e+0	1.754892e-1	1	1583	5.000000e-1	6.317119e-4	unnamed	NBN
Disease Ontology	DOID:197	glandular cell epithelial neoplasm	107	1.860840e-1	1.000000e+0	1.000000e+0	5.373918e+0	1.860840e-1	1	1.860840e-1	1.000000e+0	108	1.850986e-1	1.000000e+0	1.000000e+0	5.139886e+0	1.945568e-1	1	1755	5.000000e-1	5.698006e-4	unnamed	NBN
Disease Ontology	DOID:936	brain disease	108	1.872681e-1	1.000000e+0	1.000000e+0	5.339937e+0	1.872681e-1	1	1.872681e-1	1.000000e+0	107	1.748588e-1	1.000000e+0	1.000000e+0	5.457048e+0	1.832493e-1	1	1653	5.000000e-1	6.049607e-4	unnamed	NBN
Disease Ontology	DOID:225	syndrome	109	2.011593e-1	1.000000e+0	1.000000e+0	4.971185e+0	2.011593e-1	1	2.011593e-1	1.000000e+0	109	1.993468e-1	1.000000e+0	1.000000e+0	4.752634e+0	2.104096e-1	1	1898	5.000000e-1	5.268704e-4	unnamed	NBN
Disease Ontology	DOID:193	reproductive system cancer	110	2.095200e-1	1.000000e+0	1.000000e+0	4.772814e+0	2.095200e-1	1	2.095200e-1	1.000000e+0	110	2.033098e-1	1.000000e+0	1.000000e+0	4.654541e+0	2.148440e-1	1	1938	5.000000e-1	5.159959e-4	unnamed	NBN
Disease Ontology	DOID:17	musculoskeletal system disease	111	2.136568e-1	1.000000e+0	1.000000e+0	4.680403e+0	2.136568e-1	1	2.136568e-1	1.000000e+0	112	2.140591e-1	1.000000e+0	1.000000e+0	4.406693e+0	2.269276e-1	1	2047	5.000000e-1	4.885198e-4	unnamed	NBN
Disease Ontology	DOID:157	epithelial carcinoma	112	2.158701e-1	1.000000e+0	1.000000e+0	4.632416e+0	2.158701e-1	1	2.158701e-1	1.000000e+0	113	2.169067e-1	1.000000e+0	1.000000e+0	4.345135e+0	2.301425e-1	1	2076	5.000000e-1	4.816956e-4	unnamed	NBN
Disease Ontology	DOID:155	glandular and epithelial neoplasm	113	2.196335e-1	1.000000e+0	1.000000e+0	4.553039e+0	2.196335e-1	1	2.196335e-1	1.000000e+0	111	2.107139e-1	1.000000e+0	1.000000e+0	4.481123e+0	2.231584e-1	1	2013	5.000000e-1	4.967710e-4	unnamed	NBN
Disease Ontology	DOID:331	central nervous system disease	114	2.247960e-1	1.000000e+0	1.000000e+0	4.448477e+0	2.247960e-1	1	2.247960e-1	1.000000e+0	114	2.201408e-1	1.000000e+0	1.000000e+0	4.277146e+0	2.338008e-1	1	2109	5.000000e-1	4.741584e-4	unnamed	NBN
Disease Ontology	DOID:1287	cardiovascular system disease	115	2.464292e-1	1.000000e+0	1.000000e+0	4.057961e+0	2.464292e-1	1	2.464292e-1	1.000000e+0	115	2.586189e-1	1.000000e+0	1.000000e+0	3.598125e+0	2.779225e-1	1	2507	5.000000e-1	3.988831e-4	unnamed	NBN
Disease Ontology	DOID:863	nervous system disease	116	2.662634e-1	1.000000e+0	1.000000e+0	3.755680e+0	2.662634e-1	1	2.662634e-1	1.000000e+0	116	2.652858e-1	1.000000e+0	1.000000e+0	3.500388e+0	2.856826e-1	1	2577	5.000000e-1	3.880481e-4	unnamed	NBN
Disease Ontology	DOID:2985	chronic rejection of renal transplant	117	2.674662e-1	1.000000e+0	1.000000e+0	3.738791e+0	2.674662e-1	1	2.674662e-1	1.000000e+0	117	2.866046e-1	1.000000e+0	1.000000e+0	3.218159e+0	3.107367e-1	1	2803	5.000000e-1	3.567606e-4	unnamed	NBN
Disease Ontology	DOID:2108	transplant-related disease	118	2.674780e-1	1.000000e+0	1.000000e+0	3.738626e+0	2.674780e-1	1	2.674780e-1	1.000000e+0	118	2.866982e-1	1.000000e+0	1.000000e+0	3.217011e+0	3.108475e-1	1	2804	5.000000e-1	3.566334e-4	unnamed	NBN
Disease Ontology	DOID:557	kidney disease	119	2.854845e-1	1.000000e+0	1.000000e+0	3.502817e+0	2.854845e-1	1	2.854845e-1	1.000000e+0	119	3.062252e-1	1.000000e+0	1.000000e+0	2.992867e+0	3.341278e-1	1	3014	5.000000e-1	3.317850e-4	unnamed	NBN
Disease Ontology	DOID:18	urinary system disease	120	2.923209e-1	1.000000e+0	1.000000e+0	3.420898e+0	2.923209e-1	1	2.923209e-1	1.000000e+0	120	3.122143e-1	1.000000e+0	1.000000e+0	2.929685e+0	3.413336e-1	1	3079	5.000000e-1	3.247808e-4	unnamed	NBN
Disease Ontology	DOID:2914	immune system disease	121	3.205063e-1	1.000000e+0	1.000000e+0	3.120063e+0	3.205063e-1	1	3.205063e-1	1.000000e+0	122	3.434783e-1	1.000000e+0	1.000000e+0	2.635261e+0	3.794690e-1	1	3423	5.000000e-1	2.921414e-4	unnamed	NBN
Disease Ontology	DOID:305	carcinoma	122	3.218892e-1	1.000000e+0	1.000000e+0	3.106659e+0	3.218892e-1	1	3.218892e-1	1.000000e+0	121	3.253901e-1	1.000000e+0	1.000000e+0	2.798790e+0	3.572973e-1	1	3223	5.000000e-1	3.102699e-4	unnamed	NBN
Disease Ontology	DOID:462	cancer by anatomical entity	123	3.485076e-1	1.000000e+0	1.000000e+0	2.869378e+0	3.485076e-1	1	3.485076e-1	1.000000e+0	123	3.467081e-1	1.000000e+0	1.000000e+0	2.607835e+0	3.834599e-1	1	3459	5.000000e-1	2.891009e-4	unnamed	NBN
Disease Ontology	DOID:162	cancer	124	4.681931e-1	1.000000e+0	1.000000e+0	2.135871e+0	4.681931e-1	1	4.681931e-1	1.000000e+0	124	4.854768e-1	1.000000e+0	1.000000e+0	1.768725e+0	5.653789e-1	1	5100	5.000000e-1	1.960784e-4	unnamed	NBN
Disease Ontology	DOID:7	disease of anatomical entity	125	5.144599e-1	1.000000e+0	1.000000e+0	1.943786e+0	5.144599e-1	1	5.144599e-1	1.000000e+0	125	5.469036e-1	1.000000e+0	1.000000e+0	1.529676e+0	6.537332e-1	1	5897	5.000000e-1	1.695778e-4	unnamed	NBN
Disease Ontology	DOID:4	disease	126	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	126	6.831746e-1	1.000000e+0	1.000000e+0	1.143863e+0	8.742309e-1	1	7886	5.000000e-1	1.268070e-4	unnamed	NBN
MSigDB Cancer Neighborhood	MORF_RAB5A	Neighborhood of RAB5A	1	5.482558e-3	1.000000e+0	1.000000e+0	1.823966e+2	5.482558e-3	1	5.482558e-3	1.000000e+0	1	1.072467e-2	1.000000e+0	1.000000e+0	9.299485e+1	1.075328e-2	1	97	5.000000e-1	1.030928e-2	unnamed	NBN
MSigDB Cancer Neighborhood	MORF_PPP6C	Neighborhood of PPP6C	2	6.126247e-3	1.000000e+0	1.000000e+0	1.632321e+2	6.126247e-3	1	6.126247e-3	1.000000e+0	2	1.160660e-2	1.000000e+0	1.000000e+0	8.590952e+1	1.164015e-2	1	105	5.000000e-1	9.523810e-3	unnamed	NBN
MSigDB Cancer Neighborhood	MORF_DCC	Neighborhood of DCC	3	1.399762e-2	1.000000e+0	1.000000e+0	7.144072e+1	1.399762e-2	1	1.399762e-2	1.000000e+0	3	1.171681e-2	1.000000e+0	1.000000e+0	8.509906e+1	1.175101e-2	1	106	5.000000e-1	9.433962e-3	unnamed	OSGIN2
MSigDB Pathway	REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS	Genes involved in Homologous recombination repair of replication-independent double-strand breaks	1	9.719817e-4	1.000000e+0	1.000000e+0	1.028826e+3	9.719817e-4	1	9.719817e-4	1.000000e+0	1	1.773000e-3	1.000000e+0	1.000000e+0	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	NBN
MSigDB Pathway	BIOCARTA_ATRBRCA_PATHWAY	Role of BRCA1, BRCA2 and ATR in Cancer Susceptibility	2	1.106881e-3	1.000000e+0	7.305415e-1	9.034398e+2	1.106881e-3	1	1.106881e-3	1.000000e+0	3	2.326740e-3	1.000000e+0	1.000000e+0	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	NBN
MSigDB Pathway	REACTOME_DOUBLE_STRAND_BREAK_REPAIR	Genes involved in Double-Strand Break Repair	3	1.469031e-3	1.000000e+0	6.463736e-1	6.807208e+2	1.469031e-3	1	1.469031e-3	1.000000e+0	4	2.437470e-3	1.000000e+0	8.043651e-1	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	NBN
MSigDB Pathway	BIOCARTA_ATM_PATHWAY	ATM Signaling Pathway	4	1.514588e-3	1.000000e+0	4.998140e-1	6.602456e+2	1.514588e-3	1	1.514588e-3	1.000000e+0	2	2.216004e-3	1.000000e+0	1.000000e+0	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	NBN
MSigDB Pathway	PID_ATM_PATHWAY	ATM pathway	5	1.861710e-3	1.000000e+0	4.914914e-1	5.371406e+2	1.861710e-3	1	1.861710e-3	1.000000e+0	7	3.765745e-3	1.000000e+0	7.101119e-1	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	NBN
MSigDB Pathway	KEGG_HOMOLOGOUS_RECOMBINATION	Homologous recombination	6	2.256250e-3	1.000000e+0	4.963750e-1	4.432133e+2	2.256250e-3	1	2.256250e-3	1.000000e+0	5	3.101718e-3	1.000000e+0	8.188536e-1	3.221607e+2	3.104041e-3	1	28	5.000000e-1	3.571429e-2	unnamed	NBN
MSigDB Pathway	PID_BARD1PATHWAY	BARD1 signaling events	7	2.314823e-3	1.000000e+0	4.365095e-1	4.319984e+2	2.314823e-3	1	2.314823e-3	1.000000e+0	6	3.212404e-3	1.000000e+0	7.067289e-1	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	NBN
MSigDB Pathway	PID_ATR_PATHWAY	ATR signaling pathway	8	2.432956e-3	1.000000e+0	4.014377e-1	4.110227e+2	2.432956e-3	1	2.432956e-3	1.000000e+0	8	4.208307e-3	1.000000e+0	6.943707e-1	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	NBN
MSigDB Pathway	REACTOME_MEIOTIC_RECOMBINATION	Genes involved in Meiotic Recombination	9	2.743368e-3	1.000000e+0	4.023606e-1	3.645154e+2	2.743368e-3	1	2.743368e-3	1.000000e+0	12	9.069997e-3	1.000000e+0	9.976997e-1	1.100061e+2	9.090405e-3	1	82	5.000000e-1	1.219512e-2	unnamed	NBN
MSigDB Pathway	PID_FANCONI_PATHWAY	Fanconi anemia pathway	10	3.712515e-3	1.000000e+0	4.900520e-1	2.693591e+2	3.712515e-3	1	3.712515e-3	1.000000e+0	9	5.093135e-3	1.000000e+0	7.469931e-1	1.960978e+2	5.099496e-3	1	46	5.000000e-1	2.173913e-2	unnamed	NBN
MSigDB Pathway	REACTOME_MEIOSIS	Genes involved in Meiosis	11	5.150433e-3	1.000000e+0	6.180520e-1	1.941584e+2	5.150433e-3	1	5.150433e-3	1.000000e+0	14	1.215761e-2	1.000000e+0	1.000000e+0	8.200455e+1	1.219445e-2	1	110	5.000000e-1	9.090909e-3	unnamed	NBN
MSigDB Pathway	PID_MYC_ACTIVPATHWAY	Validated targets of C-MYC transcriptional activation	12	6.777500e-3	1.000000e+0	7.455250e-1	1.475470e+2	6.777500e-3	1	6.777500e-3	1.000000e+0	11	8.959636e-3	1.000000e+0	1.000000e+0	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	NBN
MSigDB Pathway	PID_TELOMERASEPATHWAY	Regulation of Telomerase	13	7.079564e-3	1.000000e+0	7.188480e-1	1.412516e+2	7.079564e-3	1	7.079564e-3	1.000000e+0	10	7.524386e-3	1.000000e+0	9.932190e-1	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	NBN
MSigDB Pathway	REACTOME_DNA_REPAIR	Genes involved in DNA Repair	14	7.215046e-3	1.000000e+0	6.802758e-1	1.385993e+2	7.215046e-3	1	7.215046e-3	1.000000e+0	13	1.149638e-2	1.000000e+0	1.000000e+0	8.673558e+1	1.152929e-2	1	104	5.000000e-1	9.615385e-3	unnamed	NBN
MGI Expression: Detected	7087	TS28_pituitary gland	1	7.692181e-2	1.000000e+0	1.000000e+0	1.300021e+1	7.692181e-2	1	7.692181e-2	1.000000e+0	1	6.840935e-2	1.000000e+0	1.000000e+0	1.436385e+1	6.961920e-2	1	628	5.000000e-1	1.592357e-3	unnamed	NBN
MGI Expression: Detected	9185	TS23_ovary	2	1.112863e-1	1.000000e+0	1.000000e+0	8.985836e+0	1.112863e-1	1	1.112863e-1	1.000000e+0	8	1.184382e-1	1.000000e+0	1.000000e+0	8.185572e+0	1.221662e-1	1	1102	5.000000e-1	9.074410e-4	unnamed	NBN
MGI Expression: Detected	7085	TS28_endocrine system	3	1.150618e-1	1.000000e+0	1.000000e+0	8.690984e+0	1.150618e-1	1	1.150618e-1	1.000000e+0	5	1.128084e-1	1.000000e+0	1.000000e+0	8.607347e+0	1.161798e-1	1	1048	5.000000e-1	9.541985e-4	unnamed	NBN
MGI Expression: Detected	10313	TS23_ureter	4	1.164252e-1	1.000000e+0	1.000000e+0	8.589207e+0	1.164252e-1	1	1.164252e-1	1.000000e+0	3	1.106142e-1	1.000000e+0	1.000000e+0	8.783350e+0	1.138518e-1	1	1027	5.000000e-1	9.737098e-4	unnamed	NBN
MGI Expression: Detected	17326	TS23_female reproductive structure	5	1.201198e-1	1.000000e+0	1.000000e+0	8.325019e+0	1.201198e-1	1	1.201198e-1	1.000000e+0	7	1.167720e-1	1.000000e+0	1.000000e+0	8.306169e+0	1.203924e-1	1	1086	5.000000e-1	9.208103e-4	unnamed	NBN
MGI Expression: Detected	17232	TS23_urethra of female	6	1.302071e-1	1.000000e+0	1.000000e+0	7.680074e+0	1.302071e-1	1	1.302071e-1	1.000000e+0	9	1.190626e-1	1.000000e+0	1.000000e+0	8.141245e+0	1.228313e-1	1	1108	5.000000e-1	9.025271e-4	unnamed	NBN
MGI Expression: Detected	12449	TS23_medulla oblongata basal plate mantle layer	7	1.366945e-1	1.000000e+0	1.000000e+0	7.315582e+0	1.366945e-1	1	1.366945e-1	1.000000e+0	2	7.886609e-2	1.000000e+0	1.000000e+0	1.242493e+1	8.048334e-2	1	726	5.000000e-1	1.377410e-3	unnamed	OSGIN2
MGI Expression: Detected	8255	TS23_female reproductive system	8	1.442732e-1	1.000000e+0	1.000000e+0	6.931293e+0	1.442732e-1	1	1.442732e-1	1.000000e+0	12	1.412920e-1	1.000000e+0	1.000000e+0	6.818216e+0	1.466659e-1	1	1323	5.000000e-1	7.558579e-4	unnamed	NBN
MGI Expression: Detected	9169	TS23_drainage component	9	1.457842e-1	1.000000e+0	1.000000e+0	6.859453e+0	1.457842e-1	1	1.457842e-1	1.000000e+0	11	1.384131e-1	1.000000e+0	1.000000e+0	6.965637e+0	1.435619e-1	1	1295	5.000000e-1	7.722008e-4	unnamed	NBN
MGI Expression: Detected	11964	TS23_medulla oblongata basal plate	10	1.697980e-1	1.000000e+0	1.000000e+0	5.889351e+0	1.697980e-1	1	1.697980e-1	1.000000e+0	4	1.117639e-1	1.000000e+0	1.000000e+0	8.690270e+0	1.150712e-1	1	1038	5.000000e-1	9.633911e-4	unnamed	OSGIN2
MGI Expression: Detected	17231	TS23_urethra	11	1.733427e-1	1.000000e+0	1.000000e+0	5.768919e+0	1.733427e-1	1	1.733427e-1	1.000000e+0	16	1.661756e-1	1.000000e+0	1.000000e+0	5.756541e+0	1.737154e-1	1	1567	5.000000e-1	6.381621e-4	unnamed	NBN
MGI Expression: Detected	11316	TS23_medulla oblongata lateral wall	12	1.758973e-1	1.000000e+0	1.000000e+0	5.685135e+0	1.758973e-1	1	1.758973e-1	1.000000e+0	6	1.163552e-1	1.000000e+0	1.000000e+0	8.336876e+0	1.199490e-1	1	1082	5.000000e-1	9.242144e-4	unnamed	OSGIN2
MGI Expression: Detected	8416	TS23_urinary bladder	13	1.763697e-1	1.000000e+0	1.000000e+0	5.669908e+0	1.763697e-1	1	1.763697e-1	1.000000e+0	17	1.676934e-1	1.000000e+0	1.000000e+0	5.701960e+0	1.753783e-1	1	1582	5.000000e-1	6.321113e-4	unnamed	NBN
MGI Expression: Detected	9925	TS23_dorsal root ganglion	14	1.818204e-1	1.000000e+0	1.000000e+0	5.499934e+0	1.818204e-1	1	1.818204e-1	1.000000e+0	13	1.622228e-1	1.000000e+0	1.000000e+0	5.903469e+0	1.693919e-1	1	1528	5.000000e-1	6.544503e-4	unnamed	OSGIN2
MGI Expression: Detected	8795	TS23_spinal ganglion	15	1.822471e-1	1.000000e+0	1.000000e+0	5.487056e+0	1.822471e-1	1	1.822471e-1	1.000000e+0	14	1.631358e-1	1.000000e+0	1.000000e+0	5.868900e+0	1.703897e-1	1	1537	5.000000e-1	6.506181e-4	unnamed	OSGIN2
MGI Expression: Detected	7849	TS23_peripheral nervous system spinal component	16	1.829940e-1	1.000000e+0	1.000000e+0	5.464660e+0	1.829940e-1	1	1.829940e-1	1.000000e+0	15	1.637442e-1	1.000000e+0	1.000000e+0	5.846079e+0	1.710548e-1	1	1543	5.000000e-1	6.480881e-4	unnamed	OSGIN2
MGI Expression: Detected	9934	TS23_trigeminal V ganglion	17	1.922888e-1	1.000000e+0	1.000000e+0	5.200510e+0	1.922888e-1	1	1.922888e-1	1.000000e+0	18	1.680979e-1	1.000000e+0	1.000000e+0	5.687579e+0	1.758217e-1	1	1586	5.000000e-1	6.305170e-4	unnamed	OSGIN2
MGI Expression: Detected	10083	TS23_medulla oblongata	18	1.960357e-1	1.000000e+0	1.000000e+0	5.101112e+0	1.960357e-1	1	1.960357e-1	1.000000e+0	10	1.349108e-1	1.000000e+0	1.000000e+0	7.153450e+0	1.397927e-1	1	1261	5.000000e-1	7.930214e-4	unnamed	OSGIN2
MGI Expression: Detected	7616	TS23_peripheral nervous system	19	1.978285e-1	1.000000e+0	1.000000e+0	5.054883e+0	1.978285e-1	1	1.978285e-1	1.000000e+0	19	1.757649e-1	1.000000e+0	1.000000e+0	5.427497e+0	1.842470e-1	1	1662	5.000000e-1	6.016847e-4	unnamed	OSGIN2
MGI Expression: Detected	8791	TS23_cranial ganglion	20	2.058991e-1	1.000000e+0	1.000000e+0	4.856747e+0	2.058991e-1	1	2.058991e-1	1.000000e+0	20	1.762681e-1	1.000000e+0	1.000000e+0	5.411218e+0	1.848013e-1	1	1667	5.000000e-1	5.998800e-4	unnamed	OSGIN2
MGI Expression: Detected	7845	TS23_central nervous system ganglion	21	2.070222e-1	1.000000e+0	1.000000e+0	4.830399e+0	2.070222e-1	1	2.070222e-1	1.000000e+0	21	1.771734e-1	1.000000e+0	1.000000e+0	5.382160e+0	1.857990e-1	1	1676	5.000000e-1	5.966587e-4	unnamed	OSGIN2
MGI Expression: Detected	2413	TS17_central nervous system	22	2.230048e-1	1.000000e+0	1.000000e+0	4.484208e+0	2.230048e-1	1	2.230048e-1	1.000000e+0	23	1.997435e-1	1.000000e+0	1.000000e+0	4.742639e+0	2.108531e-1	1	1902	5.000000e-1	5.257624e-4	unnamed	NBN
MGI Expression: Detected	2412	TS17_nervous system	23	2.273547e-1	1.000000e+0	1.000000e+0	4.398414e+0	2.273547e-1	1	2.273547e-1	1.000000e+0	24	2.029139e-1	1.000000e+0	1.000000e+0	4.664168e+0	2.144005e-1	1	1934	5.000000e-1	5.170631e-4	unnamed	NBN
MGI Expression: Detected	7648	TS23_reproductive system	24	2.726454e-1	1.000000e+0	1.000000e+0	3.667768e+0	2.726454e-1	1	2.726454e-1	1.000000e+0	27	2.658558e-1	1.000000e+0	1.000000e+0	3.492257e+0	2.863478e-1	1	2583	5.000000e-1	3.871467e-4	unnamed	NBN
MGI Expression: Detected	8013	TS23_metanephros	25	2.993178e-1	1.000000e+0	1.000000e+0	3.340931e+0	2.993178e-1	1	2.993178e-1	1.000000e+0	29	2.899716e-1	1.000000e+0	1.000000e+0	3.177351e+0	3.147276e-1	1	2839	5.000000e-1	3.522367e-4	unnamed	NBN
MGI Expression: Detected	2165	TS17_organ system	26	3.004442e-1	1.000000e+0	1.000000e+0	3.328405e+0	3.004442e-1	1	3.004442e-1	1.000000e+0	28	2.687975e-1	1.000000e+0	1.000000e+0	3.450842e+0	2.897844e-1	1	2614	5.000000e-1	3.825555e-4	unnamed	NBN
MGI Expression: Detected	7644	TS23_renal-urinary system	27	3.497890e-1	1.000000e+0	1.000000e+0	2.858867e+0	3.497890e-1	1	3.497890e-1	1.000000e+0	33	3.379875e-1	1.000000e+0	1.000000e+0	2.683076e+0	3.727066e-1	1	3362	5.000000e-1	2.974420e-4	unnamed	NBN
MGI Expression: Detected	2023	TS17_embryo	28	3.504112e-1	1.000000e+0	1.000000e+0	2.853790e+0	3.504112e-1	1	3.504112e-1	1.000000e+0	31	3.281190e-1	1.000000e+0	1.000000e+0	2.772979e+0	3.606230e-1	1	3253	5.000000e-1	3.074085e-4	unnamed	NBN
MGI Expression: Detected	2022	Theiler_stage_17	29	3.517739e-1	1.000000e+0	1.000000e+0	2.842735e+0	3.517739e-1	1	3.517739e-1	1.000000e+0	32	3.303888e-1	1.000000e+0	1.000000e+0	2.751830e+0	3.633945e-1	1	3278	5.000000e-1	3.050641e-4	unnamed	NBN
MGI Expression: Detected	8824	TS23_hindbrain	30	3.841897e-1	1.000000e+0	1.000000e+0	2.602881e+0	3.841897e-1	1	3.841897e-1	1.000000e+0	30	3.099139e-1	1.000000e+0	1.000000e+0	2.953667e+0	3.385622e-1	1	3054	5.000000e-1	3.274394e-4	unnamed	OSGIN2
MGI Expression: Detected	7901	TS23_brain	31	5.025340e-1	1.000000e+0	1.000000e+0	1.989915e+0	5.025340e-1	1	5.025340e-1	1.000000e+0	34	4.293954e-1	1.000000e+0	1.000000e+0	2.044074e+0	4.892190e-1	1	4413	5.000000e-1	2.266032e-4	unnamed	OSGIN2
MGI Expression: Detected	7489	TS23_visceral organ	32	5.150818e-1	1.000000e+0	1.000000e+0	1.941439e+0	5.150818e-1	1	5.150818e-1	1.000000e+0	37	5.216365e-1	1.000000e+0	1.000000e+0	1.621517e+0	6.167064e-1	1	5563	5.000000e-1	1.797591e-4	unnamed	NBN
MGI Expression: Detected	7608	TS23_central nervous system	33	5.265571e-1	1.000000e+0	1.000000e+0	1.899129e+0	5.265571e-1	1	5.265571e-1	1.000000e+0	35	4.610183e-1	1.000000e+0	1.000000e+0	1.880838e+0	5.316778e-1	1	4796	5.000000e-1	2.085071e-4	unnamed	OSGIN2
MGI Expression: Detected	7501	TS23_nervous system	34	5.331601e-1	1.000000e+0	1.000000e+0	1.875609e+0	5.331601e-1	1	5.331601e-1	1.000000e+0	36	4.686418e-1	1.000000e+0	1.000000e+0	1.844683e+0	5.420986e-1	1	4890	5.000000e-1	2.044990e-4	unnamed	OSGIN2
MGI Expression: Detected	6944	TS28_organ system	35	6.191523e-1	1.000000e+0	1.000000e+0	1.615112e+0	6.191523e-1	1	6.191523e-1	1.000000e+0	38	6.326325e-1	1.000000e+0	1.000000e+0	1.269420e+0	7.877612e-1	1	7106	5.000000e-1	1.407261e-4	unnamed	NBN
MGI Expression: Detected	6937	TS28_postnatal mouse	36	6.225233e-1	1.000000e+0	1.000000e+0	1.606366e+0	6.225233e-1	1	6.225233e-1	1.000000e+0	39	6.373878e-1	1.000000e+0	1.000000e+0	1.256862e+0	7.956322e-1	1	7177	5.000000e-1	1.393340e-4	unnamed	NBN
MGI Expression: Detected	7445	TS23_organ system	37	6.921258e-1	1.000000e+0	1.000000e+0	1.444824e+0	6.921258e-1	1	6.921258e-1	1.000000e+0	22	1.994819e-1	1.000000e+0	1.000000e+0	2.238893e+0	8.932986e-1	2	8058	1.000000e+0	2.482005e-4	unnamed	NBN,OSGIN2
MGI Expression: Detected	6925	TS23_embryo	38	7.220129e-1	1.000000e+0	1.000000e+0	1.385017e+0	7.220129e-1	1	7.220129e-1	1.000000e+0	25	2.342505e-1	1.000000e+0	1.000000e+0	2.066079e+0	9.680173e-1	2	8732	1.000000e+0	2.290426e-4	unnamed	NBN,OSGIN2
MGI Expression: Detected	6924	Theiler_stage_23	39	7.220179e-1	1.000000e+0	1.000000e+0	1.385007e+0	7.220179e-1	1	7.220179e-1	1.000000e+0	26	2.344115e-1	1.000000e+0	1.000000e+0	2.065369e+0	9.683499e-1	2	8735	1.000000e+0	2.289639e-4	unnamed	NBN,OSGIN2
MSigDB Perturbation	KANG_CISPLATIN_RESISTANCE_DN	Genes down-regulated in gastric cancer cell lines resistant to cisplatin [PubChem=2767].	1	7.969772e-4	1.000000e+0	1.000000e+0	1.254741e+3	7.969772e-4	1	7.969772e-4	1.000000e+0	2	8.866967e-4	1.000000e+0	1.000000e+0	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	NBN
MSigDB Perturbation	MOOTHA_FFA_OXYDATION	Genes involved in free fatty acid oxidation; based on literature and sequence annotation resources and coverted to Affymetrix HG-U133A probe sets.	2	1.085456e-3	1.000000e+0	1.000000e+0	9.212714e+2	1.085456e-3	1	1.085456e-3	1.000000e+0	3	2.437470e-3	1.000000e+0	1.000000e+0	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	NBN
MSigDB Perturbation	MATZUK_MEIOTIC_AND_DNA_REPAIR	Meitic and DNA repair genes important for female fertility, based on mouse models with female fertility defects.	3	2.915531e-3	1.000000e+0	1.000000e+0	3.429907e+2	2.915531e-3	1	2.915531e-3	1.000000e+0	7	4.318932e-3	1.000000e+0	1.000000e+0	2.312949e+2	4.323485e-3	1	39	5.000000e-1	2.564103e-2	unnamed	NBN
MSigDB Perturbation	SHIN_B_CELL_LYMPHOMA_CLUSTER_8	Cluster 8 of genes distinguishing among different B lymphocyte neoplasms.	4	3.480860e-3	1.000000e+0	1.000000e+0	2.872853e+2	3.480860e-3	1	3.480860e-3	1.000000e+0	6	3.987038e-3	1.000000e+0	1.000000e+0	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	NBN
MSigDB Perturbation	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP	Genes from the black module which are up-regulated in HAEC cells (primary aortic endothelium) after exposure to the oxidized 1-palmitoyl-2-arachidonyl-sn-3-glycerophosphorylcholine (oxPAPC).	5	3.730371e-3	1.000000e+0	1.000000e+0	2.680699e+2	3.730371e-3	1	3.730371e-3	1.000000e+0	5	3.544427e-3	1.000000e+0	1.000000e+0	2.818906e+2	3.547475e-3	1	32	5.000000e-1	3.125000e-2	unnamed	OSGIN2
MSigDB Perturbation	SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN	Genes down-regulated in response to UVB radiation in HFK cells (keratinocytes) immortalized by overexpression of HPV E6 and E7 viral oncogenes.	6	4.414742e-3	1.000000e+0	1.000000e+0	2.265138e+2	4.414742e-3	1	4.414742e-3	1.000000e+0	4	3.433759e-3	1.000000e+0	1.000000e+0	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	NBN
MSigDB Perturbation	DIRMEIER_LMP1_RESPONSE_LATE_UP	Cluster 3: genes up-regulated in B2264-19/3 cells (primary B lymphocytes) within 60-180 min after activation of LMP1 (an oncogene encoded by Epstein-Barr virus, EBV).	7	5.285621e-3	1.000000e+0	1.000000e+0	1.891925e+2	5.285621e-3	1	5.285621e-3	1.000000e+0	9	6.419641e-3	1.000000e+0	1.000000e+0	1.555259e+2	6.429799e-3	1	58	5.000000e-1	1.724138e-2	unnamed	NBN
MSigDB Perturbation	RIZKI_TUMOR_INVASIVENESS_2D_UP	Genes up-regulated in monolayer (2D) cultures of preinvasive (S3-C) vs invasive (T4-2) breast cancer cells.	8	5.338679e-3	1.000000e+0	1.000000e+0	1.873123e+2	5.338679e-3	1	5.338679e-3	1.000000e+0	12	7.634827e-3	1.000000e+0	1.000000e+0	1.307319e+2	7.649243e-3	1	69	5.000000e-1	1.449275e-2	unnamed	NBN
MSigDB Perturbation	PEART_HDAC_PROLIFERATION_CLUSTER_DN	Cell proliferation genes down-regulated by histone deacetylase (HDAC) inhibitors SAHA and depsipeptide [PubChem=5311;5352062].	9	5.919376e-3	1.000000e+0	1.000000e+0	1.689367e+2	5.919376e-3	1	5.919376e-3	1.000000e+0	13	8.407740e-3	1.000000e+0	1.000000e+0	1.186908e+2	8.425254e-3	1	76	5.000000e-1	1.315789e-2	unnamed	NBN
MSigDB Perturbation	LINDSTEDT_DENDRITIC_CELL_MATURATION_B	Maturation of monocyte-derived dendritic cells (DC) in response to inflammatory stimuli: genes up-regulated both at 8 hr and 48 hr after the stimulation (cluster B).	10	6.388820e-3	1.000000e+0	1.000000e+0	1.565234e+2	6.388820e-3	1	6.388820e-3	1.000000e+0	8	5.756499e-3	1.000000e+0	1.000000e+0	1.734712e+2	5.764647e-3	1	52	5.000000e-1	1.923077e-2	unnamed	NBN
MSigDB Perturbation	GEORGES_CELL_CYCLE_MIR192_TARGETS	Experimentally validated direct targets of MIR192 [GeneID=406967] microRNA; MIR192 caused cell cycle arrest in HCT116 cells (colon cancer).	11	7.232983e-3	1.000000e+0	1.000000e+0	1.382555e+2	7.232983e-3	1	7.232983e-3	1.000000e+0	10	6.861613e-3	1.000000e+0	1.000000e+0	1.454919e+2	6.873233e-3	1	62	5.000000e-1	1.612903e-2	unnamed	NBN
MSigDB Perturbation	LIN_NPAS4_TARGETS_DN	Genes down-regulated in neurons after NPAS4 [GeneID=266743] knockdown by RNAi.	12	7.854855e-3	1.000000e+0	1.000000e+0	1.273098e+2	7.854855e-3	1	7.854855e-3	1.000000e+0	11	7.303486e-3	1.000000e+0	1.000000e+0	1.366742e+2	7.316668e-3	1	66	5.000000e-1	1.515152e-2	unnamed	OSGIN2
MSigDB Perturbation	PUJANA_BREAST_CANCER_LIT_INT_NETWORK	Genes constituting the LIT-Int network of proteins interacting with breast cancer reference proteins BRCA1, BRCA2, ATM, and CHEK2 [GeneID=672;675;472;11200]; the interactions were manually curated from the literature.	13	8.136893e-3	1.000000e+0	1.000000e+0	1.228970e+2	8.136893e-3	1	8.136893e-3	1.000000e+0	17	1.116569e-2	1.000000e+0	1.000000e+0	8.931188e+1	1.119672e-2	1	101	5.000000e-1	9.900990e-3	unnamed	NBN
MSigDB Perturbation	HAHTOLA_SEZARY_SYNDROM_UP	Genes up-regulated in monocytes isolated from peripheral blood samples of Sezary syndrom patients compared to those from healthy normal donors.	14	8.481801e-3	1.000000e+0	1.000000e+0	1.178995e+2	8.481801e-3	1	8.481801e-3	1.000000e+0	16	1.072467e-2	1.000000e+0	1.000000e+0	9.299485e+1	1.075328e-2	1	97	5.000000e-1	1.030928e-2	unnamed	NBN
MSigDB Perturbation	DANG_MYC_TARGETS_UP	Genes up-regulated by MYC [GeneID=4609] and whose promoters are bound by MYC, according to MYC Target Gene Database.	15	9.822124e-3	1.000000e+0	1.000000e+0	1.018110e+2	9.822124e-3	1	9.822124e-3	1.000000e+0	19	1.590037e-2	1.000000e+0	1.000000e+0	6.264236e+1	1.596364e-2	1	144	5.000000e-1	6.944444e-3	unnamed	NBN
MSigDB Perturbation	GRADE_COLON_AND_RECTAL_CANCER_DN	Down-regulated genes in both rectal and colon carcinoma compared to normal mucosa samples.	16	1.105162e-2	1.000000e+0	1.000000e+0	9.048447e+1	1.105162e-2	1	1.105162e-2	1.000000e+0	15	1.061440e-2	1.000000e+0	1.000000e+0	9.396354e+1	1.064243e-2	1	96	5.000000e-1	1.041667e-2	unnamed	OSGIN2
MSigDB Perturbation	GHANDHI_BYSTANDER_IRRADIATION_UP	Genes significantly (FDR &lt; 10%) up-regulated in IMR-90 cells (fibroblast) in response to bystander irradiation.	17	1.105264e-2	1.000000e+0	1.000000e+0	9.047611e+1	1.105264e-2	1	1.105264e-2	1.000000e+0	14	9.069997e-3	1.000000e+0	1.000000e+0	1.100061e+2	9.090405e-3	1	82	5.000000e-1	1.219512e-2	unnamed	OSGIN2
MSigDB Perturbation	FERNANDEZ_BOUND_BY_MYC	Genes identified by ChIP within the high-affinity group of MYC [GeneID=4609] targets.	18	1.164859e-2	1.000000e+0	1.000000e+0	8.584729e+1	1.164859e-2	1	1.164859e-2	1.000000e+0	30	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	NBN
MSigDB Perturbation	BIDUS_METASTASIS_DN	Genes down-regulated in endometroid endometrial tumors from patients with lymph node metastases compared to those without the metastases.	19	1.293673e-2	1.000000e+0	1.000000e+0	7.729930e+1	1.293673e-2	1	1.293673e-2	1.000000e+0	20	1.645017e-2	1.000000e+0	1.000000e+0	6.054027e+1	1.651793e-2	1	149	5.000000e-1	6.711409e-3	unnamed	NBN
MSigDB Perturbation	NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON	Genes within amplicon 8q12-q22 identified in a copy number alterations study of 191 breast tumor samples.	20	1.327803e-2	1.000000e+0	1.000000e+0	7.531237e+1	1.327803e-2	1	1.327803e-2	1.000000e+0	1	4.839310e-5	1.627944e-1	1.627944e-1	1.431825e+2	1.396818e-2	2	126	1.000000e+0	1.587302e-2	unnamed	NBN,OSGIN2
MSigDB Perturbation	BENPORATH_MYC_TARGETS_WITH_EBOX	Set 'Myc targets1': targets of c-Myc [GeneID=4609] identified by ChIP on chip in cultured cell lines, focusing on E-box-containing genes; high affinity bound subset	21	1.387680e-2	1.000000e+0	1.000000e+0	7.206271e+1	1.387680e-2	1	1.387680e-2	1.000000e+0	33	2.610163e-2	1.000000e+0	1.000000e+0	3.806118e+1	2.627349e-2	1	237	5.000000e-1	4.219409e-3	unnamed	NBN
MSigDB Perturbation	DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN	Genes down-regulated in squamous cell carcinoma (SCC) compared to normal skin.	22	1.395226e-2	1.000000e+0	1.000000e+0	7.167300e+1	1.395226e-2	1	1.395226e-2	1.000000e+0	25	1.831837e-2	1.000000e+0	1.000000e+0	5.434036e+1	1.840253e-2	1	166	5.000000e-1	6.024096e-3	unnamed	NBN
MSigDB Perturbation	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP	Genes up-regulated in medullary breast cancer (MBC) relative to ductal breast cancer (DBD).	23	1.402227e-2	1.000000e+0	1.000000e+0	7.131512e+1	1.402227e-2	1	1.402227e-2	1.000000e+0	31	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	NBN
MSigDB Perturbation	DARWICHE_PAPILLOMA_RISK_LOW_DN	Genes down-regulated during skin tumor progression from low risk papilloma vs normal skin.	24	1.408239e-2	1.000000e+0	1.000000e+0	7.101066e+1	1.408239e-2	1	1.408239e-2	1.000000e+0	21	1.688991e-2	1.000000e+0	1.000000e+0	5.895752e+1	1.696137e-2	1	153	5.000000e-1	6.535948e-3	unnamed	NBN
MSigDB Perturbation	WHITFIELD_CELL_CYCLE_S	Genes periodically expressed in synchronized HeLa cells (cervical carcinoma), with peak during the S phase of cell cycle.	25	1.444154e-2	1.000000e+0	1.000000e+0	6.924467e+1	1.444154e-2	1	1.444154e-2	1.000000e+0	28	1.875769e-2	1.000000e+0	1.000000e+0	5.306176e+1	1.884596e-2	1	170	5.000000e-1	5.882353e-3	unnamed	OSGIN2
MSigDB Perturbation	DARWICHE_PAPILLOMA_RISK_HIGH_DN	Genes down-regulated during skin tumor progression from normal skin to high risk papilloma.	26	1.505231e-2	1.000000e+0	1.000000e+0	6.643498e+1	1.505231e-2	1	1.505231e-2	1.000000e+0	24	1.798882e-2	1.000000e+0	1.000000e+0	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	NBN
MSigDB Perturbation	DARWICHE_SKIN_TUMOR_PROMOTER_DN	Genes down-regulated during skin tumor progression: epidermis treated with the carcinogen DMBA [PubChem=6001] followed by 20 weekly applications of the tumor promoter TPA [PubChem=4792], compared to the untreated skin.	27	1.555733e-2	1.000000e+0	1.000000e+0	6.427838e+1	1.555733e-2	1	1.555733e-2	1.000000e+0	27	1.864787e-2	1.000000e+0	1.000000e+0	5.337574e+1	1.873510e-2	1	169	5.000000e-1	5.917160e-3	unnamed	NBN
MSigDB Perturbation	BRUECKNER_TARGETS_OF_MIRLET7A3_UP	Genes up-regulated in A549 cells (lung cancer) expressing MIRLET7A3 [GeneID=406883] microRNA off a plasmid vector.	28	1.571449e-2	1.000000e+0	1.000000e+0	6.363552e+1	1.571449e-2	1	1.571449e-2	1.000000e+0	18	1.215761e-2	1.000000e+0	1.000000e+0	8.200455e+1	1.219445e-2	1	110	5.000000e-1	9.090909e-3	unnamed	OSGIN2
MSigDB Perturbation	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN	Genes down-regulated in ovarian tumors from mouse models for the BMP SMAD signaling (gonad specific double knockout of SMAD1 and SMAD5 [GeneID=4086, 4090]).	29	1.716961e-2	1.000000e+0	1.000000e+0	5.824243e+1	1.716961e-2	1	1.716961e-2	1.000000e+0	21	1.688991e-2	1.000000e+0	1.000000e+0	5.895752e+1	1.696137e-2	1	153	5.000000e-1	6.535948e-3	unnamed	OSGIN2
MSigDB Perturbation	GAL_LEUKEMIC_STEM_CELL_DN	Genes down-regulated in leukemic stem cells (LSC), defined as CD34+CD38- [GeneID=947;952] cells from AML (acute myeloid leukemia patients) compared to the CD34+CD38+ cells.	30	1.946847e-2	1.000000e+0	1.000000e+0	5.136511e+1	1.946847e-2	1	1.946847e-2	1.000000e+0	34	2.697668e-2	1.000000e+0	1.000000e+0	3.681837e+1	2.716036e-2	1	245	5.000000e-1	4.081633e-3	unnamed	OSGIN2
MSigDB Perturbation	IWANAGA_CARCINOGENESIS_BY_KRAS_UP	Cluster 3: genes up-regulated in lung tissue samples from mice with tumor-bearing genotypes (activated KRAS [GeneID=3845] alone or together with inactivated PTEN [GeneID=5728]).	31	2.110968e-2	1.000000e+0	1.000000e+0	4.737163e+1	2.110968e-2	1	2.110968e-2	1.000000e+0	26	1.842821e-2	1.000000e+0	1.000000e+0	5.401497e+1	1.851339e-2	1	167	5.000000e-1	5.988024e-3	unnamed	OSGIN2
MSigDB Perturbation	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP	Genes up-regulated in ME-A cells (breast cancer, sensitive to apoptotic stimuli) upon serum deprivation for 22 hr in the presence of medium concentrate (MC) from ME-C cells (breast cancer, resistant to apoptotic stimuli).	32	2.147510e-2	1.000000e+0	1.000000e+0	4.656556e+1	2.147510e-2	1	2.147510e-2	1.000000e+0	32	2.281671e-2	1.000000e+0	1.000000e+0	4.357729e+1	2.294773e-2	1	207	5.000000e-1	4.830918e-3	unnamed	OSGIN2
MSigDB Perturbation	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	Genes down-regulated in mARMS (molecular ARMS) compared to the mERMS (molecular ERMS) class of rhabdomyosarcoma tumors.	33	2.472012e-2	1.000000e+0	1.000000e+0	4.045288e+1	2.472012e-2	1	2.472012e-2	1.000000e+0	29	1.908711e-2	1.000000e+0	1.000000e+0	5.214162e+1	1.917854e-2	1	173	5.000000e-1	5.780347e-3	unnamed	NBN
MSigDB Perturbation	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	Genes whose expression profile is specific to Cluster III of urothelial cell carcinoma (UCC) tumors.	34	2.574991e-2	1.000000e+0	1.000000e+0	3.883509e+1	2.574991e-2	1	2.574991e-2	1.000000e+0	36	3.635858e-2	1.000000e+0	1.000000e+0	2.725227e+1	3.669420e-2	1	331	5.000000e-1	3.021148e-3	unnamed	OSGIN2
MSigDB Perturbation	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL	Genes whose expression changes in Calu-6 cells (lung cancer) by TNF [GeneID=7124] were blocked partially by p38 inhibitor LY479754.	35	2.655905e-2	1.000000e+0	1.000000e+0	3.765195e+1	2.655905e-2	1	2.655905e-2	1.000000e+0	23	1.721965e-2	1.000000e+0	1.000000e+0	5.782372e+1	1.729394e-2	1	156	5.000000e-1	6.410256e-3	unnamed	NBN
MSigDB Perturbation	MOOTHA_HUMAN_MITODB_6_2002	Mitochondrial genes; based on literature and sequence annotation resources and converted to Affymetrix HG-U133A probe sets.	36	3.082442e-2	1.000000e+0	1.000000e+0	3.244181e+1	3.082442e-2	1	3.082442e-2	1.000000e+0	46	4.710240e-2	1.000000e+0	1.000000e+0	2.097791e+1	4.766920e-2	1	430	5.000000e-1	2.325581e-3	unnamed	NBN
MSigDB Perturbation	MOOTHA_MITOCHONDRIA	Mitochondrial genes	37	3.109557e-2	1.000000e+0	1.000000e+0	3.215893e+1	3.109557e-2	1	3.109557e-2	1.000000e+0	49	4.904935e-2	1.000000e+0	1.000000e+0	2.013504e+1	4.966465e-2	1	448	5.000000e-1	2.232143e-3	unnamed	NBN
MSigDB Perturbation	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	Genes up-regulated in T-PLL cells (T-cell prolymphocytic leukemia) bearing the inv(14)/t(14:14) chromosomal aberration.	38	3.413809e-2	1.000000e+0	1.000000e+0	2.929280e+1	3.413809e-2	1	3.413809e-2	1.000000e+0	40	4.103249e-2	1.000000e+0	1.000000e+0	2.411898e+1	4.146112e-2	1	374	5.000000e-1	2.673797e-3	unnamed	NBN
MSigDB Perturbation	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	Genes up-regulated in nsopharyngeal carcinoma relative to the normal tissue.	39	3.539566e-2	1.000000e+0	1.000000e+0	2.825205e+1	3.539566e-2	1	3.539566e-2	1.000000e+0	35	3.101865e-2	1.000000e+0	1.000000e+0	3.198759e+1	3.126213e-2	1	282	5.000000e-1	3.546099e-3	unnamed	NBN
MSigDB Perturbation	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN	Genes down-regulated in erythroid progenitor cells isolated from bone marrow of patients with Diamond-Blackfan anemia (DBA) and mutated RPS19 [GeneID=6223].	40	3.738203e-2	1.000000e+0	1.000000e+0	2.675082e+1	3.738203e-2	1	3.738203e-2	1.000000e+0	53	5.261359e-2	1.000000e+0	1.000000e+0	1.875364e+1	5.332299e-2	1	481	5.000000e-1	2.079002e-3	unnamed	OSGIN2
MSigDB Perturbation	GRESHOCK_CANCER_COPY_NUMBER_UP	Genes from common genomic gains observed in a meta analyis of copy number alterations across a panel of different cancer cell lines and tumor samples.	41	3.901444e-2	1.000000e+0	1.000000e+0	2.563154e+1	3.901444e-2	1	3.901444e-2	1.000000e+0	38	3.668503e-2	1.000000e+0	1.000000e+0	2.700749e+1	3.702677e-2	1	334	5.000000e-1	2.994012e-3	unnamed	NBN
MSigDB Perturbation	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	Cluster 6 of method A: up-regulation of these genes in patients with non-small cell lung cancer (NSCLC) predicts poor survival outcome.	42	3.969311e-2	1.000000e+0	1.000000e+0	2.519329e+1	3.969311e-2	1	3.969311e-2	1.000000e+0	50	4.926556e-2	1.000000e+0	1.000000e+0	2.004556e+1	4.988637e-2	1	450	5.000000e-1	2.222222e-3	unnamed	NBN
MSigDB Perturbation	MARSON_BOUND_BY_E2F4_UNSTIMULATED	Genes with promoters bound by E2F4 [GeneID=1874] in unstimulated hybridoma cells.	43	4.167922e-2	1.000000e+0	1.000000e+0	2.399277e+1	4.167922e-2	1	4.167922e-2	1.000000e+0	63	7.535154e-2	1.000000e+0	1.000000e+0	1.301659e+1	7.682501e-2	1	693	5.000000e-1	1.443001e-3	unnamed	NBN
MSigDB Perturbation	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP	Genes up-regulated in macrophages by P.gingivalis LPS (lipopolysaccharide).	44	4.318233e-2	1.000000e+0	1.000000e+0	2.315762e+1	4.318233e-2	1	4.318233e-2	1.000000e+0	41	4.146669e-2	1.000000e+0	1.000000e+0	2.386376e+1	4.190455e-2	1	378	5.000000e-1	2.645503e-3	unnamed	NBN
MSigDB Perturbation	PHONG_TNF_RESPONSE_NOT_VIA_P38	Genes whose expression changes in Calu-6 cells (lung cancer) by TNF [GeneID=7124] were not affected by p38 inhibitor LY479754.	45	4.385350e-2	1.000000e+0	1.000000e+0	2.280320e+1	4.385350e-2	1	4.385350e-2	1.000000e+0	37	3.657622e-2	1.000000e+0	1.000000e+0	2.708859e+1	3.691591e-2	1	333	5.000000e-1	3.003003e-3	unnamed	NBN
MSigDB Perturbation	BASAKI_YBX1_TARGETS_DN	Genes down-regulated in SKOC-3 cells (ovarian cancer) after YB-1 (YBX1) [GeneID=4904] knockdown by RNAi.	46	4.411758e-2	1.000000e+0	1.000000e+0	2.266670e+1	4.411758e-2	1	4.411758e-2	1.000000e+0	39	3.864260e-2	1.000000e+0	1.000000e+0	2.562642e+1	3.902223e-2	1	352	5.000000e-1	2.840909e-3	unnamed	NBN
MSigDB Perturbation	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN	Genes down-regulated in monocyte-derived dendritic cells (MDDC) after stimulation with galecin-1 (lectin, LGALS1) [GeneID=3956] compared to that with bacterial lipopolysaccharide (LPS).	47	4.480598e-2	1.000000e+0	1.000000e+0	2.231845e+1	4.480598e-2	1	4.480598e-2	1.000000e+0	47	4.764342e-2	1.000000e+0	1.000000e+0	2.073678e+1	4.822349e-2	1	435	5.000000e-1	2.298851e-3	unnamed	NBN
MSigDB Perturbation	OSMAN_BLADDER_CANCER_UP	Genes up-regulated in blood samples from bladder cancer patients.	48	4.618577e-2	1.000000e+0	1.000000e+0	2.165169e+1	4.618577e-2	1	4.618577e-2	1.000000e+0	42	4.276871e-2	1.000000e+0	1.000000e+0	2.312949e+1	4.323485e-2	1	390	5.000000e-1	2.564103e-3	unnamed	NBN
MSigDB Perturbation	YAGI_AML_WITH_INV_16_TRANSLOCATION	Genes specifically expressed in samples from patients with pediatric acute myeloid leukemia (AML) bearing inv(16) translocation.	49	4.636429e-2	1.000000e+0	1.000000e+0	2.156832e+1	4.636429e-2	1	4.636429e-2	1.000000e+0	43	4.537010e-2	1.000000e+0	1.000000e+0	2.178865e+1	4.589546e-2	1	414	5.000000e-1	2.415459e-3	unnamed	OSGIN2
MSigDB Perturbation	KIM_WT1_TARGETS_DN	Genes down-regulated in UB27 cells (osteosarcoma) at any time point after inducing the expression of a mutant form of WT1 [GeneID=7490].	50	4.691887e-2	1.000000e+0	1.000000e+0	2.131339e+1	4.691887e-2	1	4.691887e-2	1.000000e+0	48	4.894124e-2	1.000000e+0	1.000000e+0	2.018009e+1	4.955379e-2	1	447	5.000000e-1	2.237136e-3	unnamed	NBN
MSigDB Perturbation	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN	Genes down-regulated in lymphoblastoid cells from the European population compared to those from the Asian population.	51	5.267674e-2	1.000000e+0	1.000000e+0	1.898371e+1	5.267674e-2	1	5.267674e-2	1.000000e+0	59	6.390983e-2	1.000000e+0	1.000000e+0	1.539334e+1	6.496314e-2	1	586	5.000000e-1	1.706485e-3	unnamed	NBN
MSigDB Perturbation	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP	Genes up-regulated in macrophage by live P.gingivalis.	52	5.350410e-2	1.000000e+0	1.000000e+0	1.869016e+1	5.350410e-2	1	5.350410e-2	1.000000e+0	44	4.591162e-2	1.000000e+0	1.000000e+0	2.152864e+1	4.644975e-2	1	419	5.000000e-1	2.386635e-3	unnamed	NBN
MSigDB Perturbation	DOUGLAS_BMI1_TARGETS_UP	Genes up-regulated in A4573 cells (Ewing's sarcoma, ESFT) after knockdown of BMI1 [GeneID=648] by RNAi.	53	5.443076e-2	1.000000e+0	1.000000e+0	1.837197e+1	5.443076e-2	1	5.443076e-2	1.000000e+0	58	6.111898e-2	1.000000e+0	1.000000e+0	1.610804e+1	6.208082e-2	1	560	5.000000e-1	1.785714e-3	unnamed	OSGIN2
MSigDB Perturbation	ENK_UV_RESPONSE_KERATINOCYTE_DN	Genes down-regulated in NHEK cells (normal epidermal keratinocytes) after UVB irradiation.	54	5.492266e-2	1.000000e+0	1.000000e+0	1.820742e+1	5.492266e-2	1	5.492266e-2	1.000000e+0	55	5.477048e-2	1.000000e+0	1.000000e+0	1.800499e+1	5.554016e-2	1	501	5.000000e-1	1.996008e-3	unnamed	NBN
MSigDB Perturbation	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP	Genes up-regulated in ME-A cells (breast cancer) undergoing apoptosis upon serum starvation (5% to 0% FCS) for 22 hr.	55	5.536438e-2	1.000000e+0	1.000000e+0	1.806215e+1	5.536438e-2	1	5.536438e-2	1.000000e+0	56	5.886179e-2	1.000000e+0	1.000000e+0	1.673562e+1	5.975279e-2	1	539	5.000000e-1	1.855288e-3	unnamed	OSGIN2
MSigDB Perturbation	BENPORATH_CYCLING_GENES	Genes showing cell-cycle stage-specific expression [PMID=12058064].	56	5.607900e-2	1.000000e+0	1.000000e+0	1.783199e+1	5.607900e-2	1	5.607900e-2	1.000000e+0	61	7.022751e-2	1.000000e+0	1.000000e+0	1.398527e+1	7.150380e-2	1	645	5.000000e-1	1.550388e-3	unnamed	OSGIN2
MSigDB Perturbation	BAELDE_DIABETIC_NEPHROPATHY_DN	Genes down-regulated in glomeruli of kidneys from patients with diabetic nephropathy (type 2 diabetes mellitus).	57	5.861782e-2	1.000000e+0	1.000000e+0	1.705966e+1	5.861782e-2	1	5.861782e-2	1.000000e+0	45	4.666947e-2	1.000000e+0	1.000000e+0	2.117488e+1	4.722576e-2	1	426	5.000000e-1	2.347418e-3	unnamed	NBN
MSigDB Perturbation	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	Genes up-regulated in poorly differentiated thyroid carcinoma (PDTC) compared to normal thyroid tissue.	58	5.883486e-2	1.000000e+0	1.000000e+0	1.699673e+1	5.883486e-2	1	5.883486e-2	1.000000e+0	60	6.680363e-2	1.000000e+0	1.000000e+0	1.471533e+1	6.795632e-2	1	613	5.000000e-1	1.631321e-3	unnamed	NBN
MSigDB Perturbation	PUJANA_CHEK2_PCC_NETWORK	Genes constituting the CHEK2-PCC network of transcripts whose expression positively correlates (Pearson correlation coefficient, PCC &gt;= 0.4) with that of CHEK2 [GeneID=11200].	59	5.889590e-2	1.000000e+0	1.000000e+0	1.697911e+1	5.889590e-2	1	5.889590e-2	1.000000e+0	67	8.608710e-2	1.000000e+0	1.000000e+0	1.136083e+1	8.802173e-2	1	794	5.000000e-1	1.259446e-3	unnamed	NBN
MSigDB Perturbation	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	Genes up-regulated in kidney biopsies from patients with well functioning kidneys more than 1-year post transplant compared to the biopsies from normal living kidney donors.	60	5.987193e-2	1.000000e+0	1.000000e+0	1.670232e+1	5.987193e-2	1	5.987193e-2	1.000000e+0	57	5.972199e-2	1.000000e+0	1.000000e+0	1.649086e+1	6.063965e-2	1	547	5.000000e-1	1.828154e-3	unnamed	NBN
MSigDB Perturbation	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP	Genes up-regulated in macrophages by P.gingivalis FimA pathogen.	61	6.196591e-2	1.000000e+0	1.000000e+0	1.613791e+1	6.196591e-2	1	6.196591e-2	1.000000e+0	51	5.218192e-2	1.000000e+0	1.000000e+0	1.891090e+1	5.287955e-2	1	477	5.000000e-1	2.096436e-3	unnamed	NBN
MSigDB Perturbation	SCHLOSSER_SERUM_RESPONSE_DN	Cluster 4: genes down-regulated in B493-6 cells (B lymphocytes) upon serum stimulation but not affected by MYC [GeneID=4609].	62	7.399847e-2	1.000000e+0	1.000000e+0	1.351379e+1	7.399847e-2	1	7.399847e-2	1.000000e+0	62	7.524493e-2	1.000000e+0	1.000000e+0	1.303540e+1	7.671415e-2	1	692	5.000000e-1	1.445087e-3	unnamed	NBN
MSigDB Perturbation	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	Genes up-regulated in anaplastic thyroid carcinoma (ATC) compared to normal thyroid tissue.	63	7.606396e-2	1.000000e+0	1.000000e+0	1.314683e+1	7.606396e-2	1	7.606396e-2	1.000000e+0	64	7.694989e-2	1.000000e+0	1.000000e+0	1.274082e+1	7.848789e-2	1	708	5.000000e-1	1.412429e-3	unnamed	NBN
MSigDB Perturbation	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	Genes down-regulated in MCF7 cells (breast cancer) at 24 h of estradiol [PubChemID=5757] treatment.	64	7.665633e-2	1.000000e+0	1.000000e+0	1.304524e+1	7.665633e-2	1	7.665633e-2	1.000000e+0	54	5.444710e-2	1.000000e+0	1.000000e+0	1.811345e+1	5.520758e-2	1	498	5.000000e-1	2.008032e-3	unnamed	OSGIN2
MSigDB Perturbation	DANG_BOUND_BY_MYC	Genes whose promoters are bound by MYC [GeneID=4609], according to MYC Target Gene Database.	65	7.799204e-2	1.000000e+0	1.000000e+0	1.282182e+1	7.799204e-2	1	7.799204e-2	1.000000e+0	73	1.188545e-1	1.000000e+0	1.000000e+0	8.155967e+0	1.226096e-1	1	1106	5.000000e-1	9.041591e-4	unnamed	NBN
MSigDB Perturbation	ONKEN_UVEAL_MELANOMA_UP	Genes up-regulated in uveal melanoma: class 2 vs class 1 tumors.	66	8.290379e-2	1.000000e+0	1.000000e+0	1.206218e+1	8.290379e-2	1	8.290379e-2	1.000000e+0	66	8.311719e-2	1.000000e+0	1.000000e+0	1.177611e+1	8.491769e-2	1	766	5.000000e-1	1.305483e-3	unnamed	NBN
MSigDB Perturbation	NUYTTEN_NIPP1_TARGETS_UP	Genes up-regulated in PC3 cells (prostate cancer) after knockdown of NIPP1 [GeneID=5511] by RNAi.	67	8.459132e-2	1.000000e+0	1.000000e+0	1.182154e+1	8.459132e-2	1	8.459132e-2	1.000000e+0	65	8.014245e-2	1.000000e+0	1.000000e+0	1.222290e+1	8.181365e-2	1	738	5.000000e-1	1.355014e-3	unnamed	NBN
MSigDB Perturbation	NUYTTEN_EZH2_TARGETS_DN	Genes down-regulated in PC3 cells (prostate cancer) after knockdown of EZH2 [GeneID=2146] by RNAi.	68	8.521044e-2	1.000000e+0	1.000000e+0	1.173565e+1	8.521044e-2	1	8.521044e-2	1.000000e+0	70	1.056935e-1	1.000000e+0	1.000000e+0	9.204592e+0	1.086414e-1	1	980	5.000000e-1	1.020408e-3	unnamed	OSGIN2
MSigDB Perturbation	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	Common down-regulated transcripts in fibroblasts expressing either XP/CS or TDD mutant forms of ERCC3 [GeneID=2071], after UVC irradiation.	69	8.562533e-2	1.000000e+0	1.000000e+0	1.167879e+1	8.562533e-2	1	8.562533e-2	1.000000e+0	52	5.228984e-2	1.000000e+0	1.000000e+0	1.887134e+1	5.299041e-2	1	478	5.000000e-1	2.092050e-3	unnamed	NBN
MSigDB Perturbation	GEORGES_TARGETS_OF_MIR192_AND_MIR215	Genes down-regulated in HCT116 cells (colon cancer) by expression of MIR192 or MIR215 [GeneID=406967;406997] at 24 h.	70	9.671084e-2	1.000000e+0	1.000000e+0	1.034010e+1	9.671084e-2	1	9.671084e-2	1.000000e+0	69	9.137854e-2	1.000000e+0	1.000000e+0	1.068780e+1	9.356466e-2	1	844	5.000000e-1	1.184834e-3	unnamed	NBN
MSigDB Perturbation	BRUINS_UVC_RESPONSE_LATE	Late response genes: differentially expressed only 12 h after UV-C irradiation of MEF cells (embryonic fibroblast).	71	1.021113e-1	1.000000e+0	1.000000e+0	9.793235e+0	1.021113e-1	1	1.021113e-1	1.000000e+0	72	1.178136e-1	1.000000e+0	1.000000e+0	8.230383e+0	1.215010e-1	1	1096	5.000000e-1	9.124088e-4	unnamed	NBN
MSigDB Perturbation	NUYTTEN_EZH2_TARGETS_UP	Genes up-regulated in PC3 cells (prostate cancer) after knockdown of EZH2 [GeneID=2146] by RNAi.	72	1.213858e-1	1.000000e+0	1.000000e+0	8.238198e+0	1.213858e-1	1	1.213858e-1	1.000000e+0	71	1.078938e-1	1.000000e+0	1.000000e+0	9.011489e+0	1.109695e-1	1	1001	5.000000e-1	9.990010e-4	unnamed	NBN
MSigDB Perturbation	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	Genes up-regulated in TC71 and EWS502 cells (Ewing's sarcoma) by EWSR1-FLI1  [GeneID=2130;2314] as inferred from RNAi knockdown of this fusion protein.	73	1.219335e-1	1.000000e+0	1.000000e+0	8.201193e+0	1.219335e-1	1	1.219335e-1	1.000000e+0	74	1.314014e-1	1.000000e+0	1.000000e+0	7.351671e+0	1.360235e-1	1	1227	5.000000e-1	8.149959e-4	unnamed	NBN
MSigDB Perturbation	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP	Genes up-regulated in CD34+ [GeneID=947] cells isolated from bone marrow of CML (chronic myelogenous leukemia) patients, compared to those from normal donors.	74	1.224048e-1	1.000000e+0	1.000000e+0	8.169613e+0	1.224048e-1	1	1.224048e-1	1.000000e+0	76	1.472401e-1	1.000000e+0	1.000000e+0	6.531861e+0	1.530957e-1	1	1381	5.000000e-1	7.241130e-4	unnamed	NBN
MSigDB Perturbation	PUJANA_ATM_PCC_NETWORK	Genes constituting the ATM-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC &gt;= 0.4) with that of ATM [GeneID=472] across a compendium of normal tissues.	75	1.248339e-1	1.000000e+0	1.000000e+0	8.010648e+0	1.248339e-1	1	1.248339e-1	1.000000e+0	77	1.508194e-1	1.000000e+0	1.000000e+0	6.370410e+0	1.569758e-1	1	1416	5.000000e-1	7.062147e-4	unnamed	NBN
MSigDB Perturbation	DODD_NASOPHARYNGEAL_CARCINOMA_DN	Genes down-regulated in nasopharyngeal carcinoma (NPC) compared to the normal tissue.	76	1.258050e-1	1.000000e+0	1.000000e+0	7.948812e+0	1.258050e-1	1	1.258050e-1	1.000000e+0	75	1.382073e-1	1.000000e+0	1.000000e+0	6.976411e+0	1.433402e-1	1	1293	5.000000e-1	7.733952e-4	unnamed	NBN
MSigDB Perturbation	PUJANA_BRCA1_PCC_NETWORK	Genes constituting the BRCA1-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC &gt;= 0.4) with that of BRCA1 [GeneID=672] across a compendium of normal tissues.	77	1.292550e-1	1.000000e+0	1.000000e+0	7.736644e+0	1.292550e-1	1	1.292550e-1	1.000000e+0	79	1.731460e-1	1.000000e+0	1.000000e+0	5.513753e+0	1.813647e-1	1	1636	5.000000e-1	6.112469e-4	unnamed	NBN
MSigDB Perturbation	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY	Genes transiently induced only by the second pulse of EGF [GeneID =1950] in 184A1 cells (mammary epithelium).	78	1.379154e-1	1.000000e+0	1.000000e+0	7.250823e+0	1.379154e-1	1	1.379154e-1	1.000000e+0	78	1.522491e-1	1.000000e+0	1.000000e+0	6.308042e+0	1.585278e-1	1	1430	5.000000e-1	6.993007e-4	unnamed	OSGIN2
MSigDB Perturbation	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	Genes down-regulated in fibroblasts expressing mutant forms of ERCC3 [GeneID=2071] after UV irradiation.	79	1.422357e-1	1.000000e+0	1.000000e+0	7.030586e+0	1.422357e-1	1	1.422357e-1	1.000000e+0	68	9.095579e-2	1.000000e+0	1.000000e+0	1.073869e+1	9.312122e-2	1	840	5.000000e-1	1.190476e-3	unnamed	NBN
MSigDB Perturbation	BLALOCK_ALZHEIMERS_DISEASE_UP	Genes up-regulated in brain from patients with Alzheimer's disease.	80	1.561268e-1	1.000000e+0	1.000000e+0	6.405052e+0	1.561268e-1	1	1.561268e-1	1.000000e+0	80	1.768717e-1	1.000000e+0	1.000000e+0	5.391811e+0	1.854664e-1	1	1673	5.000000e-1	5.977286e-4	unnamed	OSGIN2
MSigDB miRNA Motifs	AACATTC,MIR-409-3P	Targets of MicroRNA AACATTC,MIR-409-3P	1	2.429693e-2	1.000000e+0	1.000000e+0	4.115746e+1	2.429693e-2	1	2.429693e-2	1.000000e+0	1	1.546041e-2	1.000000e+0	1.000000e+0	6.443214e+1	1.552020e-2	1	140	5.000000e-1	7.142857e-3	unnamed	OSGIN2
MSigDB miRNA Motifs	TGTGTGA,MIR-377	Targets of MicroRNA TGTGTGA,MIR-377	2	2.841031e-2	1.000000e+0	1.000000e+0	3.519849e+1	2.841031e-2	1	2.841031e-2	1.000000e+0	2	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	OSGIN2
MSigDB miRNA Motifs	TTTGCAG,MIR-518A-2	Targets of MicroRNA TTTGCAG,MIR-518A-2	3	3.507881e-2	1.000000e+0	1.000000e+0	2.850724e+1	3.507881e-2	1	3.507881e-2	1.000000e+0	3	2.204943e-2	1.000000e+0	1.000000e+0	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	OSGIN2
MSigDB miRNA Motifs	CACTGCC,MIR-34A,MIR-34C,MIR-449	Targets of MicroRNA CACTGCC,MIR-34A,MIR-34C,MIR-449	4	3.695065e-2	1.000000e+0	1.000000e+0	2.706312e+1	3.695065e-2	1	3.695065e-2	1.000000e+0	5	2.992705e-2	1.000000e+0	1.000000e+0	3.316360e+1	3.015354e-2	1	272	5.000000e-1	3.676471e-3	unnamed	OSGIN2
MSigDB miRNA Motifs	ATTCTTT,MIR-186	Targets of MicroRNA ATTCTTT,MIR-186	5	4.504027e-2	1.000000e+0	1.000000e+0	2.220235e+1	4.504027e-2	1	4.504027e-2	1.000000e+0	4	2.894409e-2	1.000000e+0	1.000000e+0	3.429848e+1	2.915581e-2	1	263	5.000000e-1	3.802281e-3	unnamed	OSGIN2
InterPro	IPR013908	DNA repair Nbs1, C-terminal	1	3.245707e-5	3.058105e-1	3.058105e-1	3.080993e+4	3.245707e-5	1	3.245707e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	NBN
InterPro	IPR016592	Nibrin	1	3.245707e-5	3.058105e-1	3.058105e-1	3.080993e+4	3.245707e-5	1	3.245707e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	NBN
InterPro	IPR000253	Forkhead-associated (FHA) domain	3	3.012930e-3	1.000000e+0	1.000000e+0	3.319029e+2	3.012930e-3	1	3.012930e-3	1.000000e+0	4	3.765745e-3	1.000000e+0	1.000000e+0	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	NBN
InterPro	IPR001357	BRCT domain	4	3.149228e-3	1.000000e+0	1.000000e+0	3.175381e+2	3.149228e-3	1	3.149228e-3	1.000000e+0	3	2.991025e-3	1.000000e+0	1.000000e+0	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	NBN
InterPro	IPR008984	SMAD/FHA domain	5	4.811901e-3	1.000000e+0	1.000000e+0	2.078181e+2	4.811901e-3	1	4.811901e-3	1.000000e+0	5	5.535402e-3	1.000000e+0	1.000000e+0	1.804100e+2	5.542930e-3	1	50	5.000000e-1	2.000000e-2	unnamed	NBN
TreeFam	TF101103	nibrin (Nbs1)	1	3.245707e-5	2.637462e-1	2.637462e-1	3.080993e+4	3.245707e-5	1	3.245707e-5	1.000000e+0	1	1.108586e-4	9.008370e-1	9.008370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	NBN
TreeFam	TF313502	OSGIN1, OSGIN2	2	1.008182e-4	8.192487e-1	4.096243e-1	9.918847e+3	1.008182e-4	1	1.008182e-4	1.000000e+0	2	2.217111e-4	1.000000e+0	9.008122e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	OSGIN2
Ensembl Genes	18316	NBN	1	3.245707e-5	5.855580e-1	5.855580e-1	3.080993e+4	3.245707e-5	1	3.245707e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	NBN
Ensembl Genes	18315	OSGIN2	2	7.862375e-5	1.000000e+0	7.092255e-1	1.271880e+4	7.862375e-5	1	7.862375e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	OSGIN2
MSigDB Oncogenic Signatures	P53_DN.V2_UP	Genes up-regulated in HEK293 cells (kidney fibroblasts) upon knockdown of TP53 [Gene ID=7157] gene by RNAi.	1	1.341030e-2	1.000000e+0	1.000000e+0	7.456953e+1	1.341030e-2	1	1.341030e-2	1.000000e+0	1	1.623027e-2	1.000000e+0	1.000000e+0	6.136395e+1	1.629621e-2	1	147	5.000000e-1	6.802721e-3	unnamed	OSGIN2
MSigDB Oncogenic Signatures	VEGF_A_UP.V1_DN	Genes down-regulated in HUVEC cells (endothelium) by treatment with VEGFA [Gene ID=7422].	2	2.493383e-2	1.000000e+0	1.000000e+0	4.010616e+1	2.493383e-2	1	2.493383e-2	1.000000e+0	2	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_DN	Genes down-regulated in comparison of CD8 T cells at 0 h versus those at 24 h.	1	1.322845e-2	1.000000e+0	1.000000e+0	7.559462e+1	1.322845e-2	1	1.322845e-2	1.000000e+0	76	2.193980e-2	1.000000e+0	5.513818e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_DN	Genes down-regulated in comparison of CD8 T cells at 0 h versus those at 24 h after stimulation with antigen-B7-1.	2	1.348943e-2	1.000000e+0	1.000000e+0	7.413209e+1	1.348943e-2	1	1.348943e-2	1.000000e+0	76	2.193980e-2	1.000000e+0	5.513818e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_DN	Genes down-regulated in comparison of CD8 T cells at 0 h versus those at 24 h after stimulation with IL12 .	3	1.364545e-2	1.000000e+0	1.000000e+0	7.328448e+1	1.364545e-2	1	1.364545e-2	1.000000e+0	76	2.193980e-2	1.000000e+0	5.513818e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_DN	Genes down-regulated in comparison of B cells from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	4	1.428072e-2	1.000000e+0	1.000000e+0	7.002449e+1	1.428072e-2	1	1.428072e-2	1.000000e+0	38	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_DN	Genes down-regulated in comparison of CD8 T cells at 0 h versus those at 72 h.	5	1.439686e-2	1.000000e+0	1.000000e+0	6.945959e+1	1.439686e-2	1	1.439686e-2	1.000000e+0	64	2.172051e-2	1.000000e+0	6.482215e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE17721_12H_VS_24H_POLYIC_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 12 h versus those stimulated at 24 h.	6	1.465652e-2	1.000000e+0	1.000000e+0	6.822903e+1	1.465652e-2	1	1.465652e-2	1.000000e+0	33	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_UP	Genes up-regulated in comparison of NK cells treated with IL15 [GeneID=3567] versus untreated NK cells.	7	1.470532e-2	1.000000e+0	1.000000e+0	6.800258e+1	1.470532e-2	1	1.470532e-2	1.000000e+0	2	1.126776e-4	2.152142e-1	1.076071e-1	9.396354e+1	2.128485e-2	2	192	1.000000e+0	1.041667e-2	unnamed	NBN,OSGIN2
MSigDB Immunologic Signatures	GSE5960_TH1_VS_ANERGIC_TH1_UP	Genes up-regulated in comparison of anergy induced CD4 [GeneID=920] T cells versus conventional CD4 [GeneID=920] T cells.	8	1.472860e-2	1.000000e+0	1.000000e+0	6.789513e+1	1.472860e-2	1	1.472860e-2	1.000000e+0	69	2.183015e-2	1.000000e+0	6.042839e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN	Genes down-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] versus macrophages cultured with M-CSF [GeneID=1435], IFNG [GeneID=3458] and Pam3Cyc.	9	1.475984e-2	1.000000e+0	1.000000e+0	6.775143e+1	1.475984e-2	1	1.475984e-2	1.000000e+0	13	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_DN	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 18 h versus cDCs infected with Newcastle disease virus (NDV) at 18 h.	10	1.482446e-2	1.000000e+0	1.000000e+0	6.745610e+1	1.482446e-2	1	1.482446e-2	1.000000e+0	9	1.930669e-2	1.000000e+0	1.000000e+0	5.154571e+1	1.940025e-2	1	175	5.000000e-1	5.714286e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN	Genes down-regulated in comparison of CD8 T cells at 0 h versus those at 72 h after stimulation with antigen-B7-1.	11	1.508606e-2	1.000000e+0	1.000000e+0	6.628636e+1	1.508606e-2	1	1.508606e-2	1.000000e+0	81	2.204943e-2	1.000000e+0	5.199310e-1	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_DN	Genes down-regulated in comparison of CD8 T cells at 0 h versus those at 72 h after treatment with trichostatin A (TSA) [PubChem=5562].	12	1.520805e-2	1.000000e+0	1.000000e+0	6.575466e+1	1.520805e-2	1	1.520805e-2	1.000000e+0	69	2.183015e-2	1.000000e+0	6.042839e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE14308_TH2_VS_INDUCED_TREG_DN	Genes down-regulated in comparison of Th2 cells versus induced regulatory T cell (Treg).	13	1.523982e-2	1.000000e+0	1.000000e+0	6.561755e+1	1.523982e-2	1	1.523982e-2	1.000000e+0	17	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE27786_LIN_NEG_VS_NKTCELL_UP	Genes up-regulated in comparison of lineage negative versus NKT cells.	14	1.525366e-2	1.000000e+0	1.000000e+0	6.555804e+1	1.525366e-2	1	1.525366e-2	1.000000e+0	29	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE14769_40MIN_VS_360MIN_LPS_BMDM_UP	Genes up-regulated in comparison of macrophage cells stimulated with LPS (TLR4 agonist) for 40 min versus macrophage cells stimulated with LPS (TLR4 agonist) for 360 min.	15	1.583242e-2	1.000000e+0	1.000000e+0	6.316153e+1	1.583242e-2	1	1.583242e-2	1.000000e+0	64	2.172051e-2	1.000000e+0	6.482215e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN	Genes down-regulated in comparison of B cells from influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	16	1.588255e-2	1.000000e+0	1.000000e+0	6.296219e+1	1.588255e-2	1	1.588255e-2	1.000000e+0	25	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 24 h versus the untreated cells at 24 h.	17	1.600241e-2	1.000000e+0	1.000000e+0	6.249059e+1	1.600241e-2	1	1.600241e-2	1.000000e+0	6	1.831837e-2	1.000000e+0	1.000000e+0	5.434036e+1	1.840253e-2	1	166	5.000000e-1	6.024096e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_DN	Genes down-regulated in comparison of CD8 T cells at 0 h versus those at 72 h after stimulation with IL12.	18	1.611774e-2	1.000000e+0	1.000000e+0	6.204344e+1	1.611774e-2	1	1.611774e-2	1.000000e+0	76	2.193980e-2	1.000000e+0	5.513818e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_CPG_2H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 2 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 2 h.	19	1.627822e-2	1.000000e+0	1.000000e+0	6.143178e+1	1.627822e-2	1	1.627822e-2	1.000000e+0	69	2.183015e-2	1.000000e+0	6.042839e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 18 h.	20	1.664334e-2	1.000000e+0	1.000000e+0	6.008408e+1	1.664334e-2	1	1.664334e-2	1.000000e+0	5	1.820853e-2	1.000000e+0	1.000000e+0	5.466970e+1	1.829167e-2	1	165	5.000000e-1	6.060606e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE14000_UNSTIM_VS_4H_LPS_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) before and 4 h after LPS (TLR4 agonist) stimulation.	21	1.668957e-2	1.000000e+0	1.000000e+0	5.991765e+1	1.668957e-2	1	1.668957e-2	1.000000e+0	22	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE2706_R848_VS_LPS_2H_STIM_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with R848 at 2 h versus DCs stimulated with LPS (TLR4 agonist) for 2 h.	22	1.673982e-2	1.000000e+0	1.000000e+0	5.973780e+1	1.673982e-2	1	1.673982e-2	1.000000e+0	3	1.688991e-2	1.000000e+0	1.000000e+0	5.895752e+1	1.696137e-2	1	153	5.000000e-1	6.535948e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_DN	Genes down-regulated in comparison of naive follicular B cells versus early germinal center (GC) B cells.	23	1.712504e-2	1.000000e+0	1.000000e+0	5.839402e+1	1.712504e-2	1	1.712504e-2	1.000000e+0	54	2.150119e-2	1.000000e+0	7.605051e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC stimulated with YF17D vaccine.	24	1.730318e-2	1.000000e+0	1.000000e+0	5.779284e+1	1.730318e-2	1	1.730318e-2	1.000000e+0	76	2.193980e-2	1.000000e+0	5.513818e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN	Genes down-regulated in comparison of microglia cells 1 h after stimulation with IFNG [GeneID=3458] versus microglia cells 6 h after the stimulation.	25	1.744963e-2	1.000000e+0	1.000000e+0	5.730780e+1	1.744963e-2	1	1.744963e-2	1.000000e+0	69	2.183015e-2	1.000000e+0	6.042839e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN	Genes down-regulated in comparison of control microglia cells versus those 6 h after stimulation with IFNG [GeneID=3458].	26	1.749438e-2	1.000000e+0	1.000000e+0	5.716122e+1	1.749438e-2	1	1.749438e-2	1.000000e+0	81	2.204943e-2	1.000000e+0	5.199310e-1	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_UP	Genes up-regulated in comparison of dendritic cells (DC) exposed to L. major versus DCs exposed to 50 worms/well B. malayi.	27	1.754132e-2	1.000000e+0	1.000000e+0	5.700827e+1	1.754132e-2	1	1.754132e-2	1.000000e+0	54	2.150119e-2	1.000000e+0	7.605051e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_UP	Genes up-regulated in comparsion of ActTreg versus ActTregTGF (see Fig. 1 in the paper for details).	28	1.755644e-2	1.000000e+0	1.000000e+0	5.695917e+1	1.755644e-2	1	1.755644e-2	1.000000e+0	41	2.128185e-2	1.000000e+0	9.914228e-1	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE13493_DP_VS_CD8POS_THYMOCYTE_DN	Genes down-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus CD8 thymocytes.	29	1.788744e-2	1.000000e+0	1.000000e+0	5.590516e+1	1.788744e-2	1	1.788744e-2	1.000000e+0	49	2.139152e-2	1.000000e+0	8.338327e-1	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 12 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 12 h.	30	1.795528e-2	1.000000e+0	1.000000e+0	5.569392e+1	1.795528e-2	1	1.795528e-2	1.000000e+0	49	2.139152e-2	1.000000e+0	8.338327e-1	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 24 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 24 h.	31	1.798834e-2	1.000000e+0	1.000000e+0	5.559155e+1	1.798834e-2	1	1.798834e-2	1.000000e+0	41	2.128185e-2	1.000000e+0	9.914228e-1	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) exposed to 5 worms/well B. malayi versus DC exposed to M. tuberculosis	32	1.807076e-2	1.000000e+0	1.000000e+0	5.533803e+1	1.807076e-2	1	1.807076e-2	1.000000e+0	81	2.204943e-2	1.000000e+0	5.199310e-1	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_DN	Genes down-regulated in comparison of contols neutrophils versus those infected with a bacterium (F. nucleatum).	33	1.807544e-2	1.000000e+0	1.000000e+0	5.532368e+1	1.807544e-2	1	1.807544e-2	1.000000e+0	54	2.150119e-2	1.000000e+0	7.605051e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_DN	Genes down-regulated in comparison of polysome bound (translated) mRNA before and 16 h after LPS (TLR4 agonist) stimulation.	34	1.813831e-2	1.000000e+0	1.000000e+0	5.513193e+1	1.813831e-2	1	1.813831e-2	1.000000e+0	15	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE3982_NEUTROPHIL_VS_BASOPHIL_DN	Genes down-regulated in comparison of neutrophils versus basophils.	35	1.822224e-2	1.000000e+0	9.944137e-1	5.487799e+1	1.822224e-2	1	1.822224e-2	1.000000e+0	21	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 8 h versus those stimulated with Gardiquimod (TLR7 agonist) at 8 h.	36	1.832169e-2	1.000000e+0	9.720674e-1	5.458011e+1	1.832169e-2	1	1.832169e-2	1.000000e+0	54	2.150119e-2	1.000000e+0	7.605051e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE27786_LSK_VS_NKTCELL_UP	Genes up-regulated in comparison of LSK versus NKT cells.	37	1.839024e-2	1.000000e+0	9.493340e-1	5.437667e+1	1.839024e-2	1	1.839024e-2	1.000000e+0	49	2.139152e-2	1.000000e+0	8.338327e-1	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP	Genes up-regulated in comparison of intrathymic T progenitor cells (ITTP) versus naive CD4 [GeneID=920] T cells from adult blood.	38	1.848083e-2	1.000000e+0	9.289049e-1	5.411012e+1	1.848083e-2	1	1.848083e-2	1.000000e+0	64	2.172051e-2	1.000000e+0	6.482215e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE20715_0H_VS_6H_OZONE_LUNG_DN	Genes down-regulated in comparison of lung tissue from wild type mice subjected to ozone for 0 h versus that from wild type mice subjected to ozone for 6 h.	39	1.854444e-2	1.000000e+0	9.082021e-1	5.392452e+1	1.854444e-2	1	1.854444e-2	1.000000e+0	41	2.128185e-2	1.000000e+0	9.914228e-1	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 48 h versus neutrophils stimulated with LPS (TLR4 agonist) at 1 h.	40	1.855328e-2	1.000000e+0	8.859191e-1	5.389882e+1	1.855328e-2	1	1.855328e-2	1.000000e+0	38	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 0.5 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 0.5 h.	41	1.862210e-2	1.000000e+0	8.675173e-1	5.369962e+1	1.862210e-2	1	1.862210e-2	1.000000e+0	49	2.139152e-2	1.000000e+0	8.338327e-1	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN	Genes down-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist).	42	1.862794e-2	1.000000e+0	8.471277e-1	5.368279e+1	1.862794e-2	1	1.862794e-2	1.000000e+0	7	1.908711e-2	1.000000e+0	1.000000e+0	5.214162e+1	1.917854e-2	1	173	5.000000e-1	5.780347e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 6 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 6 h.	43	1.863532e-2	1.000000e+0	8.277549e-1	5.366155e+1	1.863532e-2	1	1.863532e-2	1.000000e+0	60	2.161085e-2	1.000000e+0	6.879454e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_DN	Genes down-regulated in comparison of untreated CD8+ dendritic cells (DC) at 4 h versus those treated with IFNG [GeneID=3458] at 4 h.	44	1.917767e-2	1.000000e+0	8.324852e-1	5.214399e+1	1.917767e-2	1	1.917767e-2	1.000000e+0	69	2.183015e-2	1.000000e+0	6.042839e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 0 h versus PBMC cultured for 12 h with YF17D vaccine.	45	1.926059e-2	1.000000e+0	8.175050e-1	5.191950e+1	1.926059e-2	1	1.926059e-2	1.000000e+0	86	2.237830e-2	1.000000e+0	4.970064e-1	4.443596e+1	2.250430e-2	1	203	5.000000e-1	4.926108e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP	Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 1.5 h versus those at 72 h.	46	1.926846e-2	1.000000e+0	8.000600e-1	5.189828e+1	1.926846e-2	1	1.926846e-2	1.000000e+0	11	1.996530e-2	1.000000e+0	1.000000e+0	4.983702e+1	2.006541e-2	1	181	5.000000e-1	5.524862e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE3982_DC_VS_BASOPHIL_DN	Genes down-regulated in comparison of dendritic cells (DC) versus basophils.	47	1.930143e-2	1.000000e+0	7.843773e-1	5.180964e+1	1.930143e-2	1	1.930143e-2	1.000000e+0	89	2.358369e-2	1.000000e+0	5.061219e-1	4.215187e+1	2.372374e-2	1	214	5.000000e-1	4.672897e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE2826_WT_VS_BTK_KO_BCELL_DN	Genes down-regulated in comparison of primary splenic B cells from wild type mice versus those from BTK [GeneID=695] knockout mice.	48	1.935789e-2	1.000000e+0	7.702827e-1	5.165853e+1	1.935789e-2	1	1.935789e-2	1.000000e+0	69	2.183015e-2	1.000000e+0	6.042839e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_UP	Genes up-regulated in comparison of CD8 T cells with progressing HIV infection versus those with controlled HIV infection.	49	1.942969e-2	1.000000e+0	7.573614e-1	5.146761e+1	1.942969e-2	1	1.942969e-2	1.000000e+0	25	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_DN	Genes down-regulated in comparison of naive T cells versus peripheral blood mononuclear cells (PBMC).	50	1.950983e-2	1.000000e+0	7.452755e-1	5.125620e+1	1.950983e-2	1	1.950983e-2	1.000000e+0	41	2.128185e-2	1.000000e+0	9.914228e-1	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_UP	Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with vehicle (control).	51	1.971112e-2	1.000000e+0	7.382008e-1	5.073277e+1	1.971112e-2	1	1.971112e-2	1.000000e+0	10	1.952626e-2	1.000000e+0	1.000000e+0	5.096328e+1	1.962197e-2	1	177	5.000000e-1	5.649718e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE2706_R848_VS_LPS_8H_STIM_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with R848 at 8 h versus DCs stimulated with LPS (TLR4 agonist) for 8 h.	52	1.979924e-2	1.000000e+0	7.272413e-1	5.050698e+1	1.979924e-2	1	1.979924e-2	1.000000e+0	7	1.908711e-2	1.000000e+0	1.000000e+0	5.214162e+1	1.917854e-2	1	173	5.000000e-1	5.780347e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP	Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 2 h versus those at 72 h.	53	1.983622e-2	1.000000e+0	7.148525e-1	5.041282e+1	1.983622e-2	1	1.983622e-2	1.000000e+0	20	2.040425e-2	1.000000e+0	1.000000e+0	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_UP	Genes up-regulated in comparson of lung tissue from wild type mice subjected to ozone for 6 h vs that from TLR4 [GeneID=7099] deficient animal subjected to ozone for 6 h.	54	1.984273e-2	1.000000e+0	7.018447e-1	5.039630e+1	1.984273e-2	1	1.984273e-2	1.000000e+0	84	2.215906e-2	1.000000e+0	5.038548e-1	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_UP	Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 2 h versus the untreated cells at 2 h.	55	1.985440e-2	1.000000e+0	6.894892e-1	5.036667e+1	1.985440e-2	1	1.985440e-2	1.000000e+0	4	1.809867e-2	1.000000e+0	1.000000e+0	5.500305e+1	1.818081e-2	1	164	5.000000e-1	6.097561e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP	Genes up-regulated in comparison of basophils versus central memory CD4 [GeneID=920] T cells.	56	1.988410e-2	1.000000e+0	6.781898e-1	5.029143e+1	1.988410e-2	1	1.988410e-2	1.000000e+0	87	2.248791e-2	1.000000e+0	4.937001e-1	4.421814e+1	2.261515e-2	1	204	5.000000e-1	4.901961e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE3982_CTRL_VS_LPS_4H_MAC_DN	Genes down-regulated in comparison of untreated macrophages versus macrophages treated with LPS (TLR4 agonist) at 4 h.	57	1.996297e-2	1.000000e+0	6.689346e-1	5.009274e+1	1.996297e-2	1	1.996297e-2	1.000000e+0	41	2.128185e-2	1.000000e+0	9.914228e-1	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE3982_BASOPHIL_VS_NKCELL_UP	Genes up-regulated in comparison of basophils versus NK cells.	58	2.006982e-2	1.000000e+0	6.609199e-1	4.982605e+1	2.006982e-2	1	2.006982e-2	1.000000e+0	88	2.347414e-2	1.000000e+0	5.094955e-1	4.234977e+1	2.361288e-2	1	213	5.000000e-1	4.694836e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_UP	Genes up-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus monocytes treated with control IgG.	59	2.008849e-2	1.000000e+0	6.503223e-1	4.977976e+1	2.008849e-2	1	2.008849e-2	1.000000e+0	11	1.996530e-2	1.000000e+0	1.000000e+0	4.983702e+1	2.006541e-2	1	181	5.000000e-1	5.524862e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_DN	Genes down-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated with 1 ng/ml LPS (TLR4 agonist).	60	2.009729e-2	1.000000e+0	6.397637e-1	4.975795e+1	2.009729e-2	1	2.009729e-2	1.000000e+0	15	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 1 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 1 h.	61	2.010344e-2	1.000000e+0	6.294684e-1	4.974272e+1	2.010344e-2	1	2.010344e-2	1.000000e+0	64	2.172051e-2	1.000000e+0	6.482215e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_PAM3CSK4_1H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 1 h versus those stimulated with Pam3Csk4 (TLR1/2 agonist) at 1 h.	62	2.017131e-2	1.000000e+0	6.214065e-1	4.957535e+1	2.017131e-2	1	2.017131e-2	1.000000e+0	33	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 0 h  versus PBMC cultured for 3 h with YF17D vaccine.	63	2.018845e-2	1.000000e+0	6.120625e-1	4.953326e+1	2.018845e-2	1	2.018845e-2	1.000000e+0	41	2.128185e-2	1.000000e+0	9.914228e-1	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE16755_CTRL_VS_IFNA_TREATED_MAC_DN	Genes down-regulated in comparison of control macrophages versus macrophages treated with interferon alpha.	64	2.023911e-2	1.000000e+0	6.040109e-1	4.940928e+1	2.023911e-2	1	2.023911e-2	1.000000e+0	1	1.045905e-4	1.997679e-1	1.997679e-1	9.751892e+1	2.050884e-2	2	185	1.000000e+0	1.081081e-2	unnamed	NBN,OSGIN2
MSigDB Immunologic Signatures	GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_DN	Genes down-regulated in comparison of untreated macrophages at 4 h versus those treated with LPS (TLR4 agonist) at 1 h.	65	2.026143e-2	1.000000e+0	5.953743e-1	4.935485e+1	2.026143e-2	1	2.026143e-2	1.000000e+0	41	2.128185e-2	1.000000e+0	9.914228e-1	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE17721_4_VS_24H_CPG_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 4 h versus those stimulated with CpG DNA (TLR9 agonist) at 24 h.	66	2.039166e-2	1.000000e+0	5.901223e-1	4.903967e+1	2.039166e-2	1	2.039166e-2	1.000000e+0	41	2.128185e-2	1.000000e+0	9.914228e-1	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE3982_MAST_CELL_VS_BASOPHIL_DN	Genes down-regulated in comparison of mast cells versus basophils.	67	2.072041e-2	1.000000e+0	5.906863e-1	4.826160e+1	2.072041e-2	1	2.072041e-2	1.000000e+0	23	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 2 h versus those stimulated with Gardiquimod (TLR7 agonist) at 2 h.	68	2.074955e-2	1.000000e+0	5.828182e-1	4.819381e+1	2.074955e-2	1	2.074955e-2	1.000000e+0	33	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 3 h versus PBMC cultured for 3 h with YF17D vaccine.	69	2.092132e-2	1.000000e+0	5.791264e-1	4.779813e+1	2.092132e-2	1	2.092132e-2	1.000000e+0	54	2.150119e-2	1.000000e+0	7.605051e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_DN	Genes down-regulated in comparison of unstimulated dendritic cells (DC) at 0 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 8 h.	70	2.096742e-2	1.000000e+0	5.721110e-1	4.769303e+1	2.096742e-2	1	2.096742e-2	1.000000e+0	17	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_UP	Genes up-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to 50 worm/well B. malayi.	71	2.100145e-2	1.000000e+0	5.649686e-1	4.761576e+1	2.100145e-2	1	2.100145e-2	1.000000e+0	60	2.161085e-2	1.000000e+0	6.879454e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_UP	Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with control IgG.	72	2.100856e-2	1.000000e+0	5.573104e-1	4.759964e+1	2.100856e-2	1	2.100856e-2	1.000000e+0	13	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE3982_BASOPHIL_VS_TH2_UP	Genes up-regulated in comparison of basophils versus Th2 cells.	73	2.112025e-2	1.000000e+0	5.525983e-1	4.734792e+1	2.112025e-2	1	2.112025e-2	1.000000e+0	25	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_DN	Genes down-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated with 5000 ng/ml LPS (TLR4 agonist).	74	2.114013e-2	1.000000e+0	5.456439e-1	4.730339e+1	2.114013e-2	1	2.114013e-2	1.000000e+0	17	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP	Genes up-regulated in comparison of monocytes cultured for 1 day versus those cultured for 7 days.	75	2.135447e-2	1.000000e+0	5.438272e-1	4.682861e+1	2.135447e-2	1	2.135447e-2	1.000000e+0	33	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_UP	Genes up-regulated in comparison of monocytes from LAIV influenza vaccinee at day 7 post-vaccination vesus those from TIV influenza vaccinee at day 7.	76	2.147497e-2	1.000000e+0	5.396999e-1	4.656585e+1	2.147497e-2	1	2.147497e-2	1.000000e+0	23	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_UP	Genes up-regulated in comparison of mast cells versus central memory CD4 [GeneID=920] T cells.	77	2.151452e-2	1.000000e+0	5.336719e-1	4.648024e+1	2.151452e-2	1	2.151452e-2	1.000000e+0	69	2.183015e-2	1.000000e+0	6.042839e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN	Genes down-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus thymic stromal cells.	78	2.172671e-2	1.000000e+0	5.320258e-1	4.602630e+1	2.172671e-2	1	2.172671e-2	1.000000e+0	29	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_DN	Genes down-regulated in comparison of ex vivo CD8 dendritic cells versus cultured CD8 DCs.	79	2.224700e-2	1.000000e+0	5.378705e-1	4.494989e+1	2.224700e-2	1	2.224700e-2	1.000000e+0	64	2.172051e-2	1.000000e+0	6.482215e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_UP	Genes up-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to 5 worm/well B. malayi.	80	2.258192e-2	1.000000e+0	5.391433e-1	4.428322e+1	2.258192e-2	1	2.258192e-2	1.000000e+0	54	2.150119e-2	1.000000e+0	7.605051e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with Gardiquimod (TLR7 agonist) at 0.5 h versus those stimulated with Gardiquimod (TLR7 agonist) at 8 h.	81	2.282006e-2	1.000000e+0	5.381026e-1	4.382110e+1	2.282006e-2	1	2.282006e-2	1.000000e+0	29	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_DN	Genes down-regulated in comparison of memory CD8 T cells treated with IL4 [GeneID=3565] and IL7 [GeneID=3574] versus naive CD8 T cells treated with IL4 [GeneID=3565] and IL7 [GeneID=3574].	82	2.299173e-2	1.000000e+0	5.355391e-1	4.349390e+1	2.299173e-2	1	2.299173e-2	1.000000e+0	33	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE3982_BCELL_VS_BASOPHIL_DN	Genes down-regulated in comparison of B cells versus basophils.	83	2.307656e-2	1.000000e+0	5.310389e-1	4.333402e+1	2.307656e-2	1	2.307656e-2	1.000000e+0	85	2.226868e-2	1.000000e+0	5.003903e-1	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_UP	Genes up-regulated in comparison of intrathymic T progenitor cells (ITTP) versus CD4 [GeneID=920] CD8 thymocytes.	84	2.334868e-2	1.000000e+0	5.309045e-1	4.282898e+1	2.334868e-2	1	2.334868e-2	1.000000e+0	25	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 1 h versus those stimulated with Gardiquimod (TLR7 agonist) at 1 h.	85	2.350048e-2	1.000000e+0	5.280696e-1	4.255232e+1	2.350048e-2	1	2.350048e-2	1.000000e+0	60	2.161085e-2	1.000000e+0	6.879454e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	NBN
MSigDB Immunologic Signatures	GSE3982_BASOPHIL_VS_TH1_UP	Genes up-regulated in comparison of basophils versus Th1 cells.	86	2.354289e-2	1.000000e+0	5.228712e-1	4.247568e+1	2.354289e-2	1	2.354289e-2	1.000000e+0	90	2.369323e-2	1.000000e+0	5.028230e-1	4.195581e+1	2.383460e-2	1	215	5.000000e-1	4.651163e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_DN	Genes down-regulated in comparison of unstimulated macrophage cells versus macrophage cells stimulated with LPS (TLR4 agonist) for 80 min.	87	2.358633e-2	1.000000e+0	5.178148e-1	4.239745e+1	2.358633e-2	1	2.358633e-2	1.000000e+0	29	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_DN	Genes down-regulated in comparison of unstimulated macrophage cells versus macrophage cells stimulated with LPS (TLR4 agonist) for 40 min.	88	2.410066e-2	1.000000e+0	5.230939e-1	4.149264e+1	2.410066e-2	1	2.410066e-2	1.000000e+0	49	2.139152e-2	1.000000e+0	8.338327e-1	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_PAM3CSK4_2H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 2 h versus those stimulated with Pam3Csk4 (TLR1/2 agonist) at 2 h.	89	2.546058e-2	1.000000e+0	5.464012e-1	3.927640e+1	2.546058e-2	1	2.546058e-2	1.000000e+0	60	2.161085e-2	1.000000e+0	6.879454e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	OSGIN2
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 2 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 2 h.	90	2.561556e-2	1.000000e+0	5.436191e-1	3.903877e+1	2.561556e-2	1	2.561556e-2	1.000000e+0	38	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	OSGIN2
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
